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Parkinson's disease is characterized by the loss of dopamine neurons of the substantia nigra pars 
compacta (SNc) resulting in the loss of dopamine innervation into the striatum. Dopamine is 
involved in modulating N-methyl-D-aspartate (NMDA) receptor activity in the striatum and 
consequently NMDA receptor function is influenced by the pathophysiology of Parkinson's disease. 
Parkinson's disease is more frequently observed in older rather than younger patients. During 
development and aging, synaptic NMDA receptor function is altered through decreases in receptor 
expression and alterations of receptor subunit composition in the synaptic membrane. These 
changes in tum alter NMDA mediated calcium (Ca2+) currents. Ca2+ ionic fluxes enable the 
receptors to playa critical role in the regulation of synaptic function. Following loss of striatal 
dopamine, NMDA receptor function has been reported to be upregulated by increased protein 
phosphorylation and through changes in subunit composition. Two hypotheses were tested in the 
current study. The first study tested the hypothesis that NMDA receptor mediated influx of 
radioactive calcium45 (45Ca2+) into striatal sections will be significantly reduced with increasing age 
in male Long Evans rats (16 weeks old) compared to younger male adolescent rats (7 week old rats). 
In the second study, we tested the hypothesis that NMDA receptor upregulation following dopamine 
depletion in the striatum will result in increases of NMDA stimulated influx of 45Ca2+ into striatal 
sections. 
Using the method developed for measuring 4SCa2+ uptake into rat cortical sections by Lehohla et a/ 
(2000), preliminary assays were conducted on n=14 rats to determine whether incubation of striatal 
sections (350 ~m) in buffer containing NMDA (100 IJM) for 2 mins was effective in stimulating 
measurable increases in 4SCa2+ accumulation into the striatal sections and to determine the 
reproducibility of the assay. Striatal sections incubated in buffer without NMDA served as controls. 
Results from the preliminary experiments showed that the effect of NMDA (100 IJM) on 4SCa2+ 
uptake was calculated by subtracting the basal uptake of the control sections from total uptake of the 
stimulated sections. 45Ca2+ accumulation was expressed as nanomoles 4SCa2+ per milligram protein 
(nmol 4SCa2+ I mg protein). There was a significant increase in total 45Ca2+ accumulation into striata 
incubated with NMDA relative to the basal 45Ca2+ uptake of non-stimulated sections. 
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To test our first hypothesis, NMDA stimulated 4SCa2+ uptake into dorsal and ventral striatal sections 
from 7 week old adolescent male Long Evans rats (n=7) and 16 week old adult Long Evans rats (n=6) 
was measured. NMDA stimulated 4SCa2+ uptake into anterior (6.73 ± 0.81 nmoI 4sCa2+ 1 mg protein) 
and posterior (4.35 ± 0.61 nmol 4SCa2+ 1 mg protein) dorsal striata of the left hemisphere of 7 week 
old rats was significantly greater than NMDA stimulated 4SCa2+ uptake into anterior (2.07 ± 0.86 nmol 
4SCa2+ 1 mg protein) and posterior (1.49 ± 0.62 nmol 4SCa2+ 1 mg protein) dorsal striata of the same 
hemisphere in 16 week old rats (ANOVA, p<0.05). Similarly in the right hemisphere, NMDA 
stimulated 4SCa2+ uptake into anterior (5.30 ± 0.86 nmol 4SCa2+ 1 mg protein) and posterior (5.73 ± 
0.72 nmol 4SCa2+ 1 mg protein) dorsal striata of 7 week old rats was also significantly greater than 
NMDA stimulated 4SCa2+ uptake into anterior (2.86 ± 0.57 nmol 4SCa2+ 1 mg protein) and posterior 
(2.14 ± 0.46 nmol4sCa2+ 1 mg protein) dorsal striata of 16 week old rats. NMDA stimulated 45Ca2+ 
uptake into dorsal striata of 7 week old rats were 2 - 3 fold greater than that of 16 week old rats. In 
the ventral striata, NMDA stimulated 4SCa2+ uptake was significantly greater in the posterior striata 
(7.34 ± 1.43 nmol 4SCa2+ 1 mg protein) of the left hemisphere of 7 week old rats than (2.55 ± 0.66 
nmol4sCa2+ 1 mg protein) 16 week old rats (ANOVA, p<0.05). However, there were no significant 
differences in the right posterior ventral striata or the anterior ventral striata of either hemisphere. 
To test whether dopamine loss altered NMDA stimulated 4SCa2+ accumulation into rat striatal 
sections, an established unilateral 6-hydroxydopamine (6-0HDA) rat model of Parkinson's disease 
was used to induce degeneration of the nigrostriatal pathway. 6-0HDA (13.5 I-Ig/4.5 1-11 containing 
0.02% ascorbic acid in sterile saline) was infused into the medial forebrain bundle (MFB) of the 
nigrostriatal pathway (co-ordinates: lateral relative to the midline, 1.6 mm; anterior posterior relative 
to the interauralline, 4.70 mm and dorso-ventral from dura, 8.4mm -Paxinos and Watson, 1986) of 
the left hemisphere of Long Evans rats. Sham operated rats were infused with only saline and were 
used as a control. In developing the surgical technique, cresyl violet histological representation of 
the infusion needle targeting the MFB target site were obtained. Behavioural testing using 
apomorphine (0.5 mg/kg, s.c.) induced rotations were conducted to assess the extent of lesion two 
weeks post surgery. Greater than 100 contralateral rotations in response to apomorphine were 
taken as an indication of a successful lesion. Rats were selected for NMDA stimulated 4SCa2+ 
uptake assay on the basis of this criterion. Immunocytochemistry for tyrosine hydroxylase (TH) in 
coronal sections of the rat brain and brain stem was conducted 5 weeks post surgery and 3 weeks 
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post behavioural testing on n=4 rats to obtain visual confirmation of the extent of degeneration of 
dopamine producing neurons within the midbrain and the extent of dopamine loss in the striatum. 
Near complete loss of TH within the left lesioned hemisphere was observed in rats conducting >100 
contralateral rotations and confirmed a loss of dopamine neurons in the midbrain and axon terminals 
in the striatum in response to 6-0HDA infusion into the MFB. 
45Ca2+ uptake assays were conducted on striatal sections of parkinsonian rats 5 weeks post surgery 
and 3 weeks following behavioural testing. NMDA stimulated 4SCa2+ uptake into the anterior dorsal 
striatal sections (3.49 ± 0.57 nmol 45Ca2+ I mg protein) of the right unlesioned hemisphere of sham 
operated rats (n=9) was not significan~y different from NMDA stimulated 45Ca2+ uptake into the same 
anterior dorsal striatum (3.90 ± 0.80 nmol 45Ca2+ I mg protein) of 6-0HDA lesioned rats (n=10). 
NMDA stimulated uptake into posterior dorsal striata of the same unlesioned right hemisphere was 
4.20 ± 0.93 nmol 45Ca2+ I mg protein and 4.51 ± 0.89 nmol 45Ca2+ I mg protein in the sham operated 
and 6-0HDA lesioned rats respectively. In the lesioned left hemisphere, NMDA stimulated 45Ca2+ 
uptake into the anterior dorsal striatum of the sham operated rats (3.54 ± 0.66 nmol 45Ca2+ I mg 
protein) showed no significant difference from 45Ca2+ uptake into anterior dorsal striata of 6-0HDA 
lesioned rats (3.83 ± 0.64 nmol 45Ca2+ I mg protein). NMDA stimulated 45Ca2+ uptake into striata 
obtained from parkinsonian rats was not significanfiy different from NMDA stimulated 4SCa2+ uptake 
into striata obtained from sham operated rats. 
In the current study, we were able to demonstrate that 100 IJM NMDA stimulated significant uptake 
of radioactive Ca2+ ions into striatal tissue to provide a measure of striatal NMDA receptor function. 
To our knowledge this is the first study to measure NMDA mediated Ca2+ influx into the striatum in 
vitro. Furthermore, using 7 week and 16 week old male rats, we were able to demonstrate that 
NMDA receptor mediated 45Ca2+ influx in the dorsal striatum decreases two to three fold over nine 
weeks of young adult development The results of NMDA stimulated 45Ca2+ uptake following 
dopamine depletion did not confirm our hypothesis that NMDA upregulation in parkinsonian rats 
would result in increased NMDA receptor meditated Ca2+ influx into striatal sections. The data 
obtained from parkinsonian rats may indicate that upregulation of NMDA receptors as a function of 
increased phosphorylation following dopamine depletion may serve a different function that does not 




1.1 The significance of NMDA receptors 
Parkinson's disease is an age related disease in which symptoms of tremor, akinesia and 
bradykinesia are attributed to disruption of processing within basal ganglia circuitry following the 
selective degeneration of dopamine producing neurons of the substantia nigra pars compacta (SNc) 
which causes a loss of dopamine striatal innervation (Marsden and Obeso, 1994; Olanow and Tattan, 
1999; Saper, 1999). The role of N-methyl-D-aspartate (NMDA) receptors has gained prominence in 
Parkinson's disease research as the structure and function of these receptors is altered following 
dopamine depletion. in parkinsonian animal models. Dopamine plays a critical role in modulating 
cortical glutamatergic excitation of the striatal medium spiny neurons through the interaction of 
dopamine activated intracellular signaling cascades with NMDA mediated intracellular Signaling 
cascades (Reynolds and Wickens, 2002). The effects of dopamine depletion on medium spiny 
neurons are multiple; increased neuronal firing, altered dendritic spine morphology and altered 
synaptic NMDA receptor expression (Kish at ai, 1999; Arbuthnott et ai, 2000; Tseng at al, 2001; 
Reynolds and Wickens, 2002; Yasumoto et ai, 2002; Dunah at ai, 2003). 
Calcium (Ca2+) activated intracellular signals mediated by NMDA receptors playa vital role in 
regulating dendritic spine morphology and synaptic receptor expression hence Ca2+ is prominently 
involved in synaptic function and developmental and activity dependent modifications attributed to 
synaptic plasticity (Arbuthnott et ai, 2000; Allen, 2004; Cavazzini at ai, 2005). The efficiency of the 
NMDA receptors is regulated through phosphorylation (Conti and Weinberg, 1999). Not surprisingly 
then that in addition to the synaptic changes that occur, the phosphorylation state of NMDA receptor 
subunits has been found to be greatly altered following dopamine depletion (Oh et ai, 1998; Dunah 
et ai, 2000) and it has been suggested that NMDA receptor function is upregulated (Chase et ai, 
1998). In the clinical treatment of Parkinson's disease, attenuation of NMDA receptor activity is a 
strategy developed using NMDA antagonists as adjuncts to dopamine replacement therapy, L-DOPA 
(Montastruc et ai, 1997). In animal models of Parkinson's disease, NMDA antagoniSts are reported 
to have similar anti-parkinsonian effects as dopamine receptor agonists (Nash and Brotchie, 2002). 
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The prominent involvement of NMDA receptors in synaptic function and their involvement in 
Parkinson's disease has resulted in extensive study of these receptor channels and has motivated 
the development of the current study to investigate the effects of age and dopamine depletion (two 
influential factors involved in Parkinson's disease) on NMDA receptor function. 
In this chapter, the structure and regulation of NMDA receptors and their regulation of synaptic 
function through Ca2+ mediated mechanisms is discussed. An extensive discussion on the 
mechanisms involved in the interaction between NMDA mediated and dopamine mediated 
intracellular Signaling cascades during striatal neural proceSSing follows in Chapter 2. In Chapter 3 
striatal processing and significance in the basal ganglia circuitry is examined. 
1.2 NMDA receptors and glutamate neulOtransmission 
NMDA receptors are a subtype of ionotropic glutamate receptors expressed in the vertebrate central 
nervous system (CNS) (Nakanishi. 1992). Glutamate is the major excitatory neurotransmitter in the 
CNS and the highest density of glutamate receptors in the basal ganglia is found in the medium 
spiny projection neurons of the striatum (Schmidt and Kretschmer, 1997). The striatum receives 
extensive glutamatergic projections originating from the associative, limbic and motor cortices and 
the thalamic nuclei (Parent 1990; Smith and Bolam, 1990; Haber et ai, 2000; Yelnik, 2002). These 
excitatory afferents form synaptic contacts with dendritic spines of striatal projection neurons upon 
which NMDA receptors are localized (Blackstone and Sheng. 1999; van Rossum and Hanisch, 1999). 
Other ionotropic glutamate receptors expressed on dendritic spines are the a-amino-3-hYdroxY-5-
methyl-4-isoxazole propionic acid (AMPA) receptors and kainate receptors (Nakanishi, 1992). The 
ligand gated lonotropic glutamate receptors gate influxes of cations - potassium (K+), sodium (Na+) 
or Ca2+ ions into the striatal spiny neurons through an integral cation specific receptor channel to 
generate current flow (Girault et ai, 1986; Johnson and Ascher, 1987; Nakanishi, 1992; Hille. 2001). 
In addition to stimulating ionotropic receptors, glutamate activates metabotropic glutamate receptors 
(mGluRs) and these also increase intracellular ionic levels by activating the release of Ca2+ from 
intracellular stores (Nakanishi. 1994; Blackstone and Sheng. 1999; Awad et ai, 2000). mGluRs 
potentiate NMDA mediated signaling by elevating intracellular Ca2+ levels (Blackstone and Sheng, 
1999; Awad et aI, 2000). Relative to the other ionotropic receptors, NMDA receptors have the 
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greatest affinity to glutamate, generate prolonged excitatory transmission upon activation (Figure 1.1) 
and have a very high Ca2+ ion permeability (higher than K+ and Na+) (MacDermott et aI, 1986; 
Johnson and Ascher, 1987; Forsythe and Westbrook, 1988; Nakanishi, 1992; Burnashev et aI, 1996; 
Gatz et aI, 1997; Conti and Weinberg, 1999). While activation of a single AMPA receptor channel 
opening permits an influx of == 10 - 100 Ca2+ ions, a single opening of NMDA receptor channel 
conducts == 1000 Ca2+ ions (Conti and Weinberg, 1999). 
The high permeability to Ca2+ ions enable NMDA receptors to playa critical role in synaptic function 
(Nakanishi, 1992; Mori and Mishina, 1995; Blackstone and Sheng, 1999). Ca2+ is the currency of 
NMDA mediated signal transduction pathways involved in the regulation and modification of synaptic 
efficiency. Through regulated spatiotemporal patterns, Ca2+ activated signaling cascades influence 
synapse formation, dendritic spine morphology, gene tranScription, glutamate receptor expression on 
synaptic membranes, ion channel regulation, neuronal excitability and consequently the firing 
response of striatal spiny neurons to glutamate stimulation (Bourne and Nicoll, 1993; Mori and 
Mishina, 1995; Wickens and Wilson, 1998; Carroll and Zukin, 2002; Cohen-Cory, 2002; Reynolds 
and Wickens, 2002; Saimi and Kung, 2002; Sheng and Kim, 2002). In this way NMDA receptors 
regulate synaptic strengthening and weakening. 
1.3 Structure of NMDA receptors and receptor activation 
NMDA receptor channels at postsynaptic sites are generally expressed as diheteromeric complexes 
comprised of two NR1 receptor subunits co-assembled with two NR2 subunits to form an NR1INR2 
complex (Mori and Mishina, 1995; Cull-Candy et aI, 2001). NR3 subunits are also expressed in 
specific brain regions and these co-assemble with existing NR1/NR2 NMDA receptor complexes to 
influence NMDA receptor channel conductance and Ca2+ permeability (Cull-Candy et aI, 2001; 
Matsuda et aI, 2003). There are eight splice variants of NR1 subunits, and these confer specific 
functional characteristics to seemingly similar heteromeric channels e.g. NR1-1bINR2B NMDA 
receptors have higher deactivation time constants than NR1-1a/NR2B NMDA receptors (Mori and 
Mishina, 1995; Cull-Candy et aI, 2001; Pauly et aI, 2005). Of the NR2 subunits, there are four 
identified subtypes; NR2A, NR2B NR2C and NR2D (Mori and Mishina, 1995). NR1 subunits 
generally bind with a specific NR2 subunit e.g. NR1/NR2A or NR1/NR2B, however the receptor 
channels can also be expressed as triheteromers comprised of two different NR2 subunits e.g. 
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NR1/NR2A-NR2B (Kennedy, 1997; Luo at ai, 1997; van Zundert at ai, 2004). The NR2 subunits 
confer the high glutamate affinity of the receptors but differ in ligand sensitivities, kinetic properties 
and in their interactions with intracellular proteins thereby confer differential synaptic responses to 
glutamate activation (Mon and Mishina, 1995; Cull-Candy at ai, 2001; aian and Johnson, 2002). 
Each NR2 subtype confers different ligand binding affinities for both glutamate and glycine to the 
NMDA receptors (measured as the efficient concentration for half maximal response, EC50) but it is 
the NR1 subunits that influence glycine modulation of receptor function (Nakanishi, 1992; Mon and 
Mishina, 1995). Glycine is amongst one of numerous modulators that have binding sites on the 
NMDA receptors as illustrated in Figure 1.2 (Mori and Mishina, 1995; Conti and Weinberg, 1999; 
Shulman and Hyman, 1999; Cull-Candy at ai, 2001). NR1/NR2A NMDA receptors have the lowest 
affinity for ligand binding with EC50 measurements of 1.7 IJM for glutamate and 2.1 IJM for glYCine. 
NR1/NR2B NMDA receptors have a relatively greater affinity of 0.8 IJM for glutamate and 0.3 iJM for 
glYCine while the NR1/NR2C NMDA receptors have a similar affinity (0.7 IJM for glutamate and 0.2 
IJM for glycine). NR1/NR2D NMDA receptors have the greatest ligand binding affinity with 0.4 IJM 
and 0.9 IJM for glutamate and glycine respectively (Moo and Mishina, 1995). Maximal activation of 
NMDA receptor channels depends on glutamate binding to the receptors and simultaneous co-
activation by endogenous glycine (Johnson and Ascher, 1987; Mori and Mishina, 1995; aian and 
Johnson, 2002). Glycine functions as an allosteric modulator of Signal transduction by NMDA 
receptors (Wroblewski at ai, 1989) and potentiates NMDA receptor mediated Ca2+ currents (Wang at 
ai, 1996; Berger at ai, 1998). However, D-serine has been established to be a more potent 
endogenous ligand, occupying the glycine site (Berger at ai, 1998; Mothet at ai, 2000). Binding of 
ligands to the receptors induces a conformational change that alters the shape of the extracellular 
channel opening (aian and Johnson, 2002). 
Each NMDA subunit is composed of four hydrophobic transmembrane segments, TM1 to TMIV that 
span the lipid bilayer with the exception of TMII that does not transgress the entire bilayer (Nakanishi, 
1992; Mon and Mishina, 1995; Conti and Weinberg, 1999). The subunits have an extracellular N-
terminal domain and an intracellular C-terminal domain extending from TM1 and TMIV respectively; 
NR2 subunits have longer C-termini than NR1 subunits (Conti and Weinberg, 1999). The selectivity 
of the channel pore to cations is conferred by an anionic ring formed by asparagine amino acid 
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residues of the TMII segments through their inward orientation forming a channel pore (Burnashev et 
ai, 1992; Nakanishi, 1992; Loftis and Janowsky, 2003). Configuration of the asparagine residues is 
the main structural determinant of Ca2+ permeability and magnesium (Mg2+) sensitivity through the 
receptor channel (Bumashev et ai, 1992). 
Amongst the glutamate receptors, NMDA receptors are unique in that they are both ligand and 
voltage gated (Mon and Mishina, 1995). The unique voltage gating of NMDA receptors is conferred 
by the Mg2+ block of channels that persists at hyperpolarised potentials (Nowak et ai, 1984). When 
agonist binds to the receptors during membrane depolarization which relieves the Mg2+ block, Ca2+ 
ions are admitted through the receptor channels, as a result NMDA receptors respond to 
simultaneous glutamate postsynaptic stimulation and membrane depolarization (Hille, 2001). In the 
absence of ligand binding and due to the Mg2+ block, NMDA receptor channels have low open 
probability (Po) at rest (Nowak et ai, 1984; Rosenmund et ai, 1995). Channel open probability is an 
indicator of NMDA mediated Ca2+ currents (Erreger et ai, 2005). The NMDA NR1 subunits have the 
greatest influence on Ca2+ permeability and Mg2+ blockade (Nakanishi, 1992). Despite asparagine 
residues being located on the TMII segments of both NR1 and NR2 subunits, mutations of NR2 
asparagine residues do not affect Ca2+ permeability instead they reduce Mg2+ sensitivity. On the 
other hand, NR1 asparagine mutations decrease Ca2+ permeability and only slightly affect Mg2+ 
sensitivity (Bumashev et ai, 1992). 
1.4 Developmental influences on subunit expression 
Development has a major effect on the differential expression of the subunits. In the embryonic and 
neo-natal rat brain, NR2D and NR2B NMDA receptor subtypes are highly expressed but within post-
natal week two, NR2D expression is drastically reduced and NR2B expression becomes restricted in 
the forebrain while NR2A expression increases throughout the brain (Mori and Mishina, 1995). 
Altering NMDA receptor subtype composition changes the kinetics of the NMDA receptor channels 
hence the ionic Ca2+conductances. NR1/NR2D channels are open for a relatively long period; these 
channels have decay time constants of :: 5000 ms (Mon and Mishina, 1995). The time constant for 
both NR11NR2B and NR1/NR2C NMDA channels is :: 400 ms while NR1/NR2A NMDA channels 
have the fastest gating constant of:: 120 ms (Mori and Mishina, 1995). The kinetics of the different 
NMDA receptor channels function to regulate different signaling mechanisms mediated by Ca2+ I.e. 
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rapid increases activate mechanisms that are not activated by slower ionic increases hence subunit 
composition may confer temporal activation of signaling mechanisms (Cull-Candy et ai, 2001; 
Erreger et ai, 2005). The high glutamate affinity and slow gating kinetics of NR2D containing 
receptors may account for their high levels of expression during pre-natal development when 
neurons are developing to increase the efficiency of glutamate usage during early development. 
Within the developed CNS, NR1 subunits are expressed indiscriminately throughout the brain, but 
the expression of the NR2 subtypes exhibits more regional specialization (Nakanishi, 1992; Mori and 
Mishina, 1995; Erreger et ai, 2005). In the striatum, spiny projection neurons predominantly express 
NR1/NR2A and NR1/NR2B NMDA receptor complexes (Chen and Reiner, 1996; Gotz et ai, 1997; 
Loftis et ai, 2003). These NMDA receptor complexes are both expressed in the cerebral cortex and 
hippocampus, but have differential expression in the cerebellar granule cells where NR2A subtypes 
are most highly expressed and in the thalamus and olfactory bulb where NR2B subtypes are highly 
expressed (Monyer et ai, 1992; Gotz et ai, 1997). NR2C subtype expression is restricted to the 
cerebellum while NR2D generally have a low expression in the developed adult brain (Monyer et ai, 
1992; Nakanishi, 1992; Mori and Mishina, 1995). Expression of NR2D mRNA in adult rat brain 
tissue has been observed on striatal somatostatin intemeurons along with NR2A and NR2B 
subtypes (Chen and Reiner, 1996). 
1.5 Dendritic localization of NMDA receptors and development of spines 
NMDA mediated intracellular Ca2+ signalling mechanisms are localized at dendritic spines where the 
receptors are themselves organised (Blackstone and Sheng. 1999). On the dendritic spines. NMDA 
receptors are localized within a prominent protein lattice known as the postsynaptic density (PSD) 
and are associated with scaffolding proteins, kinases, phosphatases and signalling molecules 
(Kennedy. 1997; Scannevin and Huganir, 2000; Cull-Candy et ai, 2001; Lin et ai, 2004). PSD is 
direcHy opposite to the presynaptic terminal (Eccles, 1964; Blackstone and Sheng, 1999). The close 
proximity of signalling molecules, kinases and phosphatases to NMDA receptors within dendritic 
spines ensures precise Signalling as the correct enzymes are organised with specific proteins; 
protein kinases and phosphatases either bind direcUy to the receptor channels or are anchored to 
the cytoskeleton by scaffolding proteins (Pawson and Scott, 1997). There are multiple kinases and 
phosphatases involved in regulating NMDA receptor function and NMDA receptors contain 
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multiple consensus sites for phosphorylation by several different kinases (Blank et aI, 1997). 
Phosphorylation is a structural modification to ion channels mediated by protein kinases involving 
addition of charged phosphate ion molecule from adenosine trisphosphate (ATP) (Smart, 1997) and 
at PSD, NMDA receptor function is regulated through its phosphorylation state by the activ~y of 
kinases and phosphatases co-localized with NMDA receptors (Lin et aI, 2004). Phosphorylation is a 
reversible process regulated by protein phosphatases. 
In early development, neurons are initially without spines and these develop as dendritic protusions 
in response to innervation by incoming fibres to create synaptic contacts. Activation of NMDA 
receptors on dendrites induces transient and moderate increases in Ca2+ ions resulting in rapid 
elongation of dendritic filopodia and the formation of novel spines (Jontes and Smith, 2000; Segal et 
ai, 2000). Dendritic filopodia dynamically extend outwards from dendritic shaft to interact with the 
approaching axon growth cone in response to depolarizing synaptic activation (Jontes and Smith, 
2000; Segal et aI, 2000; Cohen-Cory, 2002). Blocking NMDA receptors inhibits dendritic growth 
(Cohen-Cory, 2002). An excess of synaptic contacts is initially made to provide a diverse pool of 
synapses for pruning selection of potential patterns of connectivity to establish pathways and for 
stabilization of dendritic spines (Jontes and Smith, 2000). Synaptic pruning is important for this 
process but can be blocked by NMDA antagonists (Segal et aI, 2000). 
1.6 NMDA receptors and regulation of dendritic spine morphology and architecture 
In addition to aiding the formation of dendritic spines NMDA receptors are necessary in the 
regulation of spine morphology and architecture. The framework of dendritic spines is comprised of 
cytoskeletal proteins, filamentous actin (F-actin) microfilaments and microtubules to which NMDA 
receptors are indirectly linked through binding to micro filament crosslinking structural proteins, 
namely a-actinin, spectrin (fodrin), and microtubule associated protein 2 (MAP2) as illustrated in 
Figure 1.3 (Kennedy, 1997; Blackstone and Sheng, 1999; van Rossum and Hanisch, 1999; Kasai et 
ai, 2003). In Parkinson's disease and during aging morphological alterations occur and dendritic 
spine density is significantly reduced resulting in reduction of excitatory synapses (Ingham et aI, 
1998; Meshul et aI, 1999; Arbuthnott et aI, 2000). Binding of the crosslinking structural proteins to 
NMDA receptors stabilizes the actin cytoskeleton (van Rossum and Hanisch, 1999; Jontes and 
Smith, 2000; Kasai et aI, 2003). Non-NMDA receptors do not influence dendritic morphology as they 
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are not directly associated with microfilament cross-linking proteins (van Rossum and Hanisch, 
1999). 
The morphology of dendritic spines is dynamic and is influenced by intracellular Ca2+ (Blackstone 
and Sheng, 1999; Kasai et aI, 2003; Carlisle and Kennedy, 2005). Large increases of NMDA 
receptor mediated Ca2+ ions can cause shrinkage of spines (Segal et aI, 2000). Indeed, Korkotian 
and Segal (2001) demonstrated that dendritic spines may undergo rapid actin dependent contraction 
described as a 'twitch', lasting up to 2s before the spine regains its original shape. 'Twitches' occur 
in response to Ca2+ transients (Korkotian and Segal, 2001). Spines are remodeled through 
disassembly of existing stable actin filament networks followed by re-assembly and stabilization, 
specifically the shape of the dendritic head can be altered within seconds in response to synaptic 
activity (Carlisle and Kennedy, 2005). The geometry of dendritic spines strongly influences the 
distribution of receptor binding sites and the impact of excitatory neurotransmission (Clements, 
1996). Small heads on spines present a small synaptic area and weak glutamate sensitivity as they 
accommodate a small number of glutamate receptor binding sites; transformation into large spines 
facilitates an increased number of synaptic receptors (Kasai et aI, 2003). 
NMDA receptor binding to structural proteins is modulated by Ca2+ ions. a-actin in binds with NMDA 
receptors at the C terminal of NR2B subunits at the CO region of the NR 1 C terminal when 
intracellular Ca2+ levels are low (Ehlers et aI, 1996; Blackstone and Sheng, 1999; van Rossum and 
Hanisch; Samai and Kung, 2004). Ca2+ binding to a-actinin causes a reduction in the binding affinity 
of the CO region for a-actin in resulting in its dissociation from NR 1 (Krupp et aI, 1999). Dissociation 
of structural proteins from NR 1 causes depolymerization of dendritic cytoskeletal microfilaments and 
alters the architecture and geometry of dendritic spines (van Rossum and Hanisch, 1999). The 
dissociation of a-actin in from NR1 is also induced by binding of calmodulin (CaM) to CO. NMDA 
mediated Ca2+ influx activates calcium sensing and calcium binding proteins; in particular CaM 
(Saimi and Kung, 2002). CaM exists in a soluble form in the cytoplasm and nucleus but has binding 
sites at synaptic membrane structures (Saimi and Kung, 2002). When bound with Ca2+, a Ca2+-
CaM complex forms and CaM is able to bind to its target proteins at the PSD such as NR1 subunits 
(Saimi and Kung, 2002). a-actinin and Ca2+-CaM bind competitively on NR1 (Ehlers et aI, 1996; 
Blackstone and Sheng, 1999; Krupp et aI, 1999; Samai and Kung, 2004). Ca2+-CaM displaces a-
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actinin binding on NR1 thereby induces depolymerization (van Rossum and Hanisch, 1999). Ca2+-
CaM binding to NR1 CO region also influences the NMDA receptor open probability; this is 
discussed in Chapter 2 (Krupp et aI, 1999). 
NMDA mediated Ca2+ influx influences both the depolymerization of cytoskeletal proteins and also 
increases the stability of dendritic cytoskeleton. Partial dissolution of the cytoskeletal framework 
through a-actinin dissociation from NMDA subunits is followed by increased tubulin concentration 
and polymerization of tubulin molecules mediated by MAP2 dephosphorylation (van Rossum and 
Hanisch, 1999). MAP2 stabilizes dendritic microtubules (Blackstone and Sheng, 1999). Following 
NMDA mediated Ca2+ influx, Ca2+ activation of calcineurin phosphatase dephosphorylates MAP2 to 
enable it to bind microtubules. Phosphorylation of MAP2 reduces its affinity for structural 
microtubules thereby reducing the stability of the dendritic cytoskeleton; calcineurin 
dephosphorylation increases binding of microtubules and increases dendritic stability (van Rossum 
and Hanisch, 1999). In addition to binding of microtubules, there is an increase in synaptic 
glutamate receptor expression that occurs following initial spectrin induced depolymerization (van 
Rossum and Hanisch, 1999). 
1.7 Membrane associated guanylate kinases (MAGUKsJ 
At the PSD, NMDA receptors are bound to membrane associated guanylate kinases (MAGUKs). 
MAGUKs stabilize the receptors at the synapse, regulate synaptic distribution of the receptors and 
influence the gating properties of the receptors hence intracellular Ca2+ concentrations that occur in 
response to glutamate neurotransmission (Carroll and Zukin, 2002; Dunah et aI, 2004; Lin et aI, 
2003; van Zundert et aI, 2004; Ying Lin, 2004). The MAGUKs most prominently associated with 
NMDA receptors are synapse associated protein 102 (SAP-102) (which binds to a 102 amino acid 
residue long recognition motin and postsynaptic density 95 (PSD-95) (also named SAP-90) 
(Kennedy, 1997). SAP-102 expression increases gradually from birth and is reduced in adulthood, 
whereas PSD-95 shows significant increased expression from postnatal weeks 2 and 3 to adulthood 
(van Zundert et aI, 2004). The binding of NMDA receptors to either PSD-95 or SAP-102 is subject to 
developmental shift and preferential binding to specific NR2 subunits (Tovar and Westbrook, 2002; 
Loftis et aI, 2003; van Zundert et aI, 2004). In immature neonatal hippocampal neurons, SAP-102 is 
most highly expressed and preferentially binds NR2B containing NMDA receptors at the 
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postsynaptic membrane; PSD-95 subsequenUy increases binding of NR2A containing NMDA 
subunits (Loftis et ai, 2003; van Zundert et ai, 2004). This follows the developmental pattern of NR2 
subunit expression wtth NR2B subunits expressed early in development and NR2A expression 
subsequently increasing (Mon and Mishina, 1995). PSD-95 binds to C-terminal domain of NMDA 
receptors at the PSD-95 Drosophila discs large (Dig) zona occludens-1 (ZO-1) protein (PDZ) 
recognition motif (named after the first three proteins found to contain the recognition site) on NR1 
and NR2 subunits to stabilize NMDA receptors at the postsynaptic membrane and reduce the rate of 
NR2 mediated NMDA receptor internalization (Krupp et ai, 1998; Scannevin and Huganir, 2000; 
Carroll and Zukin, 2002; Un et ai, 2003; Un et ai, 2004). Deletion of PDZ motif disrupts PSD-95 
binding and NMDA receptor localization at the synaptic site (Scan nevin and Huganir. 2000; Un et aI. 
2003; Un at a/. 2004). 
1.8 NMDA receptortrans/ocation and trafficking 
Receptor translocation from the synaptic site is a key feature of devebpil'1g synapses. Increasing 
expression of PSD-95 causes translocation of SAP-102 binding NR2B NMDA receptors to the 
extrasynaptic site (van Zundert et al, 2004). At developing cerebellar granule neurons and 
developing hippocampal synapses. NMDA receptors are not fixed but undergo exchange between 
synaptic and extrasynaptic pools (Rumbaugh and Vicini, 1999; Tovar and Westbrook, 2002). The 
high glutamate affinity for NR1INR2B receptors suggests greater efficiency when activated at the 
extrasynaptic region during glutamate spillover thereby, allowing more efficient usage of glutamate 
neurotransmission. NR2B binds glutamate 30 times longer than NR2A hence have longer open 
times permitting greater Ca2+ influx (Erreger et ai, 2005). 
Translateral displacement of receptors to the extrasynaptic site also serves to target thern for 
internalization, particularly at immature synapses (Carroll and Zukin. 2002). Phosphorylation of 
serine and tyrosine residues of the NR1 and NR2 subuntts regulates internalization. 
Phosphorylation of NR1 serine residues by PKC disrupts their binding to PSD-95 resulting in 
translocation (Carroll and Zukin, 2002). At the extrasynpatic site, tyrOSine phosphorylation of NR2 
regulates the ability of the endocytic adaptor protein (APZ) to recognize the internalisation motif 
(YELK) expressed by the NR2 subunits (Carroll and Zukin, 2002). Internalisation of receptors 
23 
reduces synaptic NMDA mediated Ca2+ influx thereby reduces activation of Ca2+ mediated signaling 
influencing synaptic efficacy (Carroll and Zukin, 2002). 
1.9 Kinases and phosphatases and NMDA receptor regulation 
Apart from preferential localization of NR2A containing receptors at the synapse, organization of 
PSD-95 at the central synaptic site mediates the interaction of NMDA receptor with kinases and 
phosphatases that regulate the phosphorylation state of NMDA receptors (Blackstone and Sheng, 
1999). Dopamine mediated intracellular signals playa significant role in activating some protein 
kinases that regulate NMDA receptor activity and Ca2+ currents. That role is compromised in 
Parkinson's disease. 
cAMP dependent protein kinase (PKA) and Ca2+/phospholipid dependent protein kinase (PKC) 
Dopamine activated protein kinases are directly associated with NMDA receptors and these 
modulate NMDA receptor function. There are two subtypes of dopamine receptors, 01 subtype and 
02 subtype; each activates differing protein kinases and signal cascades. 01 receptor subtype 
stimulates production of cyclic adenosine monophosphate (cAMP), which activates cAMP dependent 
protein kinase (PKA). 02 receptor subtype activates production of diacylglycerol (DAG) which co-
stimulates the Ca2+/phospholipid dependent protein kinases (PKC) with Ca2+; PKC contains a DAG 
binding site and a Ca2+ binding site (Sim and Scott, 1999). A more extensive discussion of 
dopamine receptors and modulation of NMDA receptors follows in Chapter 2. 
PKA is anchored to the scaffolding proteins, A-kinase anchoring proteins (AKAPs) at the PSD; 
specifically PKA is bound to AKAP79/150 or Yotiao anchoring proteins (Coghlan et aI, 1995; Klauck 
et aI, 1996; Pawson and Scott, 1997; Sim and Scott, 1999; Colledge et aI, 2000). AKAP79/150 is 
recruited to PSD by binding to PSD-95 to bring it in close proximity to NMDA receptors (Colledge et 
aI, 2000). When anchored to AKAP79/150, PKA is inactive and is localized with PKC and 
calcineurin phosphatase (PP-2B); the kinases anchor to AKAP79/150 independently of eachother 
(Coghlan et aI, 1995; Klauck et aI, 1996; Pawson and Scott, 1997; Sim and Scott, 1999; Colledge et 
aI, 2000). Yotiao binds directly to NMDA receptor on the C1 region of NR1 C terminal (Sim and 
Scott, 1999). At Yotiao, PKA co-localizes with the tonically active protein phosphatase 1 (PP-1) (Sim 
and Scott, 1999; Loftis and Janowsky, 2003). Yotiao anchoring of PKA and PP-1 limits NMDA ionic 
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flow by maintaining the dephosphorylation state of the channel (Sim and Scott, 1999). Apart from 
Yotiao anchoring, PP-1 is localised to dendritic spines by neuronal actin binding protein (neurabin) or 
spinophilin both of which are F-actin associated scaffolding proteins (Allen, 2004). 
There is dynamic interplay between the co-localized enzymes and their close localisation 
presumably serves to improve the efficiency of this dynamic interaction. For instance, PKA 
phosphorylation enhances NMDA mediated currents (Colwell and Levine, 1995; Blank et ai, 1997). 
This potentiation is regulated by PP-1 to which PKA is co-localized at Yotiao (Blank at ai, 1997). pp. 
1 in~ibits PKA phosphorylation (Svennigsson at ai, 2004; Hakansson at ai, 2004; Nishi at a/2005). 
PKA activation also induces receptor exocytosis from the endoplasmic reticulum (ER) and trafficking 
of the receptors to the synaptic membrane surface. This function requires PKC co-activation (Carroll 
and Zukin, 2002). NMDA receptor subunits are assembled in the endoplasmic reticulum (ER) to 
form functional channels and are targeted selectively to the postsynaptic membrane where they are 
expressed together with AMPA receptors and dopamine receptors (Carroll and Zukin, 2002; Salter, 
2003). PKA and PKC phosphorylate NR1 serine residues, Ser697 and Ser696 respectively and these 
serine residues flank ER retention motif on NR1 subunit (Tingley at ai, 1997; Scott at ai, 2003; 
Carroll and Zukin, 2002). Co-ordinated phosphorylation triggers ER release of assembled NMDA 
receptors resulting in receptor trafficking to the membrane surface subsequendy increasing Ca2+ 
intracellular levels (Carroll and Zukin, 2002; Scott at aI, 2003). Other proteins are also involved in 
the exocytosis and trafficking of 'new' NMDA receptors include synaptosome associated protein 
receptor (SNARE) and synaptosome associated protein 25 (SNAP) (Carroll and Zukin, 2002). 
PKC has a highly prominent role in NMDA receptor function. In addition, to phosphorylating NR1 
Ser896 to stimulate delivery of NMDA receptors to the cell surface, PKC phosphorylates NR1 Ca2+-
CaM binding region to reduce the subunit affinity to CaM affecting both NMDA receptor kinetics and 
dendritic cytoskeletal stability (Hisatsune at aI, 1997; Tingley at ai, 1997; Smart at ai, 1998; Snyder 
at aI, 1998; Oh at aI, 1998; Krupp at aI, 1999). PKC phosphorylation of the CaM binding site at 
immature synapses disrupts NMDA receptor-PSD-95 binding resulting in translateral displacement 
receptors to the extrasynaptic site where they are targeted for internalisation (Carroll and Zukin, 
2002). PKC activation can enhance NMDA currents by reducing the Mg2+ block through 
phosphorylation of NR2B C terminus serine residues Serl303 and Ser1323 and NR1 C terminus SerB89 
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and Ser800 (Chen et aI, 1992; Blank at aI, 1997; Snyder et aI, 1998; Loftis and Janowsky, 2003). 
Serine phosphorylation of NR2 subunits does not only function to directly modulate receptor channel 
hmction but is also a mechanism for preventing other enzymes binding to the NMDA subunits. PKC 
phosphorylation of NR2A Ser1416 inhibits Ca2+-CaM dependent kinase (CaMKII) binding to the 
subunit (Gardoni at aI, 2001). PKC phosphorylation is regulated by PP-1 (Snyder at aI, 1998). 
Ca2+-CaM dependant kinasa (CaMKI/) 
In response to high levels of intracellular Ca2+, cytoplasmic Ca2+-CaM dependent kinase (CaMKII) 
dissociates from F-actin and Ca2+-CaM binding to CaMKil induces auto phosphorylation of its 
threonine residue, Thr286• Autophosphorylation enables the kinase to remain active until Thr286 
dephosphorylation (Tao-Cheng at aI, 2001; Lisman at aI, 2002). PP-1 regulates most CaMKil 
phosphorylation activity (Allen, 2004) and most importantly PP-1 dephosphorylates CaMKil 
autophosphorylation of threonine residue, Thr286. Protein phosphatase 2A can also dephosphorylate 
Thr286 (Strack et aI, 2000; Allen, 2004; Tao-Cheng at aI, 2005). Dissociation from F-actin results in 
translocation of CaMKil to the synaptic membrane to bring the kinase within close proximity with 
AMPA receptors which it phosphorylates at serine residue SerB31 to potentiate the receptor activity; 
CaMKil potentiation of AMPA receptor activity prolongs neuronal response to excitation and is a key 
factor in long term potentiation (Leonard et aI, 1999; Scan nevin and Huganir, 2000; Lisman at aI, 
2002). 
At the synaptic membrane, CaMKil binds to NR1, NR2A and NR2B (Leonard at aI, 1999; Tao-Cheng 
et aI, 2001). Binding of CaMKil to NR2A is considerably weaker than NR2B binding (Strack et aI, 
2000). CaMKil phosphorylates NR2B at the region of serine residues Ser26()'1309 (Strack et aI, 2000; 
Loftis et aI, 2003). CaMKil itself can regulate its association with NMDA receptors. Phosphorylation 
of NR2B Ser1303 promotes dissociation of the kinase from NR2B (Strack et aI, 2000; Loftis at aI, 
2003). As mentioned earlier, PKC phosphorylation of NR2A also prevents CaMKil forming 
complexes with NR2 subunits. 
In addition to its role in synaptic potentiation, CaMKil plays a significant role in regulating the stability 
of NMDA receptors to MAGUK through its regulation of casein kinase II (CKII) activity. CKII 
phosphorylates NR2B Ser1480 residue at the PDZ recognition motif resulting in disruption of the 
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NMDA receptor from the MAGUKs, PSD-95 and SAP-102 (Chung et aI, 2004). The result is receptor 
intemalisationorlateraltranslocationtoextrasynapticsite.CKIl is tonically active and functions to 
control basal activity of NMDA receptors (Lieberman and Mody, 1999). The phosphorylation of 
Ser1480 is increased after NMDA receptor inactivation, and though the effect of PSD-95/NMDA 
binding has been found to result in increased channel gating, CKII phosphorylation inducing 
dissociation results in increased duration of channel openings (Lieberman and Mody, 1999). The 
role of tonically active CaMKIl in regulating CKII phosphorylation is to regulate the frequency of 
channel opening (Lieberman et aI, 1999; Chung et aI, 2004). 
NMDA receptor activation can induce dephosphorylation of Serl480 (Lieberman and Mody, 1999) as 
NMDA receptor mediated Ca2+ influx activates calcineurin (a.k.a. protein phosphatase 2B, PP-2B). 
Calcineurin dephosphoryjates CKII mediated phosphorylation (Lieberman and Mody, 1999). In 
addition, calcineurin regulates NMDA synaptic responses potentiated by PKA (Lieberman and Mody, 
1999; Krupp et aI, 2002; Rycroft and Gibb, 2004). As a result, the phosphatase diminishes the 
amplitude of NMDA excitatory postsynaptic currents and shortens the duration of receptor channel 
openings (Raman et aI, 1996; Lieberman and Mody, 1994). Calcineurin is inhibited when it is bound 
to AKAP79/150, where it co-localizes with PKA and PKC (Pawson and Scott, 1997). The phosphate 
is only bound when AKAP79/150 is not binding to PSD-95 Le. when the complex is not targeted to 
PSD (Coghlan et aI, 1995; Klauck et aI, 1996; Pawson and Scott, 1997; Colledge et aI, 2000). 
1.10 NMDA receptors and gene expression 
An important function of NMDA receptors in neurons is the regulation of gene expression, which 
plays an important role in synaptic plastiCity. Ca2+ is involved in the activation and regulation of 
transcription (Kornhauser et ai, 2002). Immediate early gene expression i.e. c-fos gene expression 
in striatal medium spiny neurons is activated by phosphorylation of cAMP/Ca2+ response element 
binding protein (CREB) following phosphorylation of extracellular signal regulated protein kinases 
(ERK 1 /2) mediated by co-activation of NMDA receptors and D1 dopamine receptors (Valjent et aI, 
2005; Yang et aI, 2004). ERK phosphorylation requires NMDA mediated Ca2+to induce immediate 
early gene expression (Konradi et aI, 1996). mGluR coactivation with NMDA receptors also 
increases ERK phosphorylation (yang et aI, 2004) as mGluRs mediate increases of intracellular Ca2+ 
levels. CREB phosphorylation leads to the activation of target genes (Komhauser et aI, 2002). 
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CREB phosphorylation occurs at Ser133 residue and requires 01 activation to activate transcription 
(Hardingham at ai, 1998). The role of 01 activation is necessary as 01 activated phosphorylation of 
OARPP-32 indirectly prevents ERK dephosphorylation by striatal enriched tyrosine phosphatase 
(STEP) (Valjent at ai, 2005; Ounah and Standaert, 2001). STEP was first isolated in rat striatum and 
was found to be located at the PSO (Salter and Kalia, 2004). OARPP-32 inhibits protein 
phosphatase 1 (PP-1) which dephosphorylates PKA phosphorylated STEP; phosphorylation of 
STEP prevents ERK dephsphorylation (Valjent at ai, 2005). In synaptic plasticity gene expression is 
a mechanism for inducing long term adaptive modifications (Hardingham at ai, 1998). 
1.11 Summary 
The greatest density of NMOA receptors in the basal ganglia is found in the striatum. Ca2+ influx is 
regulated by the variable subunH composition or NMOA receptors as different subunits have different 
glutamate binding affinHies and kinetics. Subunit composition is innuenced by development and 
activity during which NMOA receptor expression at the synapse is subject to translocation and 
internalization to influence synaptic efficacy. The stability of NMOA receptors at dendritic spines and 
their function is regulated by a number of kinases (PKA, PKC and CaMKII) and phosphatases 
(calcineurin, PP-1) through a series of phosphorylation and dephosphorylation reactions of serine 
and tyrosine residues on the NR1 and NR2 subunits. NMOA mediated Ca2+ strongly influences 
development of dendritic spines and regulation of dendritic spine morphology. The dynamic 
structure of dendritic spines is a useful mechanism for facilitating activity dependent synaptic 
modifications. A long term strategy for inducing synaptic modifications is through gene expression 
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CHAPTER 2 
SfIUATAL .\!EPlUM SPI~Y Nnt.l KONS 
Mecharwsms regulaEmg tne responsroty 01 medium spiny neurons to cortical stimuiabOn, ~re in~ral 
to the IU!lCbOn I)f NMOA r&eeplOrS The interaction between dopall'lne and glutamate activates an 
array of slQnaiing cascades l/lat calISe phosphofylalion (catalyzed by ~irtases) aM 
clephOSphOIyIaIIon (catalyzed by phosphatases) r~actoos \0 occur to mftu8I'1Ce the e~eney r/. 
NMOA recapt~ (Conti arid Welnberg, 1999) DopanIlr.e moduiatlOl1 of neurOl'laI e~citabffity involves 
a:teratiOl'l 01 intnnsic V<I~age gated cooduC\aIICes 10 InnuefU tne firing thresOOld 10 enhance or 
anenuate (he neurQoaI Ii'II"Ig response of neurons 10 glutamate mediated by NMOA receptors 
(Wickens and Wilson, 1998: Un eI ai, 20(3) Consequent!)', the functional stale of the medium spily 
neU/ons is 'profoundly alleeted' by Ihe acW11y of tt.llr dopani1e receptas (Chase and Oh, 2000). 
OOpamirle rrodulates rortico-Slfiatal·lhala1OO-OOlbcal ci'curts aOO innuences neural processong in 
!hese cvcuits through ascending spirals of newonal cormecti'lily \IIaIln'lQ/'Je Ihe midbrain dopa(llf\e 
neurons (Allirl et ai, 1989; Harer eI ai, 20(0) Precursors of cIoparnll\e synblesis l e 3,4 
d'hydrO.l)'llr.enylalanine (l-<lopa) <rid agoni;ts 1)/ dopallll1e recfllltl)lS have ~n sno'M1 10 a~viale 
akinesia and ~idily In me treatment of Parkinson's disease (MorliaslruC iii 81, 1997) 
2 I Dopamine rflCeplfNS 
There arB two families 01 00pa1TW\B receptors - 01 and 02 OOp.afTllflB receplOl'S . 011)'pe receptors 
ro::llJ(Ie Ola and Olb subtypes. The 02 type recepbrs 1nciuc:Ie 02, 03 Md [)4 subtypes (Surmeier 
61 al. 1996) The subsets 01 dopamne receplOfS are based on their allinity to dopal1"lllle agonist 
coupfrng to il!lateUular sgnals (Surmeier el ai, 1996) The dopamine receptors are coupled 10 
gOO1lOS11le trisphosphate (GTp) b..,ding reguiatOl'f ~telf\S (G-proleil"$jthat bIIld to t~ cytoplasmic 
Side of \he ~6sma membrane (H:~e. 2(01) 01 type dopamine reeeplor subtypes are coupled 10 
stimulator; (Go) iIOd ~ G-proIeu~. 02 type OOpiimM receptors <l(e wuplBd to ilhlbtlory (G) 
~Otell1s . This dllferenbal coupling is significant as ~ conlers the exC:tator; and ilhibllory effects of 
dopam~'Je on glutarr..ille transmissIOn. The opposilg roies are clearly demoostrated by the ef!ect of 
dOp<iJlllllQ receptor f\lnclion on firing aclMly 01 medium spiny neurons dunng corbcal stimula:kr1 
When 01 receptors are blocked. the excitability 01 the 5pu1Y neurons it response 10 the cortbll 
" 
stimulation is decrea5ild suggesting a flII::ilrtatory role lor tile 01 receptors [West and Gra:a, 2002) 
Whereas bloc~ il\Q 02 receptors Increases the excrtable responsiveness of tile ne<Jrons, suggestive 
01 an ;'hlbitO!)' role In modulatitlg spel'ly ne.wn response (West and Gta:e, 2002) 
22 Dl medimd signaling 
Upon doparnne snmulaung the receptors. G'proteins are activated and tIley dissociate into their 
OJns\l\1Jel1t subunits, G,-GTP complex arid ~ djrle' that act to signal to elle<;tor mote<;ules e.g 
enzymes and ion channels (Shuman and HVmar1, 1999, Hille, 2001). StlmuiatfOr1 01 01 dopamme 
receptors results In G.,,·GTP complex a:Uvabng aderl)'~1 cyclase \ lAC-II, AG· II or AC-1I1 all of 
which can catalyze cycic adenosrle J', 5' monophosphale (cAMP) production from A TP leadir.g to 
the a:bva~ 01 cAMP depe1doot prot&in kinase (PKA) (Bourne af"lj Nicol, 199J, Storm and WOIlQ, 
1996: Shulman and HVmar1, lW9: Svl!l1nigsson et ai, 20(4). PI<A pllosphorylates NMOA NRI 
subunl1s on the senne resldlll!, Sefi91 (::"yclef ar ai, 1998, FIores.Hemandez el ai, 2002: 
SveOlllgssoo e/ ai, 2004). Kinases phosptaylare ~otetns bV catalYZInQ the Iransief 01 a pllos;tlate 
m;llecule from A TP Ie wgel prot!!ins, This binding is a level$ible re<l:tion with phosphate groups 
being removed by ~o\eln phosphatases through tile process 01 dep/1ospllol'llation (HiDe. 2001 j. 
The ilCtllity 01 PKA it inhiMed by pro:ein phos~halase 1 (PP·I) (SvenmgS$Ol1 el ai, 2004, 
Hakansson et ai, 2004, NIshi el ai, 2005), ConsequenUy, efficieocy of PKA ]>I\ospiloryiabOn is 
large/'; relianl upon tile phospho!ylabon 01 the pp·t inhibitor, dopamine and cAMP - regu lated 
phosphoproteill. Mr 32 kDA (DARPP·32) fI'OIecuie at Its weonire residue. Thr" (ALlen, 2004: 
Hakansson el ai, 2004: Svemlgssoo el ai, 20(4) When phospho Thr)O DARPP..J2 binds Ie PP-I it 
prevl!I1ts pp·t anlagorusm of PKA med iated reactions thereby prevl!l1lS dephospholylalion 01 protein 
residues phosphol'ltated by PI<A (F\ofes-Hemillldel, 2002, Svemgsson til ai, 2004. ~'St'j el ai, 
2005). 01 signals potenllate N~A curroots and these are enhar;;:ed b1 inhibrllon 01 pp·l and are 
signifrr;arm; reduced in DARPp·32 koock·OU1 mice (Btank er ai, 1997; Fbres·Hemillldez el ai, 2002). 
OARPP·32 protein Is prevalent and selectr~yl!ll/'(;hed In all strratal medium s~y n!!llrons (Aizman 
er ai, 2000; Allen, 2004: Svennlgsson er ai, 2004; Nistrj er aI. 2005) ImmulIClIuorescence StudIes 
demonstrate \hal slrFalaillllll'l)f1S expressing N~A recept(lfl; also express DARPP·J2 0/l'ang et ai, 
1004) 
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2.3 02 mediated signaling 
Through 02 mediated signaling, phosphorylation of Thr34 may be reversed. 02 activated GJtti dimer 
co-activates phospholipase C (PLC) to cleave phosphotidylinositol 4,5, bisphosphate (PIP2) to its 
constituents, OAG and inosHol trisphospshate (IP3) (Hille, 2001). IP3 is involved in stimulating the 
release of Ca2+ from the smooth endoplasmic reticulum intracellular stores (Svennigsson et ai, 2004). 
Increased concentrations of intracellular Ca2+ as a consequence of both NMOA stimulation and 
endoplasmic release results in the activation of Ca2+ dependent protein phosphatases, PP-2A and 
PP-2B (calcineurin) (Svennigsson et ai, 2004; Nishi et ai, 2005). Calcineurin dephosphorylates 
phospho Thr34 OARPP-32 (Svennigsson et ai, 2004). The rate of calcineurin dephosphorylation of 
phospho Thr34 OARPP-32 can be decreased by phosphorylation of OARPP-32 serine residues by 
casein kinases (Svennigsson et ai, 2004). 
02 mediated Signaling further opposes 01 signals through the inhibition of cAMP production; 02 
receptor stimulation activates GOi-GTP complex which inhibits AC-1 activity (Svennigsson et ai, 
2004). 02 recruitment of calcineurin and inhibition of AC-1 , regulate 01 mediated phosphorylation of 
L-type Ca2+ channels and NMOA receptor channels resulting in a significant reduction in channel 
activity (Snyder et ai, 1998; Hemandez-Lopez et ai, 2000; Flores-Hemandez et ai, 2002; 
Svennigsson et ai, 2004). Paradoxically, 02 receptors potentiate NMOA receptor function through 
OAG activation. 02 signaling cascades activate the Ca2+/phospholipid dependent kinase (PKC) 
through OAG. 02 activation of PKC by OAG requires co-activation by Ca2+ ions following NMOA 
activation (Bliss and Colling ridge, 1993; Svennigsson et ai, 2004). PKC phosphorylates NMOA NR1 
subunits on the serine residues, Ser689 and SerBOO (Snyder et ai, 1998) and increases the open 
probability of the receptor channel. PP-1 dephosphorylation reactions are not restricted to PKA, 
PKC phosphorylated sites are also dephosphorylation by PP-1 (Snyder et ai, 1998). Consequently, 
PKC also phosphorylates the threonine Thr34 residue on the OARPP-32 (Svennigsson et ai, 2004). 
01 and 02 signals converge 
There is co-operative convergence of 01 and 02 mediated signals. Gos-GTP (01 activated) co-
activates AC-II with GJtti (02 activated) to stimulate cAMP production (Boume and Nicoll, 1993). 
Secondly, the Goq-GTP subunH required for activation of PLC, is the result of 01 dopamine receptor 
activation (Hille, 2001; Svennigsson et ai, 2004). Thirdly, PP-2A, mobilized through 02 stimulation, 
33 
is involved in the dephosphorylation of phospho Thr75 DARPP-32 (Svennigsson et aI, 2004). 
DARPP-32 Thr75 residues are phosphorylated by cyclin dependent kinase (cdk5) to convert DARPP-
32 into an inhibitor of PKA (Svennigsson et ai, 2004; (Nishi et aI, 2005). Dephosphorylation of 
phospho Thr75 DARPP-32 prevents PKA inhibition. Through these intricate signaling mechanisms, 
dopamine modulates neuronal excitability. 
2.4 Dopamine and NMDA signaling 
The activities of PKA and PKC are regulated by the phosphorylation state of DARPP-32 which can 
protect PKA and PKC phosphorylated proteins from dephosphorylation by PP-1. However, DARPP-
32 inhibition of PP-1 is dependent on phosphorylation of its ThrJ4 site and this is regulated to a 
certain extent by NMDA Ca2+-CaM signals. Phosphorylation of Thr34 DARPP-32 requires optimal 
intracellular concentrations of Ca2+ of R::Q.3 ~M and extracellular dopamine concentrations of 5 ~M 
(Kotter, 1994). However, basal concentrations of Ca2+ are <0.1 ~M and dopamine levels are::ll 5-
50 nM (Kotter, 1994), suggesting DARPP-32 Thr34 phosphorylation can only occur when both NMDA 
receptors and dopamine receptors are activated. 
Ca2+-CaM co-activates AC-1 with D1 stimulated Gas-GTP and this leads to cAMP production 
followed by PKA activation (Bourne and Nicoll, 1993; Storm and Wong, 1996; Shulman and Hyman, 
1999). As a result NMDA receptor activation enhances D1 receptor mediated cAMP accumulation 
(Pei et ai, 2004). Tseng and O'Donnell (2004) determined that D1 potentiation of NMDA mediated 
neuronal response was dependent on PKA activation and intracellular Ca2+, but was not dependent 
on membrane depolarization. This determination is contrary to the fact that membrane bound 
adenylyl cyclase molecules are voltage sensitive and undergo conformational change leading to 
cAMP stimulation during membrane depolarization (Storm and Wong, 1996). This implies that PKA 
can only be activated following membrane depolarIZation and indeed, D1 potentiation of neuronal 
firing only occurs at depolarized potentials (Hernandez-Lopez et ai, 1997). 
Dopamine activated PKC is co-activated following NMDA mediated Ca2+ inllux to circumvent Ca2+ 
induced inhibition of NMDA receptors (Krupp et ai, 1999). When NMDA receptors are activated 
during the depolarized 'up' state, Ca2+ influx through the receptor channels increases the intracellular 
levels. Influx of Ca2+ ions through NMDA receptor channels substantially increases the intracellular 
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ionic concentration from <0.1 IJM to == 1 IJM leading to binding to calcium binding proteins such as 
CaM to form Ca2"CaM complex (Kotter, 1994). Increases of the intracellular concentration of Ca2+ 
ions, results in negative feedback mechanism involving Ca2+ induced inhibition to down regulate 
NMDA receptor gating (Xin et ai, 2005) and limit the rise of intracellular levels (Raman et ai, 1996). 
Ca2+ induced inhibition of the NMDA receptor involves Ca2+-CaM binding to the NMDA NR1 subunit 
inducing a fourfold decrease in the open probability of the NMDA receptor channel causing the 
channels to inactivate (Ehlers et ai, 1996; Krupp et ai, 1999). PKC phosphorylates Ser690 and Serfl89 
on the NR1 Ca2+-CaM binding site to prevent NMDA receptor channel inactivation (Smart, 1997; Oh 
et ai, 1998; Snyder et ai, 1998; Krupp et ai, 1999). 
Prior to NMDA receptor activation, a-actinin binds to the NR1 subunit at the CaM binding site, this 
prevents receptor inactivation (Krupp et ai, 1999). However, when the NMDA channel has been 
activated, Ca2+ ions bind to the a-actinin causing it to dissociate from NR1 thereby allowing the 
possibility of Ca2+ induced inactivation of the receptor channel (Krupp et ai, 1999). While NMDA 
mediated Ca2+-CaM signals potentiate dopamine mediated signals, they can also attenuate them 
through the dephosphorylation of Thr34 DARPP-32 by Ca2+ dependent phosphatases. calcineurin 
and to some extent PP-2A (Svennigsson et ai, 2004). Activation of glutamate receptors promotes 
dephosphorylation of DARPP-32 at both threonine residues, Thr34 and Thr75 through calcineurin and 
PP-2A respectively (Nishi et ai, 2005). However, Ca2+-CaM activation does not occur immediately 
upon the entry of Ca2+ ions through NMDA, it is activated 1-5 min following glutamate stimulation of 
the NMDA receptors to regulate Ca2+ influx through the receptor channel (Nishi et ai, 2005) 
suggesting dopamine/glutamate interaction is under temporal regulation. In addition, Ca2+ 
dependent inactivation by CaM is observed in NR2A or NR2D NMDA receptors but not in NR2B and 
NR2C NMDA receptors (Blackstone and Sheng, 1999). Finally, stimUlation of the IP3 receptors and 
ryanodine receptors on the smooth endoplasmic reticulum to induce intracellular Ca2+ release is 
reliant on co-binding of Ca2+-CaM(Samai and Kung, 2004). 
2.5 Electroresponsive properties and neuronal excnability 
Having considered the intracellular mechanisms involved in integration of dopamine and NMDA 
mediated glutamate signals. the question still remains as to how voltage gated ionic conductances 
regulate medium spiny neuronal firing. Electroresponsive properties of medium spiny neurons are 
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influenced by aging and dopamine depletion. During aging medium spiny neurons exhibit lower 
spontaneous firing rates and have higher firing thresholds (Cepeda at ai, 1989). In Parkinson's 
disease there are increases in neuronal firing (Kish et ai, 1999; Tseng at ai, 2001; Wichmann and 
DeLong, 2003). The striatal neuronal firing response is the result of integration of the convergence 
of cortical and nigral neurotransmission with voltage gated ionic conductances that confer the 
intrinsic electroresponsive properties (Stern at ai, 1998). The differential inhibitory and excitatory 
dopamine influences, are dependent on membrane potentials (Reynolds and Wickens, 2002). 
Dopamine reduces cell excitability during neuronal hyperpolarized resting state (Lin et ai, 2003) but 
potentiates firing at depolarized potentials (Hemandez·Lopez at ai, 1997). 
The normal firing activity of medium spiny neurons is characterized by shifts between depolarized 
'up' and hyperpolarized :down' states that are driven by the presence or absence of coordinated 
cortical and thalamic inputs respectively (Nisenbaum and Wilson, 1995; Wickens and Wilson, 1998; 
Chapier at ai, 1999; Mahon at ai, 2003b). There is coherence between these voltage dependent 
states and cortical activity. Striatal membrane potentials are correlated with cortical activity which 
shifts the resting membrane potentials towards less negative potentials during the 'up' state (Chapier 
at ai, 1999; Tseng at ai, 2001; Mahon at ai, 2003a). Decortication blocks the membrane oscillation 
to the 'up' state (Kerr and Plenz, 2002). NMDA receptors are activated during this state (Reynolds 
and Wickens, 2002) and consequently mediate glutamate excitatory impact to induce neuronal firing. 
The functional state of the majority of the spiny neurons (73%) (Sandtrom and Rebec, 2003) is 
described as silant owing to their high resistance to excitability due to hyperpolarized membrane 
potentials (Calabresi at ai, 1990; Wickens and Wilson, 1998; Venance and Glowinski, 2003). 
However, spiny neurons that exhibit spontaneous activity have been described (Wickens and Wilson, 
1998; Venance and Glowinski, 2003). There are no morphological differences between these two 
types of neurons but the membrane potential during the 'up' state is higher in the spontaneously 
active neurons, suggesting a possible difference in K+ conductances (Wickens and Wilson, 1998; 
Venance and Glowinski, 2003). 
The 'up' states are periods of large numbers of correlated, synchronous cortical neurotransmission 
resulting in subthreshold depolarization (·40 to ·55 my) of the membrane potential that facilitates 
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neuronal firing of action potentials (Nisenbaum. 1995; Nisenbaum and Wilson; 1995; Mahon at ai, 
2003). During the 'down' state, intrinsic potassium (K+) ion conductances confer the hyperpolarized 
resting membrane potential (-80 to -95 mV) (Nisenbaum and Wilson. 1995; Chapier et ai, 1999; 
Mahon et ai, 2003b; Wickens and Wilson, 1998; Kerr and Plenz, 2002). Glutamate 
neurotransmission during the down state stimulates AMPA, kainate and mGlu and not the NMDA 
receptors due to the persisting voltage dependent Mg2+ block on NMDA receptors (Reynolds and 
Wickens, 2002). Hyperpolarisation is significant as it is an effective deterrent from uncoordinated 
asynchronous cortical afferents; these are too weak to overcome the high activation threshold of 
hyperpolarisation (Llinas, 1988; Nisenbaum and Wilson, 1995; Chapier at ai, 1999; Mahon at ai, 
2003b; Wickens and Wilson, 1998; Kerr and Plenz, 2002). 
2.6 Excitability and dopamine modulation 
The electroresponsive properties of striatal neurons are mediated by different types of potassium (K+) 
currents (Nisenbaum and Wilson. 1995; Llinas, 1988; Calabresi et ai, 1990; Nisenbaum and Wilson, 
1995). Inwardly rectifying K+ currents (lKir) are responsible for high activation resistance of the spiny 
neurons conferred by the hyperpolarized resting membrane potentials (Nisenbaum and Wilson, 1995; 
Chapier et ai, 1999; Venance and Glowinski, 2003). Dopamine activation of D1 receptors fortifies 
the resistance to uncoordinated excitability by increasing the activity of IKir (Lin et aI, 2003; Venance 
and Glowinski, 2003) and reduces neuronal firing output at hyperpolarized potentials (-82 mV) 
(Hemandez-Lopez et ai, 1997). Partially due to IKir, D1 receptor mediated potentiation of NMDA 
currents is minimal at hyperpolarized potentials (Cepeda at aI, 1998). NMDA receptors are also 
under Mg2+ regulating block during membrane hyperpolarisation and this contributes strongly to 
minimal NMDA mediated currents during the 'down state'. 
The inward K+ currents are deactivated when coordinated excitatory neurotransmission shifts the 
membrane potential towards more positive potentials (Mahon et ai, 2003). Blocking IKir has a similar 
effect as it causes a membrane potential shift from hyperpolarized -85 mV values to depolarized -
67.7 mV potentials (Nisenbaum and Wilson, 1995). Consequently, D1 mediated potentiation of 
NMDA currents and neuronal firing is significantly greater at subthreshold depolarized potentials 
when K+conductances are blocked (Hernandez-Lopez eta/, 1997; Cepeda et ai, 1998). 
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As potentials become less negative, the fast activating, slow inactivating K+ currents (lAs) are 
recruited. The slow inactivation properties of lAs maintain the membrane at subthreshold potentials 
thereby reducing the rate of depolarization to limit the initial response of the neuron to transient 
uncorrelated cortical inputs (Gable and Nisenbaum, 1998; Mahon at aI, 2003). The effect is a 
transitional latency period (ramp potential) before action potential generation during the 'up' state 
(Gable and Nisenbaum, 1998; Mahon st aI, 2003). By reducing the rate of depolarization, lAs hinders 
action potential generation mediated by sodium currents (INa). In most excitable cells, INa currents 
are recruited to further depolarize the membrane towards firing threshold (Llinas, 1988; Kerr and 
Plenz,2002). Na+ channels have rapid inactivation kinetics; consequently, their open probability is 
significantly reduced by slow depolarization (WICkens and Wilson, 1998). Only when depolarizing 
glutamate inputs are sufficient to inactivate lAs channels allowing ramp potential to reach threshold, 
will INa facilitate neuronal discharge to occur; the membrane depolaristaion during the 'up' state does 
not always result in action potential generation (Nisenbaum and Wilson, 1995; Wickens and Wilson, 
1998; Mahon at aI, 2003). 
However, medium spiny neuron spikes are largely dependent on voltage activated Ca2+ 
conductances rather than Na+ ions (LUnas, 1988). As a result blocking Na+ channels is not effective 
in inhibiting neuronal excitability, whereas activation of striatal neurons is blocked by cadmium (Cd2+) 
(a calcium channel blocker) and Mg2+ (an NMDA receptor channels blocker) (Ulnas, 1988). 
Furthermore, stimulation of cortical afferents elicits striatal excitation which is attenuated when 
voltage gated Ca2+currents are blocked with Cd2+ (Calabresi st aI, 1990). Ca2+ ionic conductance 
through L-type channels playa significant role in dopamine modulation of NMDA response to 
glutamate neurotransmission. 
Influx of Ca2+ ions during the 'up' state of the medium spiny neurons is also modulated by PKA 
phosphorylation of L-type Ca2+ voltage gated channels which are only active during depolarization 
(Carter and Sabatini, 2004; Svennigsson st aI, 2004). Il(Ca2+) currents increase the period of 
depolarization and allow NMDA receptors to remain open for longer (Cepeda at a', 1998). 
Dopamine 01 activation mediates PKA potentiation of Il(Ca2+) currents and 01 enhancement of 
NMDA currents is dependent upon this potentiation (Hernandez-Lopez at aI, 1997; Cepeda at aI, 
1998; Shulman and Hyman, 1999; Hille, 2001; Hakansson at ai, 2004; Svennigsson at ai, 2004, 
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Nishi et ai, 2005). Blocking the ll(ca2+) currents reduces 01 mediated enhancement of NMOA 
currents (Cepeda et ai, 1998). PKA activation follows cAMP production after 01 receptor activation 
(Svennigsson et ai, 2004). 
2.7 Summary 
Complexity of dopamine modulatory roles in striatal regulation of corticostriatal innervation is 
attributed to a multiplicity of receptor subtypes stimulated by dopamine and glutamate, in addition to 
the voltage dependent conductances mediated by K+, Na+ and Ca2+ ions. Neural processing with the 
medium spiny neurons is regulated by an array of intracellular Signaling cascades mediated by 
NMOA receptor stimulation and dopamine receptor stimulation. The G-protein coupled dopamine 
receptors stimulate intracellular signaling cascades that interact with excitatory glutamate NMOA 
mediated signals. The phosphorylation state of OARPP-32 plays a critical role in the convergence of 
intracellular cascades and in regulating the phosphorylation state of NMOA receptors to modulate 
their function. NMOA signaling is largely mediated through influx of Ca2+ ions through the receptors. 
Neuronal firing is dependent not on only the interaction of afferents, but on the voltage gated ionic 
conductances that confer the electroresponsive properties of the neurons. Efficient procesSing of all 




THE STRIATUM & THE BASAL GANGUA CIRCUITRY 
Loss of dopamine neurotransmission in the striatum due to degeneration of midbrain nuclei 
characterizes the pathophysiology of Parkinson's disease (Albin at ai, 1989). Dopamine depletion 
has profound effects not just on NMDA receptors in the striatum but also leads to global dysfunction 
of basal ganglia circuitry as demonstrated by increased activity of the subthalamic nucleus {STN} 
and basal ganglia output nuclei leading to motor disorders such as tremor. akinesia and bradykinesia 
in Parkinson's disease (Bergman and Deuschl, 2002; Wichman and DeLong. 2003). Stimulation of 
striatal NMDA receptors can also result in increased basal ganglia inhibitory output (Morari at ai, 
1996). Disruption of the basal ganglia circuitry necessitate discussion into the connectivity of the 
striatum with other basal ganglia nuclei. 
3.1 Anatomy of the Basal Ganglia 
The striatum is one of several subcortical nuclei that form the basal ganglia. The interconnected 
nuclei of the basal ganglia span the telencephalic, diencephalic and mesencephalic regions of the 
brain. The neostriatum (caudate nucleus, putamen and nucleus accumbens) is a telencephalic 
structure, the pallidum (mediaVinternal globus pallidus. lateral/external globus pallid us, ventral 
globus pallid us) and subthalamic nucleus are predominantiy diencephalic structures and the 
mesencephalic nuclei are the SN (pars compacta, SNc, and pars reticulata, SNr) and the ventral 
tegmental area (VTA) (Yelnik, 2002). 
The basal ganglia nuclei function together to integrate sensorimotor, limbic. memory-related and 
conditional cues from the prefrontal cortices (orbital. medial and dorsolateral), the motor cortices 
(primary motor cortex, pre-motor cortex, supplementary motor cortex). the somatosensory cortex. 
the hippocampus. the cingulate cortex, the thalamus, the amygdala, the dorsal raphe nucleus and 
the pedunculopontine nucleus to influence and modulate motivational. cognitive and motor 
behaviours (Albin et ai, 1989; Graybiel, 1990; Parent, 1990; Smith and Bolam, 1990; Smith at ai, 
1998; Devan and White, 1999; Haber et ai, 2000; Gonzalo at al. 2002; Yelnik, 2002). The striatum is 
the major recipient of these afferents particularly the cortical inputs via the corticostriatal pathway. 
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There are segregated basal ganglia-thalamocortical circuits which process motor, cognitive and 
limbic information and are each comprised of the two parallel direct and indirect pathways which 
cause phasic increase or decreases in the activity of the basal ganglia output nuclei. 
3.2 The Striatum 
The striatum is a vast structure commonly divided into the dorsal striatum comprised of the caudate 
nucleus and the putamen, and the ventral striatum comprised mainly of the nucleus accumbens 
(Kiyatkin and Rebec, 1996; Voom st aI, 2004). This division is based on differential cortical and 
nigral afferents to these areas. Sensorimotor and cognitive inputs are arranged in the dorsolateral 
and central dorsal striatum respectively, while the limbic input is located mainly within the 
ventromedial striatum (Haber st aI, 2000). The dorsal striatum has been commonly attributed to 
processing of sensorimotor associative inputs while ventral striatum is associated with processing 
emotional and motivational inputs from limbic cortices, amygdala and hippocampus (Albin st aI, 1989; 
Alexander and Crutcher, 1990; Parent, 1990; Voom et aI, 2004). However, there are no definitive 
boundaries between the dorsal and ventral striata, neither are there any differences in their 
cytoarchitecture or chemoarchttecture (Voom et aI, 2004). Furthermore, both striata contain medium 
spiny neurons with the same electroresponsive properties and the same intracellular processing 
mechanisms (Voom et a', 2004). However, despite the similar cytoarchitecture, the differences of 
cortical afferents may contribute to firing activity. Spontaneously active ventral striatal spiny neurons 
exhibit faster basal firing rates than their dorsal counterparts (Voom st a', 2004). The spiny neurons 
of the ventral striatum also exhibit greater reward related responses than dorsal spiny neurons 
(Schultz, 2002). 
A characteristic feature of the neostriatum is its chemoarchitecture based on acetylcholinesterase 
(AChE) expression that creates a mosaic pattern of striosomal patches amidst the extrastriosomal 
matrix which covers =80010 of the striatum (Graybiel, 1990). The matrix zones have a high 
concentration of AChE while the striosomes have a low concentration (Graybiel, 1990). The 
differential chemistry of the compartments is related to the functional innervation of corticostriatal 
and nigrostriatal inputs and the projections. Matrix neurons receive projections from deep cortical 
layers and in tum project mainly to the pallidum and the SNr while striosomal neurons are stimulated 
by projections from the superficial layer and mainly reciprocate SNc efferents (Graybiel, 1990; 
41 
Ralston, 2000; Packard and Knowlton, 2002). Corticostriatal neurons are mainly located in layer V 
and the layer III; projections from layers II, IV, and VI have also been reported (Cowan and Wilson, 
1994). Dopamine neurotransmission from the VTA and SNc innervate the striosomes and matrix 
respectively (Packard and Knowlton, 2002). Neurons of the matrix mediate cortical processing while 
striosomes process dopaminergic input to the striatum (Graybiel, 1990). Within the matrix and 
striosomes there is preferential expression of ionotropic glutamate receptors. NMDA receptors and 
AMPA receptors are most highly expressed in the matrix whereas kainite is relatively increased in 
the striosomes (Dure at ai, 1992). 
3.3 Corticistriatal and nigrostriatal afferents 
Medium spiny neurons receive convergent afferents from cortical, thalamic and dopaminergic 
nigrostriatal midbrain nuclei (Kocsis at ai, 1977). Medium spiny neurons receiving thalamic inputs 
have lower density of dendritic spines compared to spiny neurons receiving cortical input (Smith and 
Bolam, 1990). The y-aminobutyric acid (GABA) transmitting medium spiny neurons account for 
>95% of the total neuronal population in the striatum (Smith and Bolam, 1990; Smith et a/. 1998; 
Yelnik, 2002; Venance and Glowinski. 2003). The rest of the neuronal population is comprised of 
small GABAergic intemeurons and large aspiny cholinergic intemeurons (Yelnik. 2002). 
Glutamatergic corticostriatal afferents make excitatory asymmetric contact (Gray's Type 1 synapses) 
on the heads of distal dendritic spines of the spiny neurons (Eccles, 1964; Smith and Bolam, 1990). 
Glutamate neurotransmission stimulates ionotropic receptors NMDA and AMPA in addition to 
mGluRs. The properties between the ionotropic receptors differ with respect to their affinity for 
glutamate and their channels kinetics. AMPA receptors have a low affinity for glutamate relative to 
NMDA receptors and also have fast, brief gating properties (Conti and Weinberg. 1999). These 
properties and the high Ca2+ permeability mean that NMDA receptors mediate much of dendritic 
excitation. Dendritic spikes are dependent on Ca2+ conductances (Uinas, 1988). 
Though glutamate neurotransmission is the major source of input into the striatum, 21% of axon 
terminals in the striatum are dopaminergic (Kotter, 1994). The stimulatory glutamatergic effect on 
the spiny neurons is modulated by dopamine neurotransmission from neurons of ' the SNc and the 
VT A. Dopamine influence on the responsiveness of the medium spiny neurons cortical input, 
involves activation of a series of Signal transduction pathways that interact with NMDA mediated 
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signaling pathways to induce changes in the properties of NMDA receptors and voltage gated 
channels to affect the firing activity of the neurons in response to cortical input (Reynolds and 
Wickens, 2002; Venance and Glowinski, 2003) (refer to Chapter 2). 
The tyrosine hydroxylase (THt staining dopamine boutons, predominanUy form symmetric contacts 
but asymmetric synapses also occur (Pickel et ai, 1981; Kotter; 1994). Dopamine terminals 
converge onto the necks of dendritic spines that are also recipients of asymmetric. non-TH 
immunoreactive glutamate contacts (Groves, 1980; Pickel et ai, 1981; Smith and Bolam. 1990). The 
length of the dendritic spine, == 1-2 jJm, means that the synaptic terminals on the head and on the 
neck are within close proximity to create an anatomical relationship through which dopamine may 
modulate the efficacy of glutamate stimulation to influence the neuronal response to cortical input 
(Kotter. 1994). 
3.4 Basal Ganglia processing and the striatum 
Information from the striatum is processed through pallidal and nigral structures and projected back 
to the cortical regions via the thalamus; completing the corticostriatocortical loops (Packard and 
Knowlton, 2002). Brainstem nuclei also receive basal ganglia afferents through which descending 
pathways are influenced (Albin et ai, 1989; Alexander and Crutcher. 1990; Graybiel. 1990; Devan 
and White. 1999; Haber et a/. 2000; Bar-Gad and Bergman, 2001; Gonzalo at a/. 2002; Takakusaki 
et ai, 2003). A model describing basal ganglia proceSSing was developed from the functional 
anatomy of hyperkinetic and hypokinetic movement disorders associated with dysfunction of the 
basal ganglia e.g. ballism (subthalamic nucleus. STN, dysfunction), choreoathetosis. dystonia 
(striatal and pallidum disorder) and Parkinson's disease (Albin at ai, 1989). In the model dopamine 
was proposed to be significant in basal ganglia procesSing as dopamine receptor an~onists or 
agonists were used in the treatment of basal ganglia associated hyperkinetic and hypokinetic 
disorders respectively (Albin et al. 1989). 
The model proposes two segregated pathways, differentially regulated by striatal afferents that 
cause functionally opposite effects on basal ganglia output nuclei leading to the inhibition or 
,. ~ tenninl:is i1 the striatlJn can be identified by ItleIrtyrosine hydroxy1ase il11T1~. TH is thedopa'nlne ~ 
er\Z)'I1l8 responsilE forlhe conversion d DOPA 10 dqmline. 
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disinhibition of the thalamus that feeds back to cortical regions (Figure 3.1) (Albin et ai, 1989). Basal 
ganglia output nuclei comprise the internal globus pallid us (GPi) and the SNr. ThoUgh anatomically 
distinct due to their separation by the fibers of the cerebral peduncles (Albin et ai, 1989), these two 
nuclei are comprised of cytologically similar GABA transmitting neurons that project to the thalamus 
(Smith and Bolam, 1990). Henceforth the output nuclei shall be referred to as GPi/SNr. Distribution 
of peptides and selective expression of dopamine receptor subtypes, mediate activation of the direct 
monosynaptic and indirect multisynaptic pathways (Albin et ai, 1989; Smith et ai, 1998). Medium 
spiny neurons projecting directly to the GPilSNr preferentially express 01 type receptors and are rich 
in substance P and dynorphin and those of the indirect pathway preferentially express 02 type 
receptors and are rich in enkephalin and neurotensin (Alexander and Crutcher, 1990; Graybiel, 
1990, Smith et ai, 1998). According to processing of the direct/indirect pathways, integration of 
cortical information is based on convergence of input from the nuclei with the greatest volume i.e. the 
striatum, to progressively smaller nuclei suggesting a funneling and convergence of information 
(Mink, 1999; Yelnik, 2002). The striatum is twenty times the size of the GPi/SNr (yelnik, 2002). 
Striatal neurons only increase their firing activity when activated by convergent input from many 
different cortical neurons (Smith et ai, 1998). Under resting conditions, the activity of the medium 
spiny neurons is low whereas the output nuclei have high spontaneous activity resulting in continual 
tonic inhibition of the thalamic nuclei to which they project (Alexander and Crutcher, 1990; Marsden 
and Obeso, 1994; Smith et aI, 1998). Individual GPi/SNr neurons receive projections from the 
striatum (direct pathway), STN (indirect pathway) and GPe (indirect pathway) (Smith et aI, 1998). 
Phasic decreases through the direct pathway result in disinhibition of the thalamocortical connection 
to allow movement in the case of motor processing, whereas the indirect pathway by inducing phaSic 
increases has the opposite effect (Alexander and Crutcher, 1990). Corticostriatal afferents stimulate 
neurotransmission of GABA from medium spiny neurons that project directly to GPilSNr through the 
direct pathway to enable appropriate feedback to the cortical motor region to facilitate movement 
(Marsden and Obeso, 1994). 
In the altemative indirect pathway, the medium spiny neurons projecting to the external globus 
pallidus (GPe) and ventral globus pallid us (VP) are activated causing the inhibition of the tonic 
discharge of the pallidal nuclei (Smith et aI, 1998). This in turn reduces the tonic inhibitory 
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discharge of the pallidal nuclei (Smith at ai, 1998). This in tum reduces the tonic inhib~ory 
GABAergic transmission from the GPeNP to the STN thereby disinhibiting the STN enabling it to 
stimulate GPi/SNr with its excitatory glutamatergic afferents. Stimulation of GPUSNr projections 
increases inhibition ofthe thalamus (Albin at ai, 1989; Marsden and Obeso, 1994, Smith at ai, 1998). 
The indirect pathway prevents unwanted movement programs from interrupting the positive 
feedback through the inhibition of the thalamic nucleus (Marsden and Obeso. 1994). In Parkinson's 
disease the firing activity of medium spiny neurons is altered and this results in altered neuronal 
firing in other basal ganglia nuclei (Yelnik. 2002). Increased firing of the spiny neurons results in 
decreased firing of the GPe in the indirect pathway. This results in disinhibition of the STN which 
increases the activity of its GPi/SNr glutamatergic excitatory afferents resulting in increased firing 
activity of GPi/SNr neurons (Albin at ai, 1989; Yelnik. 2002). This causes massive alteration of basal 
ganglia output. 
3.5 Tha complexity oftha basal ganglia circuitry 
Though the classical directJindirect pathways model has advanced the understanding of the basal 
ganglia processing. it offers a simplistic perspective regarding the complexity of neural connectivity. 
Firstly. the striatum is not the only direct recipient of cortical information; the fastest route of cortical 
neurotransmission into the basal ganglia is via the direct projections to the STN terminals (Smith et 
a/. 1998). However. the greatest influence on the output nuclei is through the direct pathway. as 
90% of the synaptic boutons are from medium spiny neuron projections while the STN only accounts 
for <10% (Yelnik. 2002). With respect to segregation of parallel pathways based on differential 
expression of 01 and 02 dopamine receptors on specific neurons. there is increasing evidence of 
co-localization of dopamine receptors on 'virtually all' spiny neurons within the striatum (Surmeier et 
ai, 1999; Alzman at a/. 2000). Furthermore. medium spiny neurons form extensive collaterals 
resulting in lateral inhibition between neurons within the striatum (Bar-Gad and Bergman, 2001; 
Plenz, 2003). Medium spiny neurons also project to thalamus and subcortical motor areas e.g. 
tegmentum and GPe (Smith and Bolam, 1990; Parent, 1990). Neuronal tracing studies have 
revealed more complex connections within the basal ganglia including dual projections to both 
pallidal nuclei from individual spiny neurons. massive projections from the GPe to the GPi/SNr 
(Smith at ai, 1998; Bar-Gad and Bergman. 2001) and the centromedian parafascicular (CM-p~ 
thalamic complex direct projections to the striatum and the STN (Gonzalo at ai, 2002). Extensive 
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extemal projections from striatal and SNr neurons innervate directly to the brain stem beyond the 
basal ganglia to influence postural muscle tone and locomotion (Bar-Gad and Bergman, 2001: Nandi 
at ai, 2002; Takakusaki at ai, 2003). Figure 3.2 illustrates the extensive connectivity between nuclei 
of the basal ganglia. 
An interesting anomaly regarding proceSSing within the basal ganglia through direct and indirect 
pathways has been the effectiveness of the stereotaxic surgical procedures in alleviating hypokinetic 
dysfunction seen in Parkinson's disease (Marsden and Obeso, 1994). SNc degeneration results in 
the activity of the output nuclei being increased causing prolonged inhibition of the thalamus. The 
result is lack of positive feedback to the cortex to allow movement to occur. One of the surgical 
approaches to arrest dysfunction of the basal ganglia nuclei in the treatment of Parkinson's disease, 
has been the lesioning of the thalamus (thalamotomy) and of the pallidum (pallidotomy) both of 
which are effective in alleviating the symptoms of tremor, rigidity and dyskinesia (Marsden and 
Obeso, 1994; Diederich and Alesoh, 1997; Bjorklund and Dunnett, 1999; Ghika at ai, 1999). GPi 
lesions are effective against hyperkinesias and hypokinesia (Bar-Gad and Bergman, 2001). 
However, destruction of these two nuclei, according to the model of the direct and indirect pathways, 
would compromise normal voluntary movement. Lesioning of the thalamus should result in the 
destruction of pallidal outflow increasing excitation from thalamus to motor cortical regions 
theoretically causing dyskinesia. Paradoxically, this does not occur (Marsden and Obeso, 1994). In 
non-human primates (without parkinsonism), with bilateral thalamotomy, normal spontaneous 
movement is observed without motor deficits but learning of tasks was impaired. The paradox of 
surgical therapies in basal ganglia nuclei highlights the complexity of the basal ganglia circuitry and 
demonstrate that the classical model does not present complete understanding of the circuitries 
involved in information processing. 
One aspect not considered within the directJindirect model is the processing of information from non-
motor cortices and the overlap of these with the motor regions. The striatum is delineated into 
topographic sectors related to their cortical innervation - sensorimotor (connected to primary motor 
cortex, SMA and pre-motor cortex), cognitive/associative (connected to dorsolateral prefrontal cortex 
and hippocampus) and limbic/motivational (connected to anterior cingulated and orbito-median 
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prefrontal cortex) (Smith and Bolam, 1990; Parent, 1990, Yelnik, 2002). However, the direcVindirect 
model only addresses processing of sensorimotor information within the dorsal striatum. 
3.6 Striatonigrostriatal subcircuits 
Functional and anatomical co-ordination of information systems between limbic, cognitive and motor 
regions within the dorsal and ventral striatum have been recently determined through anatomical 
tracing studies and this has led to a more extensive model of processing of inputs being proposed 
(Haber et ai, 2000). The model proposes a series of spiralling striatonigrostriatal subcircuits in which 
the topographic organization of striatal information is maintained through subcircuits that are 
connected through midbrain spirals. The striatonigmstriatal model places more emphasis on 
reciprocal connectivity between the midbrain and the striatum, whereas the classical pathway 
focused on a one-way modulatory relationship only from the midbrain to the striatum (Figures 3.1 
and 3.3). The striatonigral pathway was previously described by Smith and Bolam (1990) as a 
mechanism through which limbic striata could influence the dopaminergic modulation of dorsal 
striatal information. In this model striatal compartmentalization was considered as a necessary 
aspect of processing. The D2 expressing neurons of the striosomes were proposed to feedback to 
the SNc to influence dopamine modulation of D1 expressing spiny neurons of the matrix (Smith and 
Bolam, 1990). 
Limbic information from the orbito - medial prefrontal cortex (OMPFC),dorsolateral prefrontal cortex 
and the hippocampus is similarly confined to the ventromedial aspects of both the striatum and the 
SN (VTA, and the dorsal SNc) (Haber et ai, 2000). The ventromedial striatum has the largest 
projection to the midbrain but however receives relatively fewer projections in return. The 
associative I cognitive striatum innervated by the dorsolateral pre-frontal cortex, orbital prefrontal 
cortex and the pre-motor cortex is localized to the central striatum. There is overlap between the 
different functional centers within the striatum and the nigral projections are not evenly distributed 
(Haber et ai, 2000). Nigral neurons projecting to this region from the ventral densocellular SN region 
lie between the ventromedial prOjection neurons and the ventrolateral neurons projecting to the 
motor centre in the dorsolateral striatum. The dorsolateral striatum sends the fewest projections to 
the SN, but receives the greatest nigral output 
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Reciprocal pathways link common functional regions of the striatum with the SN while the non-
reciprocal pathways feed-forward to relay to the adjacent region that differs in function. In this way 
the SN co-ordinates information between the striatal centres. There is overlap of cognitive function 
within the dorsal striatum mediating procedural and spatial learning, while the ventral striatum is also 
involved in spatialleaming and Pavlovian conditioning (Voom et aI, 2004). Indeed, Albin et al (1989) 
in recognizing the limHations of the model of the directJindirect pathways, proposed that ' ... one of the 
functions of the basal ganglia is to regulate sensorimotor interactions in a way that determines which 
sensory stimuli are used to initiate motor action and which are disregarded: 
The spiralling organization of the striatonigrostriatal pathways enables processing from the 
ventromedial striatum throughout the central striatum to the dorsolateral striatum to integrate limbic, 
cognitive and motor information. Limbic information from the ventromedial nucleus accumbens shell, 
projects to the VT Aldorsal SNc and the non-reciprocal pathway projects to the nucleus accumbens 
core which in tum projects to its own midbrain region to influence the projections directed towards 
the central associative striatum. The central striatum projects to its densocellular SNc region and 
from there projections are directed to the dorsolateral striatum. For an appropriate behavioural 
response to occur all inputs are required from the different regions (Haber et aI, 2000). Rather than 
segregation of information, the striatonigrostriatal pathways facilitate information flow between limbic, 
cognitive and motor information. Furthermore, this model is suggestive of greater reciprocal 
modulation between glutamate and dopamine transmission within the medium spiny neurons. 
3.7 Summary 
The striatum plays a cl1Jcial role in basal ganglia processing. Despite the differences regarding the 
connectivity between the nuclei, the basal ganglia models have in common the emphasiS of 
dopamine neurotransmission through the nigrostriatal pathway mediating the response of the 
medium spiny neurons to excitatory glutamate stimulation from the cortex. Previously dopamine was 
proposed to have a differential excitatory influence through the direct pathway and an inhibitory 
effect through the indirect pathway (Alexander and Crutcher, 1990). However, further studies have 
shown that the role of dopamine is more complex. 
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STUDY PURPOSE 
NMDA receptors are fundamental to the structural and functional integrity and efficiency of dendritic 
synapses. This feature of the receptors is attributed to the high Ca2+ ionic fluxes through the 
receptor channels in response to stimulation. NMDA receptor mediated influx of Ca2+ ions triggers a 
myriad of intracellular signalling cascades through which formation and archttecture of dendritic 
spines are maintained and synaptic receptor expression and kinetics are regulated as discussed in 
Chapter 1. As a result NMDA receptors contribute Significantly to synaptic modification. Such 
modification plays an important role in development and aging, consequently, the subunit 
composition and kinetics of NMDA receptors are altered. Specifically the activity of the receptors is 
reduced wtth age (Chapter 1). In the current study we tested the hypothesis that within the striatum, 
stimulation of NMDA receptors should result in a reduction in Ca2+ influx in older animals when 
compared with Ca2+ influx in younger animals. The age induced reduction of NMDA receptor 
function leading to reduced NMDA (100 IJM) stimulated Ca2+ accumulation in vitro has not been 
described in young aduH male Long Evans rats nor has it been previously described in any other 
strain. 
Due to their role in synaptic location, the function and efficiency of NMDA receptors is crKical to 
numerous synaptic activities. Efficiency of the receptor channels is highly regulated by their 
phosphorylation state (Conti and Weinberg,1999). Major changes in the phosphorylation state occur 
following dopamine depletion in animal models of Parkinson's disease such as increased 
phosphorylation of NR1 serine residues (Dunah at ai, 2000), NR2 tyrosine residues (Oh at ai, 1998, 
Dunah et ai, 2000). Furthermore there are increases in NMDA receptor expression on the synaptic 
membrane in animal models and in Parkinson's disease patients (Lange at ai, 1997). In addition to 
other abovementioned synaptic functions, NMDA receptors generate excttatory postsynaptic 
potentials and make a significant contribution to regulating neuronal excitability In response to 
glutamate stimulation by cortical and thalamic afferents. Changes of receptor phosphorylation state 
causes alterations in NMDA receptor channel open times and affects neuronal firing patterns (Yu et 
ai, 1997). In parkinsonian animals, the membrane potential of striatal neurons is increased 
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(alleviating the Mg2+ block of receptor channels) and firing activity of striatal neurons is increased 
(Kish et ai, 1999; Tseng et ai, 2001; Wichmann and Delong, 2003; Tseng et ai, 2004). 
The above evidence strongly suggests that there is increased NMDA receptor function in 
Parkinson's disease following dopamine depletion in the striatum. Indeed NMDA antagonists, 
attenuating receptor function, have been found to have similar beneficial anti-parkinsonian effects as 
dopamine replacement therapy in animals and are a used in the clinical treatment of Parkinson's 
disease (lange et ai, 1997; Oh et at, 1998). In the current study we tested the hypothesis that 
following dopamine depletion NMDA receptor upregulation should cause an increase in Ca2+ influx, 
into striatal tissue following unilateral dopamine depletion in long Evans rats. 
STUDY ONE 
Hypothesis 
Aging will result in decreased NMDA stimulated Ca2+ uptake into striatal tissue in vitro of adult male 
rats compared to adolescent male rats. 
Objective 
To determine whether NMDA stimulated Ca2+ uptake into striatal slices is reduced with age by 
comparing male long Evans rats aged 7 weeks and 16 weeks. 
STUDY7WO 
Hypothesis 
Degeneration of the nigrostriatal pathway (6-0HDA induced) will result in increased NMDA 
stimulated Ca2+ uptake into striatal sections in vitro. 
Objective 
To determine whether NMDA stimulated Ca2+ uptake into striatal sections increases following 





A complete report of the rats used for the study is provided in Annex A. 
The design of the current study and the use of animals were approved by the University of Cape 
Town Research Ethics Committee. Long Evans rats were obtained from the Faculty of Health 
Sciences Animal Unit where they were bred. The rats were housed in individual cages in the 
Department of Human Biology Anatomy Building animal house. The rats were maintained on a 
twelve-hour light/dark cycle and were provided with food pellets and water ad libitum. Male Long 
Evans rats (n=14) were used in a preliminary study to establish the technique of NMDA stimulated 
uptake of radioactive calcium-45 (4SCa2+) assay for the study. These rats were previously used to 
develop the 6-0HDA lesion technique. Of these rats, there were n=6 6-0HDA lesioned rats and a 
group of non 6-0HDA lesioned rats (n=8) which comprised of rats that were either untreated or had 
been injected with sterile saline (sham lesioned). 
When the NMDA stimulated 4SCa2+ uptake assay technique had been established, the effects of age 
on NMDA receptor function was investigated in male Long Evans rats aged 6 - 7 weeks, n=7 
(106g - 210g) and 16 weeks, n=6 (482g - 556g); these rats did not receive pharmacological or 
surgical treatment prior to uptake assays being conducted. Male Long Evans rats (n=46) weighing 
330g - 398g (aged 18 - 19 weeks at time of uptake assays) were used to investigate the effects of 
6-0HDA lesion of the nigrostriatal pathway on NMDA receptor function. To identify the site of lesion 
in the medial forebrain bundle (MFB) using the method ofcresyl violet staining, n=10 rats were used. 
The nigrostriatal pathway was lesioned with 6-0HDA in n=21 rats and n=15 rats were sham lesioned 
using sterile saline. Of the rats lesioned with 6-0HDA, n=3 were used to visually verify the extent of 
degeneration using tyrosine hydroxylase (TH) staining following behavioural assessment. From the 
sham lesioned group, n=1 rat, was used for the TH staining, in addition to n=1 unlesioned rat. 
NMDA stimulated uptake assays were conducted on n=12 of the 6-0HDA lesioned rats and on n=11 
of the sham lesioned rats. Following surgery, there were infections resulting in n=9 treated rats 
being killed. Infections were reported to the department vet and tests were conducted at Groote 
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Schuur Hospital and by the state vet in Stellenbosch. It was established that Pseudomonas 
aeruginosa was the bacterium responsible for most of the infections reported. 
4.2 NMDA stimulated 45Ca2+ uptake assays 
A comprehensive list and detail of the materials and solutions used to conduct the NMDA stimulated 
45Ca2+ uptake assays can be found in Annex A. 
4.2.1 Tissue sectioning 
Two studies involving NMDA stimulated calcium uptake assays were conducted as previously 
reported (Feldman et ai, 1990; Lehohla et ai, 2000; Lehohla et a/. 2001). In the first study. the assay 
was conducted to determine the effects of ageing on NMDA receptor function in rats aged 6-7 weeks 
(n=7) and 16 weeks (n=6). Each rat was deeply anaesthetized with halothane and decapitated. The 
brain was rapidly removed and cooled for 5 min in continuously oxygenated, ice-cold incubation 
HEPES buffer (120 mM NaCI. 1 mM MgCI2. 3.36 mM KCI. 10 mM D-Glucose, 20 mM HEPES buffer 
pH 7.4. 1.2 mM CaCI2). After 5 min, the brain was placed onto a dampened filter paper in a petri 
dish kept on ice. The purpose of the dampened filter paper was to prevent the brain from sliding 
while the posterior end of the brain, ::= 2 mm anterior to the cerebellum, was cut. The posterior brain 
surface of the block was glued onto the vibratome cutting stage using Loctite 406 glue. Prior to use. 
the vibratome bath was filled with continuously oxygenated ice-cold HEPES buffer slush made from 
frozen buffer. A new blade was cleaned with absolute ethanol and fitted into the vibratome holder in 
preparation for cutting. The blade inclination was 20°. The cutting stage was inserted into the 
chuck within the vibratome bath and clamped into position in preparation for sectioning of the brain. 
4.2.2 Dissection of striata 
The first few slices from the anterior end were of variable size and were cut to straighten the block. 
Thereafter. serial coronal sections of 350 Jlm thickness containing the anterior. intermediate and 
posterior striata were cut. The ventral striata were obtained from slices corresponding approximately 
to antero-posterior co-ordinates 11.20 mm to 10.00 mm with reference to the interauralline (Paxinos 
and Watson. 1986). The serial sections containing the dorsal striata were cut from slices 
corresponding approximately to antero-posterior co-ordinates 10.20 mm to 8.74 mm with reference 
to the interauralline (Paxinos and Watson, 1986). Consequently, the anterior dorsal striatal sections 
were obtained from either the same slice from which the posterior ventral striatal sections were 
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obtained or from consecutive slices. A nick was made in the left cerebrum to enable differentiation 
of the left hemisphere from the right hemisphere. As each slice was cut, tt was immediately 
transferred from the vibratome bath into a perforated Perspex tissue container immersed in a glass 
container and filled with continuously oxygenated ice-cold HEPES buffer. The glass container was 
kept on ice to maintain the temperature of the HEPES buffer solution at 4°C. Oxygen was bubbled 
through plastic tubing attached to the glass .container beneath the Perspex tissue container. The 
base of the Perspex tissue container comprised small-drilled holes to allow oxygen to reach the 
slices. Each slice was placed onto a cold glass slide and the striata were carefully dissected from 
each hemisphere using a curved blade. The striatal sections were transferred to individual Teflon 
vials with nylon mesh stretched across the base and held firmly to the bottom with a rubber o-ring 
fitted to a groove near the base of the tube. The vials were marked to indicate the slice number and 
hemisphere (right or left) of the striatum. The vials were held firmly in a rack that was used to 
facilitate the simultaneous transfer of all the striatal sections between sets of polyethylene wells 
containing different buffers in subsequent phases of the assay. 
4.2.3 Incubation phases 
In the first phase, dissected striata were incubated in 10 ml continuously oxygenated HEPES buffer 
contained in individual wells and equilibrated to room temperature for 45 min. The sections were 
then transferred to 35°C continuously oxygenated HEPES buffer and incubated for 5 min. NMDA 
stimulated uptake of 45Ca2+ was determined by incubating dissected striatal sections in HEPES 
buffer containing 100 !.IM NMDA and comparing the 45Ca2+ accumulation with striatal sections 
incubated in control buffer to which NMDA was not added. The incubation period was for 2 min at 
35OC. Dissected striatal sections from the anterior (1L and 1R) and posterior (3L and 3R) slices 
were used as the test sections incubated in stimulation buffer and the striatal sections dissected from 
the intermediate (2L and 2R) slice served as the controls. t' and JR' represent striatal sections 
dissected from the left and right hemispheres respectively. The experiment was concluded with a 
series of lanthanum washes at 4°C to remove excess 45Ca2+ from the surfaces of the striatal 
sections. The buffered lanthanum chloride (LaCb) solution had similar composition to the normal 
HEPES buffer solution except that CaCI2 was replaced by 10 mM LaCIa. The first wash was a rapid 
wash for 10 sec followed by a 15 min wash. These washes were conducted in individual wells 
containing 10 ml LaCI3. The final 15 min wash was in flat petri dishes containing 10 ml LaCb 
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solution. During this wash, the striatal sections were carefully freed from the nylon mesh. The 
sections were transferred to individual Eppendorf vials containing 1 ml ice-cold distilled water. 
The striatal sections were sonicated in 1 ml ice-cold distilled water to rupture the cells and release 
accumulated 4SCa2+. A 600 ~I aliquot of the sonicate was mixed thoroUghly with 3.4 ml of 
scintillation fluid (Zinsser Analytic, UK) and the counts per minute (CPMs) from the sample were 
measured using a liquid scintillation counter (Packard Tri-Carb 2100TR). A standard quench curve 
was constructed for each experiment using NMDA containing and non-NMDA containing incubation 
buffer. The purpose of the quench curve was to determine the amount of quenching in the samples 
by comparison with the standards whose quench is known. Varying volumes of distilled water 0 ml, 
50 JlI, 250 JlI, 600 JlI, 1.0 ml, 1.5 ml and 2.0 ml were added to 5 ml Teflon vials. Using a Finn pipette, 
20 JlI of the test incubation buffer containing 4SCa2+ was added into each of the vials. A separate 
standard curve was constructed for the control incubation buffer. Scintillation fluid (3.4 ml) was 
added to the vials and mixed thoroughly. The vials were placed into larger 20 ml polyethylene vials 
and taken to the liquid scintillation counter. From the counts per minute (CPMs) recorded for the 
quenched standards, a curve of percentage efficiency (this had to be calculated) was plotted against 
tSIE (amount of quench calculated by the counter) 
4.2.4 Protein determination 
The remaining sonicate was used to determine the protein content using the Miller method of protein 
determination. Protein dilutions using 1 mg/ml bovine serum albumin (BSA) were made to construct 
a standard curve. Different volumes of BSA (0 JlI, 10 JlI, 20 JlI, 40 JlI and 80 JlI) were made up to 1 
ml with distilled water. For each dilution a duplicate dilution was made in a separate test tube. 
Samples of the sonicate were made in duplicate using volumes of 80 JlI (for dorsal striatal samples) 
and 160 JlI (for ventral striatal samples) and these were made up to 1 ml with distilled water. 1 mlof 
freshly prepared Reagent A was added to all the test tubes using a Finn pipette and mixed 
thoroughly on the vortex. The samples were allowed to stand at room temperature for 10 min. Folin 
acid reagent (3 ml) was forcefully added to each test tube using a Finn pipette and mixed thoroughly 
on the vortex. The test tubes were incubated in a 50°C water bath for 10 min. After 10 min the 
samples were cooled to room temperature, before being transferred to cuvettes for the absorbance 
measurement at 650 nm in the spectrophotometer (UV-9100, Laboratory & Scientific Equipment 
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Company). The absorbance of the BSA solutions were used to construct a standard curve from 
which the dilutions of the sonicate were read to obtain the amount of protein in 80 J.l1 and 160 J.l1 of 
sonicate. The amount of 45Ca2+ accumulated in the tissue samples was expressed as nanomoles of 
45Ca2+ accumulation per milligram of protein (nmol45Ca2+/mg protein) in 2 min. In the second study, 
the assay was used to determine whether unilateral nigrostriatal degeneration attered NMDA 
receptor function in the lesioned striatum. Calcium uptake assays were conducted as described 
above following the surgical treatment and behavioral studies of the rats as described below (refer to 
Sections 4.4 and 4.5). 
4.3 Calculations and statistical analysis 
The data for NMDA stimulated 45Ca2+uptake were analysed with Student t-tests (dependent samples) 
for within factor comparison with Bonferroni correction for multiple comparisons (while pi :S wn reject 
Hi, otherwise accept Hi. Where n is equal to the number of null hypotheses that are simultaneously 
tested) (Garcia et aI, 2004) of uptake into left (lesioned) vs. right (unlesioned) hemispheres. One-
way ANOVA was used for comparison betweelll 6-0HDA lesioned and sham lesioned rats and for 
comparison between rats aged 6-7 weeks and ,16 weeks. In all the statistical analyses, statistical 
significance was taken as p< 0.05. Statistica 7 software package was used for all analyses. Results 
are given as the mean ± standard error of the mean (SEM) and uptake was calculated as nmol 
! 
45Ca2+ Img protein I 2 min. 
4.4 Surgical Procedure 
A comprehensive list and detail of the materials and solutions used to conduct the surgical 
procedures can be found in Annex A. I 
Surgery was conducted to lesion the njgrostriatl:ll pathway on n=21 rats and in n=10 animals, surgery 
was undertaken to obtain a histological reP"1entation of the site of lesion. All surgical lesioning 
procedures were conducted under semi-stertle, conditions on rats weighing 330g - 398g (aged 13 -
14 weeks). 
i 
In preparation for surgery, each rat was deeply anaesthetized with halothane inhalation anaesthetic 
(Safeline Pharmaceuticals, South Africa) place~ in a stereotaxic apparatus. The rat was pOSitioned 




Throughout the surgery, 3% halothane/oxygen anaesthesia was administered using a Blease 
vaporizer via a specifically designed and constructed nose cone that fitted over the incisor bar and 
I 
the nose of the rat. Proper positioning of thE! ear bars in the rat's ears and positioning of the head 
centrally in the stereotaxic apparatus enabled calculation of the co-ordinates from the interauralline. 
I 
The co-ordinates of the MFB were detemlined using the stereotaxic rat atlas of Paxinos & Watson 
(1986). Co-ordinates were: anterior-poste~r with reference to the interaural line - 4.7 mm and 
I 
lateral relative to the midline - 1.6 mm. A midline incision of the skin overlying the skull was made to 
expose the dura mater above the MFB target site in the left hemisphere. The dura was carefully 
I 
lifted using the bent tip of a 20Gx1% needl~ and a 0.3 mm stainless steel infusion needle was 
lowered 8.4 mm from dura to the MFB. The II needle was left in place for five minutes before being 
withdrawn slowly. The rats used to obtain histological representations of the site of lesion were 
immediately killed by the method of transcardi~1 perfusion. 
I 
The above surgical technique was used t~ infuse 6-hydroxydopamine hydrochloride, 6-0HDA, 
(Sigma, USA) into the MFB of n=21 rats and to sham lesion n=15 rats with infusion of sterile saline. 
I 
Prior to surgery, the fur above the skull w,s clipped to minimize possible infection during the 
operation and post-operatively around the sut~res. Each rat was injected intraperitoneally (Lp.) with 
desipramine hydrochloride (25mg/kg) (Sigma,: USA) at least 25 min prior 6-0HDA or saline infusion 
into the MFB (Magill et ai, 2001). The rat wa~ deeply anaesthetized and placed on the stereotaxic 
apparatus. The method of lowering the infu~ion needle to the MFB was conducted as described 
above. 
A syringe pump connected to the infusion needle regulated the rate of infusion of 13.5 J.1g/4.5 J.11 
dose of 6-0HDA into the left hemisphere (Ma~iII at ai, 2001). 6-0HDA solution was prepared with 
sterile saline and 0.02% L-ascorbic acid (Merck, Germany) just before use. At the end of the 
infusion period, 5 min was allowed for the to~n to diffuse before the needle was withdrawn slowly 
from the brain. The burr hole was sealed witH bone wax and the skin incision was sutured with silk 
suture and sterilized with 70% alcohol and iOd~ne. Sham-operated control rats underwent the same 
surgical procedure receiving only 4.5 J.11 of t~e vehicle (sterile saline with 0.02% ascorbic acid). 
I 
Following the surgery, animals were carefully \T1onitored for weight loss and any signs of stress. In 






addition to the ad libitum availability of the dry pellets for 2 weeks following surgery to minimize 
weight loss. The animals responded well to the wet pellet feeding. 
4.5 Behavioral assessment of lesion 
A complete list and detail of the materials and solutions used to conduct the behavioural 
assessments can be found in Annex A. 
Fourteen days after surgery, n=17 6-0HDA lesioned and n=14 sham lesioned rats underwent 
behavioural assessment to determine the extent of degeneration of dopamine neurons innervating 
the striatum. An established technique of apomorphine-induced rotations was used (Ungerstedt and 
Arbuthnott, 1970; TiIIerson et aI, 2001). The rats were placed in rotameter drums and the rotameter 
recorded the number of quarter rotations made by the rat over a period of 90 min using the 
Automatic Rodent Monitor programme. The first 30 min of the recording session was used to 
acclimatize the rats to the new environment and to record the baseline rotational movement. After 
30 min, the rats were removed from the drllTls and were subcutaneously injected with 0.5 mg/kg 
apomorphine (apomorphine hydrochloride hemihydrate. Sigma, USA). The rats were retumed to the 
drums immediately following the injection and the rotational response to apomorphine was recorded. 
6-0HDA lesioned rats (n=3) exhibiting less than 400 contraversive quarter rotations i.e. 100 
complete rotations were removed from further analysis involving NMDA stimulated 45Ca2+ assays. 
More than 100 complete contralateral rotations has been established to represent a loss of >90% of 
dopamine in the striatum (Ungerstedt, 1971). On the basis of this criterion, n=14 6-0HDA lesioned 
rats, completing >100 contralateral rotations were selected for further study. Sham lesioned rats did 
not exhibit contralateral tuming in response to apomorphine. but rather conducted predominantly 
ipsilateral rotations. At the end of the recording session, the rats were retumed to their individual 
cages and transported to the animal house. 
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4.6 Histology 
A comprehensive list and detail of the materials and solutions used to conduct aI/ histology stUdies 
can be found in Annex A. 
4.6.1 Transcardial perfusion 
To conduct the histology on brain tissue to obtain a representation of the site of lesion using cresyl 
violet staining and to obtain a visual record of the extent of lesion using tyrosine hydroxylase 
staining, n=14 rats were transcardially perfused. The rats, which had undergone lesioning 
operations, were perfused five weeks following 6-0HDA injection i.e. 21 days after behavioural 
assessment (section 4.5). The method of transcardial perfusion was employed as it was the only 
method that allowed the efficient clearing of blood from the brain tissue and the complete perfusion 
of the brain with paraformaldehyde fixative. For this to occur it was necessary that the rat's heart 
was still beating during perfusion. 
The operation was conducted as humanely as possible with each rat being deeply anaesthetized by 
placing it in a halothane filled airtight chamber. Under deep anaesthesia, the thorax of the rat was 
opened to expose the heart. The rat was perfused with 150 ml 0.15 M phosphate buffer saline (PBS) 
solution p.H 7.4 through a 20Gx1 % perfusion needle inserted into the left atrium. Perfusion with 
saline was followed by fixation with 300 ml solution of 4% paraformaldehyde (PFA) in 0.15 M PBS 
p.H 7.4 solution. 50 ml syringes were used for perfusion as they facilitated the most accurate 
measurement of the volume administered. Following the perfUSion procedure, the brain was 
removed from the cranium and was placed in a glass vial containing 20% sucrose for cryoprotection 
ovemight. In most cases the tissue only required ovemight cryoprotection, however, if the brain did 
not sink it was left in the sucrose for an additional 24 hrs. The brain was removed from the sucrose 
solution and was embedded in tissue freezing medium within tin foil moulds, frozen over liquid 
nitrogen vapour and stored at -80°C wrapped in parafilm until removed for sectioning. Using a 
cryostat, 20 !.1m sections of brain containing the striatum and the midbrain (SN and VT A) were cut at 
-20°C and placed on gelatinized glass slides in preparation for cresyl violet and tyrosine hydroxylase 
staining. 
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4.6.2 Cresyl violet Nissl staining 
Sections used for cresyl violet staining were air~ried overnight prior to use. The 20 !-1m sections on 
the slides were placed on staining racks and rinsed brielly in distilled water. They were incubated in 
the cresyl violet solution for 20 min. Following cresyl violet incubation the sections were cleared in 
distilled water for 1 min and subjected to a series of dehydration steps in 90% alcohol (1 min),95% 
alcohol (1 min) and 100% alcohol (1 min x3) followed by clearing in xylene. The slides were then 
mounted with Entellan. 
4.6.3 Tyrosine hydroxylase staining 
Sections of the brain tissue containing the midbrain (SNc and VTA) and the striatum were stained for 
the dopamine synthesis regulating enzyme, tyrosine hydroxylase, to confirm whether degeneration 
had occurred. Tyrosine hydroxylase staining was conducted on the brain from n=2 6-0HDA 
lesioned rats completing >100 complete rotations and n=1 rat completing <100 rotations. The brains 
from n=1 sham lesioned rat and from n=1 unlesioned animal were also stained for tyrosine 
hydroxylase. 
Prior to processing for immunohistochemistry, the sections had to reach room temperature. Each 
section on each slide was encircled with a grease pap pen. The purpose was to ensure that during 
the incubations, the reagent would not run off and would be concentrated in the area of the section. 
Following encircling with pap pen the slides were immersed in 0.15 M PBS p.H. 7.4 if found to have 
reduced in moisture during encircling. The brain sections were prepared for staining by initially 
quenching their endogenous peroxidase activity to reduce background staining. The sections were 
incubated with hydrogen peroxide solution in a humidifying chamber for 30 min at room temperature 
followed by a series of 3 washes of 10 min each in 0.15 M PBS p.H 7.4. Blocking serum was 
prepared and immediately applied to each slice; the sections were incubated for 30 min at room 
temperature in the humidifying incubation chamber. After 30 min, the blocking solution was blotted 
from the sections. This involved gently tapping each slide onto absorbing paper towels to remove 
excess solution. Primary anti-monoclonal anti-tyrosine hydroxylase antibody solution was prepared 
just before use. The primary antibody solution was applied onto each slice and the sections were 
incubated overnight in the humidifying chamber kept in a fridge at 4°C. 
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The overnight incubation was terminated with a series of x5 10 min washes in 0.15M PBS pH 7.4. 
The sections were then incubated with biotinylated secondary antibody in the humidifying chamber 
for 1 hour at room temperature. The biotinylated secondary antibody solution was prepared just 
before use. The sections were washed 4 times with 0.15M PBS pH 7.4 with each wash lasting 10 
min. Avidin-Biotin-Peroxidase Complex (ABC) reagent (Elite kit, Vector Laboratories, USA) was 
used to visualise the staining. This had to be prepared thirty minutes before use as per kit 
instructions. The sections were incubated with ABC reagent for 30 min at room temperature in a 
humidifying chamber. This was followed by x2 5 min washes in 0.15 M PBS pH7.4. 
3,3'-diaminobenzidine (DAB) peroxidase (Vector Laboratories, USA) was used to obtain a dark blue 
stain. Precautions were necessary as DAB is noxious and needs to be handled with care. The 
slides were removed from the 0.15M PBS pH 7.4 wash and laid out onto absorbing paper in a 
demarcated area of the work bench. DAB solution was prepared as per kit instructions and was 
applied to the sections. The sections were incubated at room temperature until a dark blue stain had 
developed. The sections were washed for 15 min in running distilled water. In addition to 
demarcating a work area, a large beaker of diluted bleach solution was placed within the work area 
and all the equipment that came in contact with the DAB solution was incubated for a week within 
the solution before being further processed with normal washing or being disposed of. A plastic bag 
was also placed nearby within the work area to allow gloves and used absorbing paper to be 
disposed of immediately after use. The sections were then dehydrated in alcohol, cleared in xylene 




5.1 PRELIMINARY STUDY 
NMDA stimulates 45Ca2+ uptake into striatal sections 
Preliminary data was acquired to detennine whether 100J.lM NMDA could stimulate 45Ca2+ 
uptake into dorsal striatal sections following 2 mins incubation in vitro. NMDA stimulated 
45Ca2+ uptake into striatal tissue was measured from untreated rats and rats that were 
used to develop the 6-0HDA lesioning technique (n=14). The results from the untreated 
rats and sham lesioned rats were not significant and are reported as one group, non 6-
OHDA lesioned rats (n=8), Results for the complete statistical analyses are reported in 
Annex B. A copy of a spreadsheet used for calculation of nmol 45Ca2+ in striata from each 
rat is provided in Annex B. Measurement of total 45Ca2+ uptake into striatal sections from 
non lesioned rats, showed that within both hemispheres, total 45Ca2+ uptake into the 
anterior (1 Land 1 R) and posterior (3L and 3R) striata incubated in buffer containing NMDA 
(100J.lM) was significantly increased (student t-test, p<O.05) above basal (unstimulated) 
45Ca2+ uptake into intennediate sections (2L and 2R) (Table 5.1a, Figure 5.1a). Results 
from 6-0HDA lesioned rats (n=6) were similar with levels of 45Ca2+ uptake into anterior and 
posterior striata being Significantly greater than basal levels (Table 5.1a, Figure 5.1b). 
NMDA significantly increased 45Ca2 ... uptake into striatal sections obtained from non 
lesioned rats and 6-0HDA lesioned rats (student t-test, p<O.05). 
Table 5.1a TotalCSCa2+uptake Into anterior (1L and 1R) and posterior (3L and 3R) striatal sections 
following 2 min Incubation In buffer containing NMDA (100 J.1.M) and basal CSCa2+ uptake Into 
Intennedlate striata (2L and 2R) in the absence of NMDA. 
4SCa2+uptake Into striatal sections (nmol 45Ca'· Img protein) 
GROUP 1L 1R 2L 2R 3L 3R 
NON n=8 13.22 14.03 7.09 6.40 11.73 12.57 
LESIONED :t :t :t :t :t :t 
RAT 1.31 1.35 0.86 0.70 1.27 1.38 
* * * * 
8-OHDA n=6 9.14 10.41 5.28 5.14 8.11 10.14 
LESIONED :t :t :t :t :t :t 
RAT 1.12 1.74 0.88 0.97 0.98 1.68 
* * * * 
*NMDA stimulated significant Increases In 4SCa2+uptake Into anterior and posterior striata compared to 
basal (unstimulated) uptake In both groups (Student t·test (P<0.05) plus Bonferronl correction p<0.025). 












"ca2' UPl'AKE INTO NON 6-OHDA 
LESIONED RATS 
1L 1R 2L 2R 3L 3R 
SECTION 
Figure 5.1a Preliminary re.ults from non lealoned rats (n=8). *NMDA (100 jJ.M) 
stimulated .Ignlflcant Increase. In 45C&2+ uptake Into the anterior (1L and 1R) and 
posterior (3L and 3R) dorsal striata In the left and right heml.pheres relative to bMal non-
stimulated uptake (2L and 2R) (Student t .... t (P<0.05) plu. Bonferronl correction p<0.025). 
Data are reported as mean ± .em (nmol 45Ca2+ Img protein). Data are reported In Table 
5.1a. 
PREUMINARY RESULTS 
4Sea1. UPTAKE INI'O 6-OBDA 
LFSIONED RATS 
1L 1R 2L 2R 3L 3R 
SECTION 
Figure 5.1b Preliminary results from 6-OHDA 1 .. loned rats (n·6~ * NMDA (100 jJ.M) 
.timulated .Ignlflcant Increa ... In 45C&2+ uptake Into the anterior (1L and 1R) and 
po.terlor (3L and 3R) dorsal .triata In the left and right heml.pheres from basal non-
.tlmulated uptake (2L and 2R) (Student t-test (p<0.05) plu. Bonferronl correction p<0.025). 
Data are reported a. mean ± .em (nmol 45Ca2+ Img proteln~ Data are reported In Table 
5.1a. 
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5.2 AGE EFFECTS ON NMDA STiMULA TED 45Ca2+ UPTAKE 
NMDA receptors are critical in the regulation of pre-natal and post-natal synaptic 
development. A group of rats (n=13) was studied to determine whether there were age-
dependent differences in 45Ca2+ uptake into the dorsal and ventral striata of adolescent 
and adult rats (aged 7 week and 16 week old) follOwing NMDA (100jlM) stimulation. The 
rats in this group did not receive any prior treatment. Results for the complete statistical 
analyses reported below are reported in Annex B. 
5.2.1 NMDA stimulated 45Ca2+ uptake In rats aged 7 weeks 
5.2.1.1 Dorsal Striatum - 7 week old rats 
In the 7 week old rats (n=7), the total 45Ca2+ uptake into dorsal striatal sections incubated 
in NMDA (100jlM) (1L, 1R, 3L and 3R) showed significant increase above basal 45Ca2+ 
accumulated in non-stimulated striatal sections (2L and 2R) (Table 5.2a). The results 
show that NMDA evoked a significant increase of 45Ca2+ uptake into striatal sections above 
control levels. 
To determine the level of effect oJ NMDA stimulation, a measure of the NMDA effect on 
45Ca2+ uptake was calculated by subtracting basal 45Ca2+ uptake derived from intermediate 
unstimulated striatal sections (2L and 2R) from total 45Ca2+ uptake into the anterior (1 Land 
1 R) and posterior (3L and 3R) striatal sections. NMDA stimulated 45Ca2+ uptake is 
presented as 1l-2L (left anterior striatum), 1 R-2R (right anterior striatum), 3L-2L (left 
posterior striatum) and 3R-2R (right posterior striatum). NMDA stimulated 45Ca2+ uptake 
into striatal sections was compared within the left hemisphere i.e. 1 L-2L vs. 3L-2L and 
within the right hemisphere i.e. 1 R-2R vs. 3R-2R. Within the left hemisphere, NMDA 
stimulated 45Ca2+ uptake into the anterior dorsal striatum (1L-2L) was not different from 
stimulated uptake into the posterior dorsal striatum (3L-2l) (Table 5.2b, Figure 5.2a). 
Within the right hemisphere, NMDA stimulated 45Ca2+ uptake in the anterior dorsal striatal 
section (1 R-2R) was also not different from the posterior dorsal striata (3R-2R) (Table 5.2b, 
Figure 5.2a). There were no Significant differences in 45Ca2+ uptake stimulated by NMDA 
between anterior and posterior dorsal striata within either the left or the right hemisphere. 
The response to NMDA stimulation was compared across the hemispheres using 
Bonferroni correction for multiple comparisons. There were no differences in NMDA 
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stimulated 45Ca2+ uptake into the anterior dorsal striatum of the left hemisphere and into 
the anterior dorsal striatum of the right hemisphere i.e. 1 L·2L vs. 1 R·2R (Figure 5.2b). 
There were also no differences in 45Ca2+ uptake into the posterior dorsal striata i.e. 3L·2L 
vs. 3R·2R (Figure 5.2b). 
Table5.2a Total45Ca2+ uptake Into the dorsal and ventral striata of rats aged 7 weeks (n=7). 
Total 45Ca2+uptake Into striatal sections 
(nmol45Ca2+ Img protein) 
STRIATAL 1L 1R 2L 2R 3L 3R 
REGION 
DORSAL n=7 11.42 10.01 4.69 4.70 9.05 10.44 
STRIATUM t t t t t t 
0.75 0.89 0.39 0.47 0.82 0.64 
* * • • 
VENTRAL n=7 12.80 10.65 4.48 4.80 11.27 10.32 
STRIATUM t t t t t t 
1.64 1.45 0.36 0.55 1.38 1.02 
* * * * 
* NMDA (100J1M) evoked significant Increases in 45Ca2+ uptake Into NMDA Incubated sections (1L, 1R, 
3L and 3R) compared to basal (unstimulated) uptake Into dorsal and ventral striatal sections not 
Incubated in NMDA (2L and 2R) (Student t-test (p<O.05) plus Bonferroni correction p<O.025). Data are 
reported as mean ± S8m (nmol45Ca2+ frog protein). 
Table 5.2b NMDA (100J1M) stimulated 45Ca2+ uptake Into the dorsal and ventral 
striata of rats aged 7 weeks (n=n 
45Ca2+ uptake into striatal sections 
(nmol45Ca2+ Img protein) 
STRIATAL 
REGION 'II '" tsem 
DORSAL 
STRIATUM n=7 6.73 0.81 5.30 0.86 
VENTRAL 
STRIATUM n=7 6.89 1.41 5.85 1.49 
3L·2L tsem 3R·2R tsem 
DORSAL 
STRIATUM n=7 4.35 0.61 5.73 0.72 
VENTRAL 
STRIATUM n=7 7.34 1.43 5.52 1.10 
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...... Il101\;111 h ............. (1 R·2R ... lR·lRV). Thoro .... "" diftoronc:llin II""wllltCI "C." 
op!aM _ 11._ .... n"nl lllUta \AHOY"). lin .. ,. ... ,.pO!1tCI .. '"'In J; Ifm 
lIIfIOI "C .... """ prgIIOOo. 0Ita .. NjIOIWI ln T_ Hb. 
5.2.2 NMDA Stimlllit.li "Cr- Up,n. into ./rU~ 0/ "_hhl ,,'. 
H .1.1 DorW Strl,b -16 wu,I: ojdrm 
Results br !he compIe'd1 SlatlSbCaI analyses reponed ~ art repotlld In AmtX 8 
COmpansotI 01 kItaI "Cal. uptake JIb dorsal slriatal s.eclions (ll . lR. lL ard lR) 
i"cIIbafed In NMDA ( lDO,l.M) "MIl nc:n-sllm.llal8d strialal stdIOnS (2l1lld 2R) shoWtd Nt 
NMDA ewlced a $~ rclea5e ot 'SC;a]' uprat alIove basal Ievel5 no Itnatal 
seC\lOI1S obtarled tom rats aged 16 weeks (Table 5.3a) Measurement 01 NMIlA. 
stmu!aled llCal' uplab (catIIlated as described ~. S8C\JDf1 5.1) Showed IN! w'1I*I 
Ihe !ell. hemsphere .• ~. Ujltake inIo ltle a"\Ie!IJI" sVir ... 1 S8C1IOII$ (ll·2l) WOIS rot 
dofferenl from llCa'· uptake 11tD!he poslel'o" slIlatai 5eCtion:s (31·lL) (Table 5 3b Figure 
S.3a) In Itle righlilelTl5phere tr.ere was no doflt!ence between 11(; .. - upcakt irtl lilt 
iIIlleoor striatal 5eC\JDf1 (lR·2R) arod '!Cal- IIptab Into !he poS!erbr stnatum (3R·2R) 
(Table 53b. Figure S.la) CompariSOn at '!CII· upUle inIo sIDiIal sectIonS if'Ilhe left 
tlemlsphe!e With uptake into s!Nla III Itle I'l\IhI IIernIsp/lere showed !here were no 
69 
diMnces 111 '!Cal- uptake bEllYeeo !he anterior stnata (1 L-2l \'S 1 R·2R) and postenor 
striata (3L-2L \'S. lR·2R) (Table S.3b, F"gure 5.3bJ 
"CJ'. uptlke into SlriJl"lectionl 
(nmol "CI" Img PfOl~n) 
STRIATAL " " " " " " REGION 
OQIISAL .. , 5.9( 6.93 ).U ' .K 5.11 '" STRIATUM , , , , , , 
0.71 .. " ,.~ 0.$1 D.n ,.~ • • • • 
VENHW. ,., I." •. " .. " U5 7.11 m 
STRIATUM , , , , , , 
0.65 0.10 0.55 ,.U ,.U '" • • • • 
·HMDA . - 11ICtlO ... , ifI "C'" iorio HIlDA ;"011_ strimI HCtIomI (1Il0l> I ~ {1L 111. JL ItId lRI COIrijIlrICI 10 ...... ~ptW InlO _ •• e..Ia ......... 111._121 .l1li ZRI ($IUdI1'I\ was! 
(11<0.05) pIo. BoI>IIrronI _Il0<l p<Q.02S). D¥ .... ntpor\lod I. _ 1 _ (nrr<>I "C'" Img ... " 
TIOI. "'" HMDA (I~J ..... ~1\fCI "Co" uplalt InIO Ibt <1O<U1.1111 'fII!IrII .InIQ of 
fltllQMIlh'lt'" )11"4~ 
"1;.." "J'r ,\~ ,1< TO , N rnlOM ",. 0 l'O.n ' MIt'M .,. M." ru " 'n"" ~ UO< " ""S""U~ 
AHltRI:lR $lCE 
I:iBI PCl'UlIO~ &tJ:E 
.""",,,== '"." ..................... ' " ..... -
r'9." U. HilDA liDO IJIiII.timl,llolod ''Co'' "pI.k.'mo ,.,<11", •• d pOOl,n", dmu, . I!lm 01 
16 _ oil! ,..~ fn"~ No ",g",~_1 <lJllflIne. I~ "~tah 1~1. "' • ..,1Oti« ooel "".tenor "" ot. wI"'i. 
111,,0/1 on<! .. , n~ ~ ..... ph .. (StII_ 14'" (II"'Q Q5) pili. S .. I." .. 1 o." .. toon p<Q.OlS~ C . ... o 
~ .. m .. n ! .... (nmol"C:a'+lI'IIg ~""oi") CO ......... ,.,rtod ,. T .obI. S.l~. 
• =lEFT~li~UI£ = R1GWIH(MISPH£RE 
r'V"N S.ltI NIIC" I'lDO " "') __ "C.'. ",Uk, 11110 ,"- doo'UI.Iri •• 01 "'. ''''.J. riglll ~.,...jlt._ 01 16 _ .... ta1. ~~ No .. goirtcan, ",fI.,.ne. I. 
"fila'" _ 110. loft ..... "111>1 IIom>spI\«''' ISWllon, Hul (p>G,0$1 ph" 
ao.. .... onj c __ p>Q.02S~ 0. ..... rtpon~ .. "'U. t 10," l""'" ''CI'' II'II; 
PfOItm). ColO '" rtponod .. 10l1li SJb ,1>6 f.,. .. 5.1o. 
-, 
5.1_2_2 VIlllI1~ SItU/" 
'!Cr' ~ _ meilSUlllCl on !he ventral srnaa 01 tie 16 wooi; ok! rils (n:6) NMlA 
(100 1J"'l 511'lUa1 p}fIUlI n:reases III ~a1' upta!:e onlO the ant¥ior (1L, lR) Mel 
posIefu Pl 3R) stnaeiI reIaII'I9 10 basal IeYIIIs rne~ on 1'lOft-SUTIb:ed s'nallli 
sedIOrs (2L. 2R) (Table 5.3i1) Res>Jts of !tie ~ eflecl sIloIwed thal1here wefe no 
d,f'.e(enc4!S in '1(; .... uptake into artenoI' (1L-2L) aid poslena (Jl-2L) SlnaIii in !he \ell 
~ nor _there any dif'aences in uptake 1110 an;eoor (lR-2R) iII\d posllnCl' 
(JR-2R) ~1ZlI in !he nght hern$p1B'e (Table 5.lb), Reds comp¥Il!I ~a1' uptake 
across the t\emIspI"oefes wefe smlaf Therl! _e 110 differences on sl.irlIJ\aIed <!Cr' 
uptake inlo I'eI1\IaI Slnala t>etNee!\ the left and nght ~ (Table 5 3b) 
S.2.2.1 NMDA Stimul"l,d"Cr uptilh inlo dorSi/VI. vlti/a/slli," 
StunJla1ed "Cr- uptake into fie anteror dasal stnalil (1L-2L and lR·2R) was ~ared 
wilt1 '-'Cal. uptake Into the poslefior 1'eRU"a! striata (3L-2LV and lR-2RV) witun each 
hemisp/lere I e 1L-2l vs. 3l-2L Y and lR-2R.os lR-2RY as preVIOUsly descnbed (relef 10 
section 5.2 1 3). There were 1'10 SlIlnificant d,nereoces In '!C ... ·l4'tako IeviIIs be_ the 
dooal and venlfal striata into ellhur \he left 0/ !he nght hemsphlfaS 0116 week old rats 
(Table 5.3b. Figure 5.3c) 
f'" ..... u.: h_ t'lqIlIl_ ...... -c..-.-,.I010 .... ""'.oj ..... _01004 ... '" 11_ aid 
... (I004I. • I I "Co>" ~ I0IO _ ... _ 0fIII _ ..... _01 oI'Irt.o ~ ... 1110 Io!I _~ 
tRoll ... ll-a'll ........ _phOr' tI~·:II ... :111-211'11 rt.oo, ..... _one .. In 0IIm0.¢_ "Co~ 
..... _ ... "'"" .... __ 11_ 1-I0OI IP>U5) pi .. _oni _octIon ~0l5) 
1Im __ n_£_to-aI'"Co" I.,.,._1 D ...... '-""'.,TabltS. .. 
n 
5.l3 Ago • • fffffl 011 HMDA stimllllt9d .. C'" IIp~.,- 7 -.I: VI. 16 ..... old ria 
To delSnTWle ItotJeIller !here were iIIIY age depenclert chaoges in NUDA slmulal!d ecr' 
l4llake no stnaIi. sllmUtated ~take into striata from rats aged 7 .....em (n-7) was 
COI"IlNIred WIlIl ~take !OIO 51r'lata from I3!S aged 16 weeks (n·6) ResiJIs lor !he r.cmple\e 
stalIS!I:aI analyses ~ below are reported in Annex 6 
s.u . t Dotul Sflj, l' _ 1 WH. VI . 16 -.I: old TlIS 
In boIh fie lell. and rght ~, stlmlAa1l:!d '!Cal. up:<lke into Iile anteri:Jr dmsal 
s:nata (1 L·~ and lR·2R) was sqIIfcan1iy greater in 7 ¥leek old !illS thal 11 16 WE!i!k QtI 
Ii1I5 (Tabl!! 54&, Fgure S.4a) In the posrericr stnata (3L-~ am 3R-ZRJ, levels 01 
S1mJIa~ '!Cal. accumLtMloo were also S9r11ficanlly Ngher In 7 we(!k old rats lllan 11116 
~ okI ral5 {hble 54a Figure 54a! Resutts demonstrate thaI NMDA evoked 
sl\IllIfcantly grea1!ll '!Cal" upw,\e levels into dOlSal slliata of 7 weelc old !illS ~red 
W1th 16 week old rats In addi!lOfl tQ c.omparing stimulated up:ake be:ween the two il9!I 
gfl.lIljlS, basal unstimulated uptake was~. In the left ~isphefll mean u~take of 
7 \III!I1k I)kj [315 was 4 69:!: 0.39 mKlI ''Cal+1mg proIeln and 16 week old rats was J S6 ± 
065 mKlI"CB1'11TQ prolalh (Tables 5.la and S.3a, Figure 5.4b) In the nght hemISphere 
the uptake for the 7 week and 16 week old rats was 4.1 :t 0.47 nmoI "Cal' /mg protein 
irrd 4 06 ± 0 51 mKlI ':(:a'" 1111\1 protein res~\lVet,- (Tables S.2a arJI S.3a, Figure S.4b). 
Comparison of basal uptake mto the oorul striallJlll showed !here \11M no signmcil11 
difference betweoo the two ages 
bbl. U I "(:1'·lnlo Iho 6011 0/ ' lritu. of 'O!Olgtd I ,""", In" 1) 
=IiW~OLDAAIS 
• _ 1IO;EEKOlDRAI5 , • • .~ , . 
p' 
, ' " Jl · ~ , 
• 
'C." ' •• >11 
FigLlI. $.,," Compa ri .on oJ til •• g. tHeel on NMOA ' IOoo I' tocl "CI" uplake In the 
Oo,U I ,tn,to 0' I woo_ (IIa'l"nd '6 " • • k old "to (n" ~ Thlt . ..... i ""I~ "" "!I)' higher 
"Plio' -..s.",d In J week old rltl when comportd " ,th '6 _ k old ",IS (ANOVA. p<O.OS) 
RHUh, .,. moon", If .. omol ''Ca'' 1"'11 prot" • . O.ta ... 'eporud in htH . Soh , 
OOKSA!. STlU,\TlIM 
nASAL '''ca'" UI'r ,\XE 
fil/U" 5.' 0 B.ul ''CI'' "~tak.lnIO tho liersl l ,trlal.l from Ihl lolt h",".~orl 
Ill) ,nd 111. righ! h'mi'phl'. (l R) oJ IIlI '6 .... , ' n" J " .. k old 1>1 .... nol 
oignifi<lnlly d fttronl (ANOVA, p>O.05~ Rnulti .,. m •• n t Ifm "mol ''Co'' 1"'11 
pr<Iteln Oota tr .... po~.d In lobi .. \.ll'nd ~la 
S.Ll.t V,nlT.' S/l'";'I,-7 WHt ilnd 15 Welt oIdrm 
'Mlen !he efleet 01 age on NMOA sW!WJ\a'.ed '1CiI!' up\JQ was a-a!TWl8d n !he ~entr. 
stnata br upw.e Into IIle anlenOr 5:rlaIa In boIh hemrsphefes, Ill ....... no $9fldicarc 
ditIerence In uptalle inti smta of 1 week old f. COII"Iplll"ed 10 uPtake InIO SN\a of 16 
wee«. old fillS (Table 54b. Fvure 54c) The resu1t5 01 b uptal:e Into riJh1 pos1erO' 
ventral Sb'~ta wen! SirTIllar as bre \\"35 no dilferenoe betWeen h twO age Q"rOUP' (Table 
5 4b. Figure 5 4c). HOrH!V$".lhere was Sl9n.1can!Iy greater Slimullted uptake 1m 1he left 
politencl" stna13 of 7 week old rets compared 10 smnula'.ed U~I In 16 wee\: old flits 
(Table 5 4b, Fl;jure 54c) BaSII'ICa" uptal:.e InIO ht lI8I1b'aI Slnat. was also comPlI"ed 
In lIle nofl-Sllmulat&cl sl11m II Ihe Ittl hlIff\$~ (21.), mean bas. up:ake n-co stnala 
from II 7 week old rllt was 4 48 i 0.36 nmol ~a"I"'J pro1ein iHld was 4.56!; 0.55 nmoI 
~Cal' Img grotein Into 5b'iatll lrom 16 wee~ old rat n..., rnul1$ show lila! i1 IN !ell. 
hemISphere. IIII!fll was no (lilfarence n basal uptake (T 0016 5.21 a-ld 5 31, Filure 5.4d). 
In IIlI right hemISphere lIle btllal uptake tor the 7 1'1,* and 16 week ok! rIllS was 4.80:t 
0.55 nrnoj 'ICa1'/mg protein IWld 4 55 ± 0 68 nmol'!CB" Img protein rnpectll'eli (TItlJes 
5.21 and S.3B. Fig ure 54dJ In bo1I1 helTllSph&rn !here was 00 SIgnificant difference," 
btII. uptake 1110 the ventrlll sll\atl between Ihe two II\Ies. 
hili. 5.~ HMOA fl~MJ .~....;.td '1(;", "P1.tlnl.o lilt .... ntrll wiou 0' rll. "lied 7 .... , k. (n-71 
...... II-".( .... ~ 
w~ If(o Ii ..... old I.e n j#.HOVA.. p<Q.M) Retu!U; ........ % 
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fltLn Uc A.go tII.a Oft ., .......... d "',.' "pto~. llIIo 11>0 .. mrol .\rioto 7 _k old 
,ab ..... c ....... ." wlh If __ aiel ~II TII ...... ;II SlOnillQnlI, ,."" .. ~pUlo.. mI".,," 
, ... 0 .... POI!If\OII~I_ '" 11>0 loft ".....pIo ... ,., 1 _. old nil ~""P"' d I. Il1o 16 
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, '!l "': TIlA I. ;;UUTU'I 
It'S,," "coo" L PT,'Ioa, 
=IiWUlIS 
_ IWUI\S 
~~'t S.4<j Bo .. , "CI" upto .. lIIIO .. nltaI Wi.~ ol, ... ." ... d 16 "'"" old 
.. II. Bow "C .... up:.ol<o lnIo tho _01 otMt,o rn.. u.. left iImIIlphtte (2lJ or 11>0 
ngM html.pIooroIZRJ_ lilt 16 weoIo ond 1 ..... oId ~ was IIOillgnilkomly 
<1." ... 111 I"NOVA, j»O ~S~ Ruut'.s ort moln" ..... nmoI "Co>-~ prGUin. ~ .. 
.,. ' t ponod In Tabl •• !.:z. and 1.).0 
5.l EFFECTS OF DOPAMINE DEPLETION BY 6--OHDA lESIONJNG ON "C~ 
UPTAKE 
5.3.1 Vtrlf1cll/on of pOJition 01 Infusion nef/d~ at r~rllel/eslon 5/19 
To obtat1 a VISual rtpfesootabOO 01 the posit!Oll of the infuSIOn needle althe "'FB larget 
IesIOl1 Sit durll"ig surgery. hlSlOIogy 01 the Infusion needle a1 tile tars" site was obtained 
from tre>y! I'l0l&1 stafoed t<IfOI\iM sections. The slideS were used to map lhe POSlbOO 01 
the needle ~p OOki Pa.rnos aM Watsoo a~as (2004) diagrams as presented beklw Table 
5 Sa shows the co-oroin .... 8$ used to map the positi>n 01 the needle infusJorr wlth,n each rat 
Dalll 1Ir' presetlled lrom n:8 rats. as sedI;)nS from n~2 rats were washed /rom !!.des 
dUr1"9 the cresyl WlIeI Starn"$ P~1.I1I Figure 5.5a shows hal! the atlas diagram 01 a 
c:oronaIS8C!IOII 01 a rat b'311 ~ the ""B 4 70 rmr rela\iYe p the ntelBlllllllIne (Pau"iOS 
Irod Watson, 1986) ju~ With hall a aesyl vUrt stai'led eDlOlla) secbor'l that 
conesponds apJrOXma:eIy WlflIhEr antmlr pos/e1'O" rllgOl aM $/loWs the po$'bOO 01 the 
neecllel4l The needle ~ posilDn appears medial II Ihrr target MFB sila F"lgrns S 5b 
and S 5c show t!l<IIlI h<f 01 the ralS (n:4). the needle trps were posrtrOtlId .. 006 - 0 \. 
rmr postenor kI the lIlended 1arget site 11'- lies 4 70 IJlIII anlefl)l klltre llter.ual k\e 
(PalillCl> iIId Watson, 1986) ' The needll lP.as pIoc8d aI AP 4 56 mm II n-2 fats (ra 
""3 rd rat 020) rd at N> 4 64 rM1 rr n:2 r.I15 (tal 017 om 0 19) Till poslllOfl of Ih8 
needle on n:4 rats was E 0 I - 046 mm iRl!fO" 10 AP 4 70 rM1 relat.w klltM! inllraural 
line (Figures 5 Sd·5.5g) Data obIafled from the CJes~ 'IIOIeI stillled sectrons show 1hat 
the needll was ~ilCIId at va'1able...w1D postloor posI\KlOs Irom N target ~LfIi'.es 
oflhe tE8 
• ite'"'"'"~_tltIi-BI ....... P_n "N-. 1!1III6) ~ ~""' PIIirIoI blWan (XO(I 
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5.l.2 BWviour~ Assessmenl - Apomorphln. /nduc&d tolelions 
Results for !he OO'lIpIete statisncal analyses reported below are re~ in Annex B. Tables 
5.6a ¥ICIS.&b st-cw tie nurrber aI rota\lOO1s cooduc1ed in response 10 apomorJl/lme by sham 
i!SIOI'led (I\" 14) and &-OHM IeslOOed (1F17) rats rtiS~w~y From Tab!e S.6a, n:9 shan 
IesiOr1i!'d rats tondlt;led <100 ~raj ro!atJons wtvle n:5 rats conducted <50 contrillateral 
~tIIS AI s/IiI'lI ItsIoned laRS were se'Ected lor t..1I1!le1 study Apomorphine lOduced 
>100 CIJOlI~:e ~aIa~~ rotatioos 11 n:14 rats lesioned with 6-0HOA, W,lh n~1 rat 
alfIIl£ttlg <100 CQ'Italatmll rotaIIOrl$ . lpsI!ateral 10taliOi'lS were eonducltd by n'2 6-
OHDA Iesl(l1ed rats (Tab~ 5611) 6-0HOA IesII;ned lals. eor.cl..:~ng >100 contralavlral 
rota:JonS (f\>12) wenr selecttd lor NMOA 5IITlIiated OSCa:· uptake SllJdy while n~2 \lll!re 
selecied b I)'rll$IIIe hyItoxytase study One &-OHM IHIone<l rat conducting ipsllaleral 
rota:JOn$ Wa! selected lor 1yrO$Q! hydrDxytase sUl1 The remallllng 2 rats not conducMg 
>100 eontralilleral fQtatofll wefe re'llCMld hlm fur1tler S~1 Frgure 5 6 shaws the average 
flIrnbef of rOlalions made by &-OHM IeSlOlllCl (n~1 4) IWld ~ IeslOllltd (n-14) rats 
selec:ed fOf M1her silldy II ~ ca/tU!lloOtah 3$$1y 
TlbIo 5.61 TIIbIt __ .... '"'"'** 01 ~_ (U"'II I tg) lncIu:od 1"CIWI0tIII 
~ondIIettI! loy h"MO'Ij oI\wOI'-- mo ~III) . 
"" ROTATIOHS 
. ~~"''''_UIq .,"'-tc _km .......... 16 ._ l<rl"ll"q_""&::re! 
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- -'" ~'-OHO'" 
FIg"" U ~ .. (O.li "'9 1 kCI) induc:od I"OIIIiono ollllbitod by I-OHOA 
I ......... nd llam 1 .. 1 ....... flits 1hII ..... ltleetocl lot fuMot Itucly Gonuoj.,.,,1 
fcutioftl Itt pOliti .. on 11M y-ull .nd ipIIIIIonI roc.tkm ".,.1I1n Sham 
lotionod ... conducto<lli 1 "pIUIIotoI tCIIa!IOdI. $1111Ctod I-OHOA 1flI000td "to 
ConduCiod 213:t 4] contrlll.unll"ClUllons. Raub Itt mo .. :1; ..... ......,1. Otu 
... _"" In TobItt 5.&0 ",d Uti. 
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5,3.3 IOletent 01 cle-generation-Immunocytochemisll)' 
InVll\lnocyt\lCnemistry conducted on a sag,nal section of the brain staJl1ed fo( tile dopamine 
synll1e5ls· regulating I!!lZyme, IyroSrlI! hydroxylase. hlgtWg!1ts fie (!opanine cClIICenlr.!ied 
areas oilhe basal ga~lia. The dOpilmlne fibres originate from ~ neurons 01 tile modbra1l1 
and lr.I~e the MFB to the sll"ia:i.ITI (Figl.l"e 5.7a) Figure 5.7b shows secbOns obtained 
from rats that rIad lIIdergor.e a~Lr,e . IJ'ldtlCed rotatiQl1s. The s/1am is-slOned rat 
conducted 55 ipsilateral rotaOOI'lS and stained JX)Saive 11)1 tyrosine l1ydroxl'lase In the 
midbraill (SNclVTA) and in the smtum in both hemispheres IFigl.l"e 57bi) 6·0HOA 
andtlCed degenerabOn 01 dopamme prodUC1I1\I neultlllS of It1e rnrdbrain '" It1e left is-sIOMd 
hellllsphere, resulbng in lack 01 tyroSine hydroxylase (FtgW"e 5.7bii) The S.GiOA Mm:)I)ed 
rat conducted 381 complele CDfIlralaterai rotati:IOS Figure 5.7biil shows tyrosl!le 
hydroxylase In S.OHOA les:Oned rat with partial degeneration 01 the left medial midbra;n , 
The IlISIOned rat conducted 104 compiete Ipsilateral rotabons. Degefl8fa~on of neurons in 
lI1e mJdI!ra,n SNc and the VTA (FlQure 57b) from lIl!\ls(m of 6-OHOA InItl the MFB 
c!emcII1strates retrograde degeneration, Lack of tyrosifle hydroxylase stallling In the striatum 





Hguro S.I. S.~IUII MetiO/l 01 Long Evan. ,aI b,oI. WI.td 10, tylOsI ... hydro.yln. 
highl~"" tho do~ <one.nIT.ltd ,ro .. v.lttIi" 1M h • ." g.ngb: IfIe midbnin. mo,j~ 
IQrob,aI " b..rdI. tMFB l i nd III. m.lUm. Sfdjon <or, .. PQnd' ' ~pi<I"''''l.ly lo 2.1Om:n 
...... to tho IIicIIrot 1',';"", & W.tson (191161. 
SHAM lESIDNEO RAT 
55 complete lpsRat.ral rOblions 
'" 
6-OHOA LE SJONEO RAT 
101 completelpsll' teral 
Ii 
6-OHDA LES IONED RAT 
381 complete contr.l~11IIlI1 robtions 
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compIMIpoilllO<ll fOIH_ 
TVltlSine hydr(\;l(y\a$e stain~ 01 'tie stlawm, 5 weeks POSI lUlV&rt confmled degeoerulOll 
to !lave been compjete Wohn Ihe sblatum II! toe !me NIIhe 05C~. upla~e assays were 
coroccted Figures 57c and S.7d show stained comnal sea!01I5 representalm 01 tile 
an:e!lof (1L and )R). mterme<liate (2t and 2R) and posterior (3L and 3R) slriata of sllam 
and 6.QHOA Ies10ned rats used \lflhe NMDA sllmutared 'I~' UPlake iISSaY ~!he shim 
IeSl)ned rats. tyrOSine hydfQX'flaS& was complete 11'1 bom!he sh;tm Ie~ Ieft!W'd rile ngIlt 
hemispheres Foli)wlf\g IXlmpiele g·OHDA IesiOn$, dopafllW\e loss was lI1!Iorrn Ihrougto.rt 
lIIe dorul and verttral stnata lrom ameriOr to pos!eriol reQ'oos in r.l1S lhaI had ~1eted 
~100 wnplete COIl\lil latera l fIltal.OOS In 6-OHDA IeSlOlled ral that had condLC!ed <100 
complete contriIlalerai rotallons, t)'T'llStne hydroxylase fs j)ilrtla/ly reduced ,n the ventral 
smatum al1d in the do~omed,al strialum (Ftgures 5 7c and 5.d) 
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Flgu,. SJo R",, '' ',n!>"'''' .. rial co,onal .. ~Ion. 01 ,;\I Or~in .howing <loP"""' to"";"'" Il>in.d 
I ... ly,osll1e ~ydr",ylo .. "Ullin .triIlO, Th ... rial ,".lIon. " .. I !rom ,h ... I •• ;onld lon tIwi loll) ;Wld r.-
OIiOA I .. ionld fOil Ion , .. riglll). look oll1'o"nl hydro.yI ••• :ainlllg In 1M I.~ II<ml.ptllre oJ tho 
fo.O~A 1 .. lonod ,ats llL, 2L, Jl) 'Qn~' ... ntl' <omplet. d"".mi". Io u roll"";ng 6-OHO.l. InJICI",n 
InlO !I>t MFB. Thl ... ttlion ...... thOi ;" tIwi &-0I1DA. Ie.loned .. t. <lop ... ; •• 10 .. In thl Itft 
hom .. "" ... wlO "'10"" 110m IhI I ntorior 10 thl p<>1tori", . tn _um Th ..... Clio ••• " rep,u.nl.i"" 
01 1M .Kllo,,, 01 tllI ant.rI .... inte' .... <IIr1. and po.I.orlo, obi"" If"", whiCh tlrl dorlal wiota ... '. 
di .. ""t.d 10' NMO.l. .timul.!Od "C." "Pl"kl .Iudi ... BtIow ...... ,iaI CGl'onal HeliOnl I,om. 6-O~.I. 
Ie, ioned ral with .,.rtial . trl.ul Mgtn.,.ti.." T 1'0.1". hydrw:y l, .. I. porti.lly " d"eod ,n "'" docs.1 
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ng" " ' ,/ 0 R0p'0 • • n",l,. .... I .. co,,,,,.1 .tc1I"". 0' ,., D,aI" .no .... g aOIW"I" Itrrnlnal$ 
. wood I .. 1i"" ;M nld' oryf . .. within • • m,al . 1';., .. Th, .. ri. l l tclionl w." f",m I h>m IHion.d ,.1 
t.l8(0" tho l o'tl .n~ 6-0KlA Itw lled rats (D" Ih. nghl~ u<k of I)'roOln, "y<lroxyf ... ' \lilli'li in tho hoft 
homi .pht .. of t/1t &-OKDA 1 .. IOI1ed .310 (11. 2:.., JlI 'o"fi mH ..... ''''''pie!. dop.mj"" 10 .. lolf<>Winli 6· 
OHDA i"itcti>n into lho MFB. Tho ... tctien. Ihow 111.! in tho i-OKDA I ... oned .. ts dopanl .. 10 .. in 
th. I,ft hom. pn." w.' unij",m from tn, Int. ri .. to Iho POSI,rio, .Inolum. Thtll OKI,on . or • 
.. p .... ' U.ti"" of Iho ucti on' of tho ."lI rio ... Int_. 11 a",! poolanO' _1 .. 1 Itn>\.o ,,"om whith 
'""!tal I lri>la , •• ". di .. tc!. ~ lor NMDA ,limul:u.d ''C.'' "PI-'I<, . 1"diU. e.4ow or • • trio! <0"",.1 
.. c~~n. Iron • 6-OKDA I .. "",.~ rot .. !II 1>0111 . 1 , In>l.1 dOll, nor.tion Tl"",ln. hrdro' 71 ... In til. 





NMOA SnMULATEO llCa1' UPTAKE 
NMDA 3timu~tion increlSes "'e.,. Up/Ike Into SHAM !es/ontd IJfJ 
DaHl saillllm - SI-£oUI iesioned"ts 
Resuas b" !he complete slaZIICaI analyres reported beklw are reponed in Anne~ B. In me 
sIlam IeSOfled rats, ne anTl.'ro' (ll and lR) ax! jXlStenQf (3L iII'd lRJ stnatal secbOnS 
Inc!maIed in NMDA (100j.JM) had slgfiIicaIdy grea'.er OOCr a:;:currulaton alXlve me basal 
"'Ca" ar::cumutanon ... r(U}·stunu:a!ed stnalal secllOn (Zl iII'd 2R) (Table 5 7a. F'Gure 5 Sa) 
The basal <lCa2- uptake (Ito !tie lJl1e!"O" sb'lal1lm ol the left he'lllSphere (2LJ was 001 
ddle!eft from basal "Ca" uptake ho Ihe slrim ol the right hemISphere (ZR) (Table 511, 
Flgtft S.8a). NMDA (100 }1M) SIQIlbl1ly irJ::leased OSCr'u~U dorsal $~Ia! we\lcns 
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NMDA StllTlUtated '\Cal" uptake WOIS cak:ulaled as prelliously desoibed (secllOl'l 6.1) by 5Ubtnldll"lg 
the blilsal uptake from the IOtal uptilke Stmulated '5Ca2" Uptill\e into the antero,. slriata (1 L·2l) .M 
uotal.e WIlO!he posteriDt s!l'iata ()L·2l) of 1I1e!ell hemisphere sIIo'Ned no stabsocal difference (Table 
5 lb. Figllre 5 Sb) RtsIJIs d stmJla1ed '5Ca2"uptake in the right hemlsphere between the anterior 
ana poSleflOr strw were smIar; !here was no slallSllCaI di/IerenCe blllween upla~e in \tie anler'or 
(I R·2R) and 11"1 toe po$lefI)r (JR.2R) s!rIalll (Table 5.6b, FigIn 56b). AoaltsOs 01 stinulated upt8~ e 
between l\emI$pheIes. snowed trlill stlmJlated "Ca" uptake into !he anlenQf Stnalll of t!1e left 
l1enllsp/lere (ll·2\.) was not ditrereol tan uptake 1Il!0 the anteriOr striata 0' Ihe Oijhl hem~here 
(IR·2R) (Table S.Th. FigIn 5.&:). smltlr1y. s:rmuIaed "Cal ' upIa~e "10 toe p05ll/n01" Slnatil (lL· 
2L and 3R·2Rj was not di1ereot (laNe 5.Th, Figure 5.8c) 
Tobie Sorb HIlDA rtinwtllOd "Ca" ",,11M inIc> oIcnII .... _1I11rlu 01 stWIlnIonod 
~. 
, 
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(S\udIfII 14nc !P>O.MI pM I ~~~~ nm .. nt .. m {1'IfI">Ol . 
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Slt"-,, LE SIOi\'I] D R.\TS 
"00" III'T AKE ,\."11]IllOI< AN l> POSTER IOR Sf NlUl' M IIUti L" ~,\CI I II HIISP' I F.R ti 
_ ANTERIORSUCE 
= f'CSTERtORSLK:E 
Figu1I5.Sb W.thin .. ch lItmi.pht,. 01 1"' SHAAI I .. io_ rI1 NMDA ."mul.1Od "PI'~' WI. 
comp3' od btl"""n tho ilt\lorlor .nd ~ ... rio, do"., ""OWrn. Tho ... _ I no tlgni~"'1 ~iH,,,"'t 'n 
upt.k. _" tho 'nt.n", Slnllurn 1M Ih. posl."", .. ri.tum In bal .. Mmi.p ....... (".<lenl t·t.1I. 
~O.05). Roo.a ..... mu/\ i Hm "mol '>C ... Img ~"'t.in (n"9). 0111 III IIponed in Tobl. 5.lb. 
, 
" • :. ... 
u , 
• • .1 • 
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SII .\ .'I I. I>S ION I! n K.i\TS 
"00" II 1'1'.ual 1:'< TO LEfT , .... \i I) 
RI{; IIT II E.'!ISl'II Il RES 
_ LEFT HEMISP!iERE 
= RIGHT HEMISP+tE~E 
Fig"'. 5.6< N),IOA OII",.IOItd '>CI" .pto • • Into ll>e do".' W I .. , complring 11\. 
I. h 'nionod .. ~ht .nI .. i.,."d html.p~ ... SHAM I ... .,., •• ",II (n-9l. Th.,. WI ... 
"gnilic. ", <liH ........ In IIpllk. be1wtfn tM ... Ion,o ' n<! "nluio",o ""mi.pIo ... 
,,'u,.nll.(l'$\. p<O.D5). R .. uh. ". ",un:t 10m ... 01 "CI" 1m; prottln. DIII.a 
apol'ltdln Table 5.1b."d .. pr.Hnttd in Flgu,. 5.31>. 
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13.4.1.2 
Total uptalce Into the ve!ltral stnata of SHAM lesioned rats was measured III n=5 rats In !he 
1Bft: and the nght t1emtSpheffis of !lie sham lesooned rats. totaI·SC~· uptal\e ir\to anterior (lL 
~ lR) alld posterklr (3L iI1d 3R) ventral sTliata was signiflCan~1 greater !han basal uptake 
(2L and 2R) (Table 5.8a, Figure 5.8d) Swnulated '1Ca'. uptal<e 1010 the anterior (lL·ll) 
and pos\e1JO( (3Ul) ~n~al s~i ata s~ no sigruficant dlflerenQ! with., the IBft 
hemisphere 00( was rIlere a sigruficant dlffefeoce tletween 1he antenor (1R·2R) and 
postew (3R·2R) slriata of \he right hemlsptlf!re (Table 5.6b) The stimulated 'lC~· uptake 
nto rile anterior striata 01 the left (1 L·2l) and righl (1 R·2RJ hemispl1eres was not lhfferen! 
(Table 5 7b), SUmula~ 'SCi¥ ' uptake into the ~rior striata (3L·2L and 3R·2R) was also 
not different (Tabe 5.70). 
' -E li TRAl. Sf R' AT AI. ' 'ca'' UPT AKF. 
·Sll.\. ... i U IOSH' RATS 
s£e1JO~ 
Figur. S.8d TOIII "CI" upIIg Imo 'ffiII,aI st,l ... of SHAM IH lo ..... rlU (""5). 'NIdIlA 
(I~MI,tin"ll .. d l~nllk:.", upIIg into ..",';", (1l InO 111) Ind pcsllfl", ,I';'" (3L Ind 
JRj II>ov. bout "Co" "PUg Inlo ..... ·.t ... uIaIor1 .trilU I2L Ind lR~ R ..... U." M"n ± 
"M ........ 'OC",' iMQ 1""0"'"" Dot .. ,. '"port'" 1ft h~. SolI. 
91 
i3.4.1.3 NMDA SrimuIiI!8d "C¥' ~e wo dorsal illdvuntril sl1iit.1- SHAM lesJooed 
". The results compa'l1g stimulaled <lCi¥' uplake into dorsal aod ventral stnala I(e pfO'lded 
hefB i!S mean ± standard del'la~on 01 \tie mean. S~mulated <!Cal-- uptake of dorsal (ll·2L 
and tR·2Aj and ~~al (3l·2LV and 3R·2R\I) sriata oo!amed from the same slite or from 
corlSecuIi'Ie slices, stlowed /hal uptake Inl<l the dorsal slriata lL·2L, 3.43 ± 1 .89 nmol "Ci¥' 
11119 prole,n. was nol signifl\:3n1l)' diffatllnt from uplake Inl<l the venlr.ll stnatum (3L·2L\I) 
mei!Sured to be 4 49 ± 2.63 "roo! '!Cal-/mg protem (Table 5.7b, Fig~re 5.Se) in the leli 
hemisphere. In II1e right henispllere, uptake inlO lI1e dorsal sll'iatum (1 R·2R), 2.89 1 1.54 
nmol'ICa1- lmg protelll was SlgnifiC..,t~ lass man uptake inlO the Vef\traI slf~tum (3fI·2R\I). 
4.82 ± 1.37 omoI <l(;at'lmg protein (student t·test. p<O 05) (Table 5.7b Figure S_8e) 
I 
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NMDA slimulation incruses " C.,· upld"nto 6·0HDA IfsiCtled ,.'5 
DclRI strl,rum - 6-CflDA iesicnvdro1l:S 
Resutts fer the tomplete statis~car analyses reported below are fElportil'C! in Annex B. 
Measuremeot 01 total OSCa2• uptake Into dO!SaI striatal setllOIlS or 6-OODI\ resklned rats 
(no 10). sl\o"i.ed tIlal tile total <~a" ao;umulation 01 the anlenor (1l and 1 R) and posterior 
(3L and 3R) sections was SI\Inr!ical\~Y diflarenl (p < 005) from the basal uPla~e 01 the 
eonlTOl sections (2L and 2Rj (Table 58a. Figure 59a), NMDI\ (100 11M) stimulatil'C! a 
sigr1loca fl! increase ol''C~' uptake into dorsal striatal sections in 6-OHOl\ resioned rats 
Measurements of ~aI 'leal- uptalce into the s'r~a of tile left Ies>oned ilerrosphere (2l) 
and the nght unleslOlled (2R) WIfe f'IOI slgnrficafltl)' differellt (Tab~ 5l!a, Figure 5,9a) 
~. I," ~ o. ~ •• I." 
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OOIt SA .. ST ItL\T .... ''ca''" UI't'MU: &'0 11 ().\ U ;OO," f.D KATS 
SECTIOH 
fl9\l .. U.TO\.IIIII(:". ....... l!'IIe "" .... till .. _ I-OHDA 1nIo .... _ C.·10~ 
'HMD'!' [1~) ~.ocI "tr'Ifoc:a.nIir 1'_ "Co~ ..... Iou iorul ....... IINta 
(l. .nII lRj ItId I'OIIeriot llrilll (3i. ./HI lRj ""~ ,.I0Il ..... 1!'iIO non-ltimWlH 
,b1.IIII MeIlont (ZL I<Id 2R.jl ....... "'" 10 normoI bufIott /It"""" , ...... p<t.OS~ AHuita 
.... ",""i tim omolUCl"I"" PfOtoIoC .. l0~ o.u ... ~ 1ft lot" 5. ... 
Maasu~ment oC s~mu!ated 0!Ca'. uptake w~ used !O dete/T1i'le whetrer Itlefe ",ere a'lY 
dl!1ererces in uptake 01 an\t!llor and POSletcr sliiata wfllWl each t.!~e, and !O 
delerrrw'l& wheiller lhere W«e any drfferercE!$ ... uptake n h left herns~e and the IIjU 
herms~e There was no dl!1ererce In $I ..... ulated f5Cal- uptake ontl the arr.enor slriata DC 
ltI& ~It ~slO!l8d ~re (I L-2l) and 1M pClSlOI'OI strtaUl (3L-,l) neither was !here any 
dhrJCe In Simulated O!Cal-uptake WlIO Ihe antenor ~ta o! the oght hemisphere (1 R·2R) 
and the posleoor striata (3R-2R) (Table 5 7b, FI\IU/e S7b) The results oIlhe dillererx:e 01 
stO'!lllated '!Ca'-lJjlIake Wl!O the left 1e5lOlled hemisphere and into the riGht lesb"oed 
hellllSjlllere shew thai !here was no difference itl '!Cal- uplal«llnto the anterior Slrl<lta, nor 
was toe" iIfly diller&nee itlto posleoor Sll'iata (Table 5.8b, Figure 59c) TOOre was no 
SlgrUc.nI dillerence In ntnJlated f5C.1• uptake itlto the left 6-OHDA lesioood hemlS!*Jere 






Il·2L ~ sem lR·2R .1 sem 
(,ottD.' LES l oOoi~D .... n 
''co'' un AI<E ~"TO ",,,UKK,. A"D ""'TfiRK>K >Tn" u" '.-.rtlIS 00\01 110" ISO'III' n . 
='NTERllRSU;E 




fig.r , U~ NMDA ,tim""ltd ''Ca'' upt>" Into dOrlol .u·.t> ";I~n .~,h "ml.lthor. olm. 
'·OIlDA Il1 ionld '01. 1.'IDI. Stimul.tld ""t>);, wn <omporod 1>otwten thl "nlll'ior ,nd 
po . lt"or do .. al Slrltl> In tho loft ""d rigl>1 "'m"phtrQ. No oi gnl~c>"' diN.",n," in u",,~. 
1>o1Wtln 11>1 .ntl rior lI~OIum and 11>0 p01lO~or .!,I"um in both hemllphl'H. Ro,.'tI or" 
,oport. d •• "'tlll\:; .. '" nmol "C," Img 1>"010,", D'ta.ro "l'Ort"" ., Tobl. 5.ab. 
"~ 
UU2 
6. 0Jll>A LUIO.~· Hl> .... T5 
• 
FIg ... Uc: NIoIDAIIlmvIIlIld "Co" "Plcakt Into dOrtoillrilli com~lIi~ Iht ~ 
Inion.:! ... rillhI ""'"iontd ~ ... i"",.rt &-aIllA InionH , .. ("'IO~ No .Igniflc,.t 
di~ in "pIM' ~ tho IttIontd ond "",nI_ h .... op/>o" (.Iud, ., Hnt, 
,.,U$~ R ... 1h ,,' ~ .. ...... :I: HIll nn\OOI "Col' InIg prultln. 0." Vl' 
..portod 1ft h.lI. U II. 
Total upjate 11110 .. vennl SIJIaIa of 6-OHOA ItSlOoed rats was rl'eaSUted ill n·4 rats 
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6.1 NMDA (100 pM) stimulated 45Ca2t- uptake response in striatal sections 
In this study we were able to demonstrate that NMDA receptor-mediated Ca2+ influx can be 
measured in striatal tissue in vitro using the assay as described by Lehohla et al (2000). To our 
knowledge, these are the first such measurements to be made in striatal tissue using this method. 
Preliminary experiments were conducted to determine whether 100 ~M NMDA was effective in 
stimulating significant levels of 45Ca2+ uptake into 350 ~m thick striatal sections and to confirm the 
reproducibility of the assay (Table 5.1a, Figure 5.1). Measurement of 45Ca2+ uptake into striatal 
tissue from 7 week old rats, n=7, (Table 5.2a), 16 week old rats, n=6, (Table 5.3a), sham lesioned, 
n=9, (Table 5.7a, Figure 5.8a) and 6-0HDA lesioned rats, n=10, (Table 5.8a, Figure 5.9a) confirmed 
that NMDA (100 ~M) was effective in stimulating significant 45Ca2+ influx into dorsal striatal and 
ventral striatal sections. 
Lehohla et al (2000) reported NMDA stimulated 45Ca2+ uptake into Long Evans rat barrel cortex was 
28 - 31% above basal 45Ca2+ uptake levels. The results of the current study show that NMDA (100 
~M) evoked a greater response in the striatum than in the barrel cortex. Results from 7 week old 
rats show that NMDA stimulated 45Ca2+ uptake was 117 -156% above basal levels (Tables 5.2a and 
5.2b). In 16 week old rats N MDA stimulated increases of 38 - 70% above basal 45Ca2+ uptake levels 
(Tables 5.3a and 5.3b). These results suggest that a two to three fold decrease in NMDA stimulated 
response occurs over 9 weeks of growth. The results from the ventral striata were similarly 
increased in both 7 week and 16 week old rats (Tables 5.2a, 5.2b, 5.3a and 5.3b). In the lesioned 
rats, the NMDA stimulated 45Ca2+ uptake response above basal levels was also higher than the 
levels reported by Lehohla et al (2000). NMDA stimulated increased 45Ca2+ uptake in the sham 
lesioned rats by 54 - 71% above basal 45Ca2+ uptake levels (Tables 5.7a and 5.7b, Figure 5.8a) 
while in the 6-0HDA lesioned rats, increases of 45Ca2+ uptake were 78 - 93% above basal 45Ca2+ 
uptake levels in response to NMDA stimulation (Tables 5.8a, 5.8b, Figure 5.9a). 
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6.2 Effect of age on NMDA stimulated 45Ca~ uptake response 
6.2.1 Dorsal Uptake 
When the NMDA stimulated 45Ca2+ uptake in anterior dorsal striata of 7 week old rats was compared 
with uptake in 16 week old rats, uptake into anterior striata of 16 week old rats showed a 69% and 
46% reduction in the left and right hemispheres below uptake of 7 week old rats (Table 5.4a, Figure 
5.4a). In the posterior striata of 16 week.old rats, NMDA stimulated 45Ca2+ uptake was decreased 
66% and 63% in the left and right striata below NMDA stimulated 45Ca2+ uptake of 7 week old rats 
(Table 5.4a, Figure 5.4a). These results show a significant decrease in stimulated uptake of 16 
week old rats compared,to 7 week old rats and suggests that during 9 weeks of growth from juvenile 
to young adult development, there is an average decrease of = 60% in dorsal striatal NMDA 
mediated Ca2+ influx. 
6.2.2 Ventral uptake 
Results comparing ventral striatal 45Ca2+ uptake in 7 week and 16 week old rats also indicate a 
tendency for 45Ca2+ uptake in the older animals to exhibit a reduction in NMDA mediated 45Ca2+ 
influx in all striatal sections. In 16 week old rats, NMDA stimulated 45Ca2+ uptake into ventral anterior 
striata of the left and right hemispheres was 49% and 32% below NMDA stimulated 45Ca2+ uptake 
into anterior ventral striata of 7 week old rats (Table 5.4b, Figure S.4c). In the posterior ventral 
striata of the right hemisphere in 16 week old rats, the NMDA stimulated 45Ca2+ uptake was 41 % less 
than in NMDA stimulated 45Ca2+ uptake in 7 week old rats (Table 5.4b, Figure 5.4c). Whereas 
NMDA stimulated 45Ca2+ uptake in the posterior striata of the left hemisphere of 16 week old rats 
was reduced by 65% compared to NMDA stimulated 4SCa2+ uptake in 7 week old rats. Surprisingly, 
the only significant difference in NMDA stimulated ventral striatal 45Ca2+ uptake between 7 week and 
16 week old rats was in the posterior section of the left hemisphere were the reduction during 9 
weeks of growth was greater than 500". 
The above results showing significant reduction in NMDA receptor mediated 45Ca2+ influx with 
increasing age from 7 weeks to 16 weeks concur wtth reported age dependent attenuation of NMDA 
receptor activity attributed to reduction of NMDA receptor density that occurs in rats (Mitchell and 
Anderson, 1998; Wenk and Barnes, 2000, Bai et ai, 2004). There are major changes of dendritic 
spines that occur, including shrinkage and loss and these undoubtedly contribute to the reduction of 
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NMDA receptor density (Levine et ai, 1988; Dunia et ai, 1996; Segovia et ai, 2001). Owing to this, 
the results from the ventral striatal 45Ca2+ uptake showing lack of Significant difference were indeed 
surprising. 
6.2.3 Striatal Ca2+ homeostasis and age 
Basal uptake was compared to determine whether differences in NMDA stimulated 45Ca2+ uptake 
between 7 week and 16 week old rats could be a factor influencing the levels of 45Ca2+influx. There 
was no significant difference in basal 45Ca2+uptake into dorsal or ventral striata between adolescent 
7 week old rats and young adult 16 week old rats (Tables 5.2a and 5.3a, Figures 5.4b and 5.4d). 
These results are consistent with the findings of Griffith et al (2000) that intracellular Ca2+ 
concentrations are unchanged and that Ca2+ homeostasis is not compromised with age. 
6.3 6-0HDA lesion technique and extent of degeneration 
6.3.1 MFB lesioning and apomorphine induced rotations 
In the current study the 6-0HDA model of Parkinson's disease was established by conducting 
histological mappings of the needle tip positions around the MFB and by conducting behavioural 
assessments of the lesion followed by immunocytochemistry. In targeting the MFB, the mappings 
shown on the atlas diagrams, show variability of the needle tip position (Figures 5.5a - 5.5g). In n=1 
rat, the needle was positioned too ventral from the intended target suggesting possible error in lesion 
technique (Figure 5.5e). The main factor influencing variability in the study may be attributed to 
natural variability of rat brain sizes and shape. In n=14 sham lesioned rats and n=17 6-0HDA 
lesioned rats, apomorphine induced rotations were used to assess extent of dopamine depletion. 
Results from sham lesioned rats in the current study show that 19 ± 8 rotations ipsilateral to the 
lesion were conducted (Table 5.6a, Figure 5.6a). The mean number of rotations conducted by 6-
OHDA lesioned rats was 233 ± 43 complete contralateral rotations (Table 5.6b, Figure 5.6a). This 
is consistent with Hudson et al (1993) who showed that apomorphine injection did not produce a 
Significant number of rotations in non-Iesioned rats. Moore et al (2001) found that a contralateral 
rotational bias in response to apomorphine only occurred when >70 - 80% degeneration of midbrain 
dopamine neurons and striatal dopamine fibres had occurred in rats infused with 6-0HDA into the 
MFB. This suggests that in the current study, >70% degeneration was achieved in 6-0HDA lesioned 
rats selected for NMDA stimulated 45Ca2+ uptake assays. 
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6.3.2 Tyrosine hydroxylase immunoreactivity 
Tyrosine hydroxylase staining of the midbrain and the striatum confirmed that degeneration, shown 
by TH staining, was minimal in sham lesioned rats; there was complete staining in the striatum and 
midbrain of both hemispheres (Figures 5.7b - 5.7d). In a 6·0HDA lesioned rat that had conducted 
381 contralateral rotations, there was near complete loss of TH ipsilateral to the site of 6-0HDA 
injection (Figures 5.7b - 5.7d). Immunocytochemistry was conducted on a 6·0HDA lesioned rats 
that had exhibited 101 ipsilateral rotations in response to apomorphine. There was a reduced TH in 
the midbrain and in the medial dorsal and medial ventral striata but the reduction was not as 
extensive as the degeneration observed in 6·0HDA rat conducting >100 contralateral rotations 
(Figures 5.7biii, 5.7c and 5.7d). These results confirm the findings by Carman et aJ (1991) that the 
number of TH immunoreactive neurons that remain unlesioned is correlated to the number of 
contralateral rotations conducted in response to apomorphine; the fewer the number of degenerated 
neurons the fewer the number of contralateral rotations. Apomorphine induced rotations are a useful 
predicator of the extent of midbrain degeneration of dopamine neurons and dopamine terminals in 
the striatum (Carman et ai, 1991). The results of TH immunocytochemistry obtained from the serial 
sections confirmed that 5 weeks post surgery, there was near complete depletion of dopamine 
neurons in the entire striatum of the lesioned left hemisphere in 6·0HDA lesioned rats selected for 
NMDA stimulated 45Ca2+ uptake assay and that in selected sham lesioned rats, dopamine 
innervation remained intact within both hemispheres. 
6.4 Effects of dopamine depletion on NMDA 45Ca24- uptalceresponse 
6.4.1 NMDA stimulated 45Ca2+ Uptake in lesioned lIS. unlesioned hemisphere 
Having confirmed through TH immunoreactivity that there was near complete depletion of dopamine 
in the left striatum, ipsilateral to the 6·0HDA lesion, it was expected that there would be increases in 
NMDA receptor mediated 45Ca2+ influx in the left striatum relative to NMDA stimulated 45Ca2+ uptake 
in the striatum of the right hemisphere that had intact TH immunoreactivity. NMDA stimu lated 45Ca2+ 
uptake into the anterior striatum of the left hemisphere was 2% less than NMDA stimulated 45Ca2+ 
uptake into the anterior striatum of the right hemisphere whereas in the posterior striata NMDA 
stimulated 45Ca2+ uptake into the striatum of the left lesioned hemisphere was 2% more than uptake 
into the striatum of the right hemisphere (Table 5.8b, Figure 5.9c). These differences in NMDA 
stimulated 45Ca2+ uptake between striata of the 6·0HDA lesioned left hemisphere and the 
lOS 
unlesioned right hemisphere were marginal and not significant (Table 5.8b, Figure 5.9c). These 
results from 6-0HDA lesioned rats were similar to the results of NMDA stimulated 45Ca2+ uptake 
measured in sham lesioned rats. In the sham lesioned rats there was a 2% difference in NMDA 
stimulated 45Ca2+ uptake between the anterior striata of the left and right hemispheres. In the 
posterior striata NMDA stimulated 45Ca2+ uptake levels in the right hemisphere were 17% higher than 
NMDA stimulated 45Ca2+ uptake levels in posterior striatum of the left hemisphere (Table 5.7a, 
Figure 5.8c). There was no significant difference in NMDA stimulated 45Ca2+ uptake between the 
sham operated left hemisphere and the unlesioned right hemisphere. These results suggest that 
mechanical stress induced by the surgical procedure did not disturb NMDA mediated 45Ca2+ influx. 
6.4.2 Comparing sham lesioned and dopamine depleted striatal uptake 
NMDA stimulated 45Ca2+ uptake into the anterior dorsal striata of 6-0HDA lesioned rats showed 
increases of 8% and 11% in the left and right hemispheres respectively above NMDA stimulated 
45Ca2+ uptake in sham lesioned rats (Table 9a, Figure 5.10a). In the posterior striata of 6-0HDA 
lesioned rats, NMDA stimulated 45Ca2+ uptake in the left and right hemispheres showed 32% and 7% 
increases respectively above NMDA stimulated 45Ca2+ uptake levels of sham lesioned rats (Table 9a, 
Figure 5.10a). There was no significant difference in NMDA stimulated 45Ca2+ uptake between 6-
OHDA lesioned and sham lesioned rats. It is of interest that while the measurement of the left 
posterior striatum was the highest measurement in the 6-0HDA lesioned rats, the measurement 
from the same striatal section was the lowest measurement in sham lesioned rats. While these 
findings could suggest that NMDA receptor function in the posterior striata of the lesioned 
hemisphere was attenuated in response to sham operations and enhanced in 6-0HDA lesioned rats, 
this does not seem likely as there were no significant differences between the left lesioned and the 
right unlesioned hemispheres in either sham lesloned or 6-0HDA lesioned rats. 
To determine whether changes In basal uptake may have masked upregulation of NMDA receptor 
mediated 4SCa2+ influx in dopamine depleted animals, basal uptake between striata of sham lesioned 
and 6-0HDA lesioned rats was analyzed. Although there was a tendency for basal 4SCa2+ uptake to 
be lower in striatal sections obtained from 6-0HDA lesioned rats compared to sham lesioned rats, 
there was no significant difference between the two groups (Figure 10b). Sham operated rats had 
25% greater uptake in the left hemisphere and 15% greater basal uptake In the right hemisphere 
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than 6-0HDA lesioned rats. Our investigations examining the differences in NMDA receptor function 
in the dopamine depleted striatum do not support the Original hypothesis that reported upregulation 
of NMDA receptors would translate into increased ionic flux of 45Ca2+ in response to NMDA 
stimulation. 
6.4.3 Dorsa-ventral differences 
NMDA stimulation seemed to evoke a higher 45Ca2+ influx response in ventral striata than in dorsal 
striata but there was no significant difference in NMDA stimulated 45Ca2+ uptake between the dorsal 
and ventral striatal 45Ca2+ uptake in either sham lesioned or 6-0HDA lesioned rats (Tables 5.7b, 5.8b 
and Figures 5.8e and 5.ge). The lack of statistical significance in these results may be attributed to 
the small number of rats (n=4 in 6-0HDA lesioned rats and n=5 in sham lesioned rats) used in the 
analysis which could also account for the large standard deviation from the mean. 
6.5 NMDA stimulated 45Ca2+ uptake into anterior and posterior striatal regions 
Lehohla et at (2001) reported differences in 45Ca2+ uptake between rostral, middle and caudal barrel 
cortices. In our study we sought to identify whether similar regional differences between anterior and 
posterior striatal regions existed. In the 7 week old rats, anterior dorsal striata showed 35% increase 
above posterior dorsal striatal uptake in the left hemisphere but showed an 8% decrease below 
uptake in the posterior dorsal uptake in the right hemisphere (Table 5.2b, Figure 5.2a). There were 
no significant differences between anterior and posterior dorsal uptake in either hemisphere in 7 
week old rats. In 16 week old rats, anterior dorsal uptake levels were 28% higher than uptake levels 
In the posterior striatum in the left hemisphere and were 25% higher than posterior striatal 45Ca2+ 
uptake in the right hemisphere (Table 5.3b, Figure 5.3a). However, there were no significant 
differences in anterior-posterior 45Ca2+ uptake in either hemisphere. In 6-0HDA lesioned rats, the 
trend was reversed with NMDA stimulated 45Ca2+ uptake levels into the posterior striata showing a 
tendency to be higher than levels in the anterior striata. In the left hemisphere, NMDA stimulated 
45Ca2+ uptake into the anterior striatum was 17% less than uptake into the posterior striatum. In the 
right hemisphere, NMDA stimulated 45Ca2+ uptake into the anterior striatum was 14% less than 
uptake into the posterior striatum. These differences between anterior and posterior NMDA 
stimulated 45Ca2+ uptake in 6-0HDA lesioned rats were not significant. In the sham lesioned rats 
anterior striatal uptake in the left hemisphere was 1 % higher than uptake into the posterior striatum 
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though in the right hemisphere the anterior striatal uptake was 17% below posterior striatal uptake 
(Table 5.7b, Figure 5.8b). In all the animals studied there were no significant differences in NMDA 
stimulated uptake between anterior and posterior striata and that there was variability in anterior· 
posterior NMDA stimulated 45Ca2+ uptake. 
6.6 Conclusion 
6.6.1 Findings on striatal NMDA receptor function 
In the current study we set out to determine whether aging would result in decreased NMDA 
stimulated 45Ca2+ uptake into the striatum and whether dopamine depletion induced by degeneration 
of the nigrostriatal pathway increases NMDA stimulated 45Ca2+ uptake. We were able to 
demonstrate that 9 weeks of growth from adolescence to young adulthood in male Long Evans rats, 
results in reduction of NMDA receptor mediated 45Ca2+ influx of up to 69%. These results support 
the findings that striatal glutamate innervation and NMDA receptor responsiveness hence neuronal 
excitability are reduced with age (Cepeda at ai, 1989; Cepeda at ai, 1996; Segovia et ai, 2001). To 
our knowledge, this is the first study to demonstrate such a SignifICant reduction of NMDA receptor 
function in the dorsal striatum using the in vitro NMDA stimulated 45Ca2+ uptake assay. 
The second hypothesis we tested was that degeneration of the nigrostriatal pathway would resuR in 
increased NMDA stimulated 45Ca2+ uptake. The results from the study did not concur with this stated 
hypothesis. Instead we found that there are no differences in NMDA stimulated 45Ca2+ uptake 
between 6-0HDA lesioned and sham lesioned rats and neither are there any differences in NMDA 
stimulated 45Ca2+ uptake within the 6-0HDA lesioned rats comparing the striatal 45Ca2+ uptake from 
the lesioned and the unlesioned hemispheres. These results rather suggest that reported 
modifications of NMDA synaptic expression and phosphorylation state in parkinsonian rats may 
serve a different function from altering receptor mediated Ca2+ influx. Dunah at al (2000) described 
changes in subunit composition on the synaptic membrane attributed to internalization. 
6.6.2 Functional mechanisms for consideration 
A factor that could have masked any upregulation of NMDA receptor function may have been the 
morphological changes that occur i.e. dendritic spine atrophy following dopamine depletion (Ingham 
at ai, 1998; Meshul at ai, 1999; Arbuthnott at ai, 2000). This would influence the number of 
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functional NMDA receptors stimulated in the assay. The morphological changes could be attributed 
to increased Ca2+ influx which causes a reduction in the binding affinity of NMDA receptor subunits 
for crosslin king structural proteins resulting in depolymerisation of cytoskeletal proteins (Krupp et aI, 
1999; van Rossum and Hanisch, 1999). As a result, despite their necessary role in synaptic function 
and modification, Ca2+ influxes are tightly regulated in neurons as they can also induce 
neuropathological disturbances that cause cell death (Hardingham and Bading, 2003). One could 
speculate that to counter possible collapse following dopamine depletion, homeostatic mechanisms 
in surviving spines would be increased in response to increased NMDA receptor mediated Ca2+ 
influx. Ca2+ influx is substantially influenced by homeostatic regulation of intracellular Ca2+ levels 
that occurs to counter changes in neuronal excitability (Yeung et aI, 2004). Increases of the 
membrane potential of the medium spiny neurons that follOW dopamine depletion would also 
increase NMDA receptor mediated influx of Ca2+ ions (as the Mg2+ block is removed) and in addition 
the opening of voltage gated Ca2+ channels would increase Ca2+ intracellular levels (Tseng et aI, 
2001). It would be necessary to study whether the activity of Ca2+-ATPase is enhanced following 
dopamine depletion in the striatum to understand some of the mechanisms involved in regulating 
levels of intracellular Ca2+. 
6.6.3 Sensitivity of the NMDA stimulated 45Ca2+ uptake assay 
The issue of sensitivity of the NMDA stimulated 4SCa2+ uptake assay was considered particularly as 
NMDA receptor mediated currents are maximal at depolarised potentials and with glycine co-
stimulation; two conditions not included in the assay. To induce membrane depolarization in the 
study would have skewed our measurements of the N MDA mediated 4SCa2+ uptake response as a 
consequence of the invariable activation of other channels including L-type voltage activated Ca2+ 
channels. Though as mentioned above, previous studies have found that membrane potential of 
spiny neurons does become less negative in response to dopamine loss and this was not a variable 
we could control easily in our preparation. Co-stimulation of NMDA receptors with glycine increases 
the open probability of receptor channels hence the number of open NMDA receptors and this 
influences the amplitude of Ca2+ currents (Jahr, 1992). Lehohla et al (2000) in developing the assay 
found that addition of 1mM glycine to the assay did not result in a significant difference in NMDA 
stimulated 4sCa2+uptake into the barrel cortex and it was deemed unnecessary to add glycine to the 
assays used in the current study. A further factor that may have influenced activation of the NMDA 
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receptors is the use of halothane anaesthetic prior to killing the rats for the assay. Halothane 
reduces the amplitude of NMDA receptor mediated excitatory postsynaptic potentials (Nishikawa et 
a', 2000). Finally, the conclusive results of the effects of age on NMDA stimulated 45Ca2+ uptake 
serve as a strong indication that the assay was indeed sufflCienUy sensHive to in measuring NMDA 
mediated Ca2+ influx into the striatum. 
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ANNEXA 
K GROUP lesioned 5/10/04 & 
RAT WEIGHT WEIGHT 
week pre-lesion (g) at lesion (g) 
K1 317 352 
K2 302 343 
K3 305 341 
K4 304 336 
K5 297 331 
K6 304 331 
K7 303 330 
K8 297 329 
K9 298 336 unlesloned 
M GROUP lesloned 
RAT WEIGHT 
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6/1012004 
WEIGHT WEIGHT 






















































































KGROUP Type of lesion Number apomorphine Post lesion 
RAT WEIGHT rotations treatment 
CHANGE from 
date of lesion (g) 
K1 -88 6-OHDA 1419 TH staining 
K2 -31 8-0HDA 1950 Ca UPTAKE ASSAY 
K3 -66 6-OHDA 1341 Ca UPTAKE ASSAY 
K4 -73 6-OHDA 453 Ca UPTAKE ASSAY 
K5 -45 6-OHDA 760 Ca UPTAKE ASSAY 
K6 -53 sham 16 Ca UPTAKE ASSAY 
K7 -17 sham o Ca UPTAKE ASSAY 
K8 -12 sham 45 Ca UPTAKE ASSAY 
K9 82 unlesioned 93 Ca UPTAKE ASSAY 
MGROUP Type of lesion Number apomorphine Post lesion 
RAT WEIGHT rotations treatment 
CHANGE from 
date of lesion (g) 
M1 -83 6-OHDA 1104 Ca UPTAKE ASSAY 
M2 -72 6-OHDA 595 Ca UPTAKE ASSAY 
M3 -45 6-OHDA -402 TH staining 
saorificed 2111/04 
cyst infection 
M4 6-OHDA 208 died in cage 20/10/04 
suspected urinary 
tract infection (blood filled 
erect genetalia) 
M5 -40 6-OHDA 1700 Ca UPTAKE ASSAY 
M6 -83 8-0HDA 707 TH staining 
sacrificed 2111/04 
cyst infection 
M7 -10 sham not rotated sacrificed 20/10/04 
stitch infection and cyst 
M8 329 364 35 338 -26 324 330 
ANNEXA REPORT OF RATS USED FOR STUDY 
M9 322 359 37 325 -34 350 392 
M10 292 336 44 309 -27 317 344 
M11 310 365 55 325 -40 328 367 




N GROUP lesioned 16/10/04 & 17/10/04 
RAT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT 
week pre-lesion (g) at lesion (g) CHANGE (g) day 2 post lesion (g) CHANGE (g) week 1 post lesion (g) week 2 post lesion (g) 
N1 301g 381 80 349 -32 324 366 
N2 291g 349 58 not survive surgery 
N3 327g 387 60 359 28 310 290 
N4 320g 396 76 359 37 333 370 
N5 292g 360 68 342 -18 334 380 
N6 294g 355 61 326 -29 319 348 
N7 330g 379 49 351 -28 306 344 
N8 303g 361 58 336 -25 354 385 
N9 290g 338 48 324 -14 345 360 
N10 305g 358 53 334 -24 308 cyst 
N11 322g 385 63 371 -14 368 cyst 
M8 -34 sham -220 TH staining 
sacrificed 2111/04 
cyst infection 
M9 33 sham -303 Ca UPTAKE ASSAY 
Mi0 8 sham 26 Ca UPTAKE ASSAY 
M1i 2 sham -278 Ca UPTAKE ASSAY 
M12 12 sham -22 
M13 Needle placement TH staining and cresyl violet staining 
M14 Needle placement 
M15 Needle placement 
NGROUP Type of lesion Number apomorphine Post lesion 
RAT WEIGHT rotations treatment 
CHANGE from 
date of lesion (g) 
N1 -15 6-0HDA sacrificed 9/11/04 
cyst Infection 
N2 
N3 -97 6-0HDA 661 sacrificed 2111/04 
suspected urinary tract infection 
bladder from autopsy shows 
thickish yellow urine and blood 
N4 -26 6-OHDA sacrificed 2111/04 
cyst infection 
N5 20 6-OHDA sacrificed 9/11/04 
cyst infection 
N6 -7 6-OHDA sacrificed 9/11/04 
cyst infection 
N7 -35 sham -67 sacrificed not used in study 
N8 24 sham -83 sacrificed not used in study 
N9 22 sham -98 sacrificed not used in study 
N10 sham sacrificed 27/1 0/04 
cyst infection 
organs to Stellenbosch 
N11 sham taken to Stellenbosch alive 27/10/04 
N12 307g 355 48 332 -23 328 350 





o GROUP lesioned 4/11104 & 5/1112004 
RAT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT 
week pre-lesion (g) at lesion (g) CHANGE (g) day 2 post lesion (g) CHANGE (g) week 1 post lesion (g) week 2 post lesion (g) 
01 364 390 26 353 -37 302 300 
02 346 359 13 333 -26 316 284 
03 310 335 25 320 -15 346 
04 345 370 25 335 -35 330 398 
05 333 356 23 322 -34 301 333 
06 343 362 19 317 -45 
07 307 340 33 300 -40 263 212 
08 345 370 25 336 -34 
09 358 379 21 342 -37 
010 335 355 20 319 -36 297 322 
011 366 391 25 387 -24 355 372 
012 351 388 37 350 -38 330 360 
013· 347 398 51 362 -36 364 382 
014 346 385 39 355 -30 328 340 
015 375 410 35 385 -25 




N12 sham sacrificed 2111/04 
cyst Infection 
N13 Needle placement 
N14 Needle placement 
N15 Needle placement 
N16 Needle placement 
o GROUP Type of lesion Number apomorphine Post lesion 
RAT WEIGHT rotations treatment 
CHANGE from 
date of lesion (g) 
01 -90 6-0HDA 705 Ca UPTAKE ASSAY 
02 -75 6-0HDA 1977 Ca UPTAKE ASSAY 
03 6-0HDA sacrificed 13111/04 
cyst infection 
04 28 6-OHDA -197 sacrificed not used in study 
05 -23 6-OHDA 1022 Ca UPTAKE ASSAY 
06 6-0HDA sacrificed 9/11/04 
Paws with blOod from scratching nose 
stitches untouched 
07 -128 6-OHDA 648 Ca UPTAKE ASSAY 
08 6-0HDA died In cage 9/11104 
Nostrils red 
eyes filled with red ftLid 
09 6-OHDA sacrificed 9/11/04 
cyst infection 
010 -33 6-OHDA 1872 Ca UPTAKE ASSAY 
011 -19 sham -91 Ca UPTAKE ASSAY 
012 -28 sham 127 Ca UPTAKE ASSAY 
013 -16 sham -134 Ca UPTAKE ASSAY 
014 -45 sham -157 Ca UPTAKE ASSAY 
015 sham -12 Ca UPTAKE ASSAY 
016 14 sham -80 sacrificed not used in study 
017 Needle placement 




















2.1.1 SURGICAL LESION. PROCEDURE 
• Airtight container 
• Blease vaporisor (Clinical & Medical Services, 4 Stanley Road, Observatory, 
South Africa) 
• 2-bromo-2-chloro 1:1:1 trifluoroethane with 0.01% thymol (Halothane) (Safeline 
Pharmaceuticals LTD, 1 Manchester Road, Wadeville, South Africa) 
• Desipramine hydrochloride 
Desipramine hydrochloride No 0-3900 (Sigma Chemical Company, St Louis MO 
63178, USA). 
Desipramine hydrochloride USP grade 0-125 (Research Biochemicals 
Incorporated, 1 Strathmore Road, Natick, MA 01760 USA). 
• Hamilton Syringe (Hamilton Bonaduz AG, OH-7402 Bonaduz, Switzerland) 
• L-Ascorbic Acid (Merck, 64271 Darmstadt Germany) 
• Medical Oxygen (Air Liquide, Cape Town, South Africa) 
• Silk suturing thread (CliniSilk 3/0) CliniSut, Sasurel (Pty)L TD 21 McHardy Avenue, 
Holland Park, Port Elizabeth 6001, South Africa 
• Stereotaxic apparatus 
• Syringe Pump (Model 341 A. Sage Instruments, Division of Orion Research 
Incorporated, 840 Memorial Drive Cambridge, MA 02139, USA) 
• 2,4,5-Trihydroxyphenethylamine (6-hydroxydopamine) Hydrochloride (6-0HDA) 
(Sigma Aldrich Company, St Louis MO 63178, USA). 
2.1.2 BEHAVIOURAL ASSESSMENT OF 6·0HDA LESIONING 
• Apomorphine hydrochloride hemihydrate (Sigma Chemical Company, St Louis MO 
63178, USA) 
• Automatic Rodent Monitor V2.02~ (Software by Andre Skarzynski, April 1992) 
• Plastic rotameter drums 
2.1.3 NMDA SnMULA TED CALCIUM UPTAKE ASSAY 
• Airtight container 
• Branson Sonifier 250 (Branson Sonic Power Company, Danbury, CT 06810, USA) 
• Calcium Chloride (CaCI2.2H20) (Merck NT Laboratory Supplies, Unit 11, Fedsure 
Park, Midrand, South Africa) 
• D-Glucose (Merck NT Laboratory Supplies, Unit 11, Fedsure Park, Midrand, South 
Africa) 
• Eppendorf vials 
• Lanthanum Chloride (LaCb.7H20) (Merck, 64271 Darmstadt, Germany) 
• Liquid Scintillation Analyzer (Tri-Carb 2100TR, Packard Bioscience Company) 
• Loctite 406 glue 
• Magnesium Chloride (MgC/2.6H20) (Merck NT Laboratory Supplies, Unit 11, 
Fedsure Park, Midrand, South Africa) 
• Medical Oxygen (Air Liquide, Cape Town, South Africa) 
• (N-[2-Hydroxyethyl]piperazine-N'·[2ethanesulfonic acid}) HEPES (Sigma Chemical 
Company, St Louis MO 63178, USA) 




• Paint brushes 
• Perspex multiwell container 
• Perspex tissue container 
• Phase flow heater (FH16-D, Grant Instruments (Cambridge) Ltd, Shepreth, 
Cambridgeshire, SG8 6GB, England) 
• Plastic Water bath 
• Polyethylene vials (20m I) 
• Polystyrene containers 
• Potassium Chloride (KCI) (Merck NT Laboratory Supplies, Unit 11, Fedsure Park, 
Midrand, South Africa) 
• PVC Manifold tubing (0.25mm, Watson-Ma~ow Ltd, Falmouth, Cornwall, TR11 
4RU, England) 
• Radioactive 45Ca2+ (Perkin Elmer Life & Analytical Sciences, 549 Albany Street, 
Boston, MA 02118, USA) 
26.93 mCi/ml (23rd January 2004) 
69.62 mCi/mi (14th May 2004) 
• Scintillation nuid (Zinsser Analytic, Aquasafe 500 Plus, Howarth Road, 
Maidenhead, Berkshire SL61AP, UK) 
• Sodium Chloride (NaCI) Merck Chemicals, 259 Davidson Road, Wadeville 1428, 
South Africa) 
• Staining glass dish 
• Surgical instruments (forceps, scalpel, blades etc) 
• Teflon vials (5ml) 
• Vibrotome (Series 1000 Sectioning system, ARH Horwell) 
2.1.4 PROTEIN DETERMINATION 
• Bovine Serum Albumin (BSA) (Miles Laboratories, South Africa) 
• Copper Sulphate (CuS045H20) (Merck Chemicals,259 Davidson Road, Wadeville, 
South Africa) 
• Cuvettes 
• Finnipipette (Thermo Electron Corporation, P.O. Box 100, FIN-01621 Vantaa, 
Finland) 
• Folin-Ciocalteu's Phenol Reagent Acid (Merck, 64271 Darmstadt, Germany) 
• Sodium Carbonate (Na2C03) (Merck NT Laboratory Supplies, Unit 11, Fedsure 
Park, Midrand, South Africa) 
• Sodium Potassium Tartrate (Na+K+-Tartrate) (BDH Chemicals LTD, Poole, 
England) 
• Testtubes 
• UV-VIS Spectrophotometer (UV-91 00, Laboratory & Scientific Equipment 
Company (Lasec), Cape Town, South Africa) 
• Water bath (Techne Cambridge Ltd, Duxford, Cambridge, England) 
2.1.5 TRANSCARDIAL PERFUSION 
• Airtight container 
• 2-bromo-2-chloro 1:1:1 trifluoroethane with 0.01% thymol (Halothane) (Safeline 
Pharmaceuticals LTD, 1 Manchester Road, Wadeville, South Africa) 
• Gelatine (Davis Gelatine Industries (Pty) LTD, 25 Verster Street, Delporton, West 
Krugersdorp, South Africa) 
• JungTissue Freezing Medium (Leica, Instruments, GmbH, Postfach 1120, 
Heidelberger Street, Nussloda, Germany) 
• Leica CM 1850 Cryostat (Leica, Instruments, GmbH, Postfach 1120, Heidelberger 
Street, Nussloda, Germany) 
• Liquid nitrogen (Air Liquide, Cape Town, South Africa) 
• Microscope slides & cover slips (Labstar 100, Laboratory & Scientific Equipment 
Company (Lasec), Cape Town, South Africa) 
• Paraformaldehyde (Merck-Schuchardt, Schuchardt 85662 Hohenbrum, Germany) 
• Phosphate Buffer Solution (0.15M) PBS 
• Syringes(50ml) 
• Sucrose (Merck Chemicals,259 Davidson Road, Wadeville, South Africa) 
• Surgical instruments 
2.1.6 TYROSINE HYDROXYLASE IMMUNOSTAINING 
• Biotinylated secondary antibody (Sigma Chemical Company, St Louis MO 63178, 
USA) 
• Cy3 Conjugated Affinipure F(ab')2 Fragment Donkey Antimouse IgG (Lot 51344) 
Jackson ImmunoResearch Laboratories, 872 West Baltimore Pike, PA 19390, 
USA) 
• 3,3' -diaminobenzidine (DAB) Peroxidase Substrate Kit S K 4100 (Vector 
Laboratories, Inc, Burlingame, CA 94010, USA) 
Buffer Stock Solution 
DAB Stock Solution 
Hydrogen Peroxide Solution 
Nickel Solution 
• 4,6 Diamidino-2-Phenylindole dihydrochloride (DAPI)(Lot D-9542 Sigma Chemical 
Company, St Louis MO 63178, USA) 
• Dehydrating alcohol solutions 
• Entellan Mounting Medium (Merck, 64271 Darmstadt Germany) 
• Grease pap pen (Science Services, Postfach 190949, Munchen, Germany) 
• Horse serum blocking solution (Sigma Chemical Company, St Louis MO 63178, 
USA) 
• Humidifying incubation chamber (The chamber was constructed from Tupperware 
plastic containers into which removable Perspex frame specially constructed by 
UCT Department of Human Biology Workshop) 
• Hydrogen Peroxide (0.3%) H202 
• Mouse monoclonal anti-tyrosine hydroxylase Clone TH-16 (Sigma Chemical 
Company, St Louis MO 63178, USA) 
• Mowiol Mounting Medium (Hoechst Chemical Company, Germany) 
• Phosphate Buffer Solution (0.15M) PBS 
• Technical Methanol 
• Triton X-100 (BDH Chemicals, Poole, England) 
• VECTASTAIN Elite ABC (Avidin-Biotin-Peroxidase Complex) Kit (Vector 




2.1.7 CRESYL VIOLET NISSL STAINING 
• Acetic Acid (Associated Chemical Enterprises, Gauteng, South Africa) 
• Cresyl Violet (SOH Chemicals, Poole, England) 
• Sodium Acetate (Hopkin & Williams LTD, Essex, England) 
Thionin (SOH Chemicals, Poole, England) 
ANNEXA 
22 PREPARATION OF SOLUTIONS 
22.1 SURGICAL LESIONS PROCEDURE 
Ascorbate Stock Solution 
O.2mg of L-ascorbate was diluted with 1 ml sterile saline solution to give a concentration of 0.2%. 
This solution was only used for one day. However, due to the low concentrations and to enable 
ease of weighing the ascorbate, a stock solution was made. 
6·0HDA Solution 
6-Hydroxydopamine hydrochloride (3 mg/ml) was dissolved immediately before use in ice-cold 
sterile saline containing 0.02% ascorbate to prevent autoxidation of the 6-0HDA. The total volume 
made varie~ with each operation depending on the amount weighed. 
2.2.2 BEHAVIOURAL ASSESSMENT OF 6-0HDA LESIONING 
Apomorphine Solution 
Apomorphine (O.Smg/kg) was dissolved in sterile saline solution immediately before use. The 
amount weighed depended on the weight and number of rats assessed. The apomorphine 
solution was freshly prepared on the day of assessment. 
22.3 NMDA STIMULATED CALCIUM UPTAKE ASSAY 
The following stock solutions were made up and used as described below: 
CaC12.2H20 (12mM) 
1.76 grams of CaCb.2H20 (147.02 g/mol) were dissolved in one litre of distilled water. 
D·Glucose (100mM) 
18.02 grams of D-Glucose (180.1 g/mol) were dissolved in one litre of distilled water. 
HEPES (200mM) 
47.66 grams of HEPES (238.3 g/mol) were dissolved in ~OOml of distilled water. The solution was 
adjusted to pH to 7.4 by adding SM NaOH drop by drop. The solution was then made up to one 
litre with distilled water. 
KCf (33.6mM) 
2.52 grams of KCI (74.S6g/mol) were dissolved in one litre of distilled water 
LaCb.7H20 (100mM) 
37.14 grams of LaCb.7H20 (371.37 g/mol) were dissolved in one litre of distilled water. 
MgCI2.6H20 (10mM) 
2.03 grams of MgCb.6H20 (203.3 g/mol) were dissolved in one litre of distilled water. 
NaCI (102M) 
70.12 grams of NaCI (58.44g/mol) were dissolved in one litre of distilled water. 
NMDA (100mM) 
1.47 grams of NMDA (147.1 g/mol) were dissolved in 90IJI of distilled water. The pH was adjusted 
to 7 by mixing with 101J15M NaOH. The solution was wrapped in foil to avoid exposure to light and 
was stored at 4°C. The solution was used within two weeks. 
Working solutions 
HEPES Buffer Solution 
The solution was freshly prepared in a 500ml volumetric flask. To the volumetric flask, 50ml of 
each of the abovementioned stock solutions was added to the volumetric flask and the final volume 
was made up to the mark with distilled water. The solution was comprised of the following 
concentrations: 120mM NaCl, 1mM MgCI2, 3.36mM KCI, 10mM D-Glucose, 20mM HEPES buffer 
pH 7.4 and 1.2mM CaCb. 
Lanthanum Chloride Washing Buffer 
The solution was made from the abovementioned stock solutions with the exception of CaCI2 which 
was substituted with LaCb. 20ml of the stock solutions was added to a 250ml volumetric flask and 
the final volume made up with distilled water to the mark. 
Test Incubation Solutions 
The test solutions were prepared as follows. In a glass vial 0.22J.l1 of 45Ca2+ was added to 2.2ml of 
12mM CaCI2 stock solution, to give a solution of cold and hot calcium with a final concentration of 
1 J.lCi/J.ll. Into two 10ml volumetric flasks. 1 ml of each of the stock solutions, used to make up the 
HEPES buffer excluding CaCI2, was added. 1 ml of the solution of cold and hot calcium was 
aliquoted to each of the two 10ml volumetric flasks. This gave a final concentration of 1.2mM of 
CaCI2 in both the test and control solutions, each containing the same amount of radioactivity. One 
of the volumetric flasks was designated to contain the test stimulation solution and to this 10 J.l1 of 
100mM NMDA stock solution was added. The final concentration of NMDA in the test stimulation 
solution was 10mM. Distilled water was added to both the volumetric flasks to make the final 
volume up to 10ml. 
2.2.4 PROTEIN DETERMINATION 
The following solutions were made up and used as described below: 
Bovine Serum Albumin (BSA) 
50ml solution of 1 mglml was made up by carefully dissolving SOmg of BSA with distilled water. 
CuS045H20 (1 % w/v) 
2.5 grams CuS045H20 (249.68 g/mol) was dissolved in distilled water to a total volume of 2S0ml. 
Folin Acid Reagent 
A dilution of Folin Reagent was made with distilled water to a ratio of 1: 10. The solution was 
freshly prepared before use. 
Na2C03 (10% w/v) 
50 grams Na2C03 (105 g/mol) were dissolved in O.SM NaOH to a total volume of 500ml. 
NaOH (0.5M) 
20 grams NaOH (40 g/mol) were dissolved in 1 litre of distilled water. 
Na+K+·Tartrate (2% w/v) 
5 grams Na+K+-Tartrate (282.22 g/mol) were dissolved in distilled water to a total volume of 250m/. 
Re.gentA 
1% CuS045H20 was mixed with 2% Na+K+-Tartrate to a ratio of 1 :1. 
2.2.5 TRANSCARDIAL PERFUSION 
Gelatinized solution and slide preparation 
Gelatinized solution was made by mixing 10 grams gelatine with SOOml distilled water in an 
Erlenmeyer flask. The solution was mixed in a 50°C water bath until the gelatine had fully 
dissolved. Microscope slides were washed by placing on slide racks and immersing in staining 
glass dishes filled with 2% Deconex detergent (Borer Chemie, Zuchmil, Switzerland). The slides 
on the racks were rinsed thoroughly in running tap water followed by rinsing in distilled water before 
being dried in the oven set at 50°C. Once the slides were dried, they were placed in previously 
warmed staining glass dishes filled with the gelatine solution and dipped into the solution 30 times. 
The slides were removed from the solution and returned to dry overnight in the oven set at 50°C. 
1.5M Phophate Buffer Stock Solution (PBS) 
The x10 Stock solution was made by dissolving 80 grams NaCl, 2 grams KCI, 14.4 grams Of 
Na2HP04 and 2.4 grams KH2P04 in 800ml of distilled water. The pH was adjusted to 7.4 with 5M 
NaOH. Distilled water was added to make up the solution to 1litre. 
A 0.1SM PBS working solution was made by mixing the stock solution with distilled water to a ration 
of 1:10. 
4% Parafonnaldehyde Solution 
40 grams of paraformaldehyde were mixed in 800ml 0.1SM PBS made from the stock solution. 
The mixture was covered and mixed on a stirring magnetic plate with the heat set at 40°C. 
20% Sucrose solution 
200 grams of sucrose were mixed wi til O.1SM PBS working solution to make the solution to 1 litre. 
2.2.6 TYROSINE HYDROXYLASE 
Avidin-biotin-peroxidase complex (ABC) Reagent 
All reagents were contained in the SIGMA ABC VECTA KIT and were mixed as directed by the 
instructions enclosed. Exactly two drops of Reagent A were added to Sml PBS buffer and was 
mixed thoroughly. To this solution, two drops of Reagent B were added and mixed thoroughly. 
The ABC Reagent was prepared and allowed to stand for thirty minutes before use. 
Biotinylated Secondary Antibody 
The antibody was diluted in freshly prepared blocking solution as described above to a dilution of 
1 :400. At least Sml total volume was required for 2S slides :. 13111 antibody in S.2ml blocking 
. solution. 
Blocking Serum (For Initial Blocking and for dissolving primary monoclonal antibody). 
3 drops (1S0J,LI) of horse blocking serum (yellow label) was added to 1 Oml of 0.1SM PBS solution 
containing 0.2% (20JlI) Triton X-1 00. 
Blocking Serum (For secondary antibody) 
3 drops (1S0JlI) of horse blocking serum (yellow label) was added to 1 Oml of O.1SM PBS solution. 
This solution did not contain Triton X-1 00. 
DAB Solution 
All reagents were contained in the SIGMA DAB KIT and were mixed as directed by the instructions 
enclosed. To Sml dH20, two drops of Buffer Stock solution were added and mixed well. To this 
solution, four drops of DAB Stock solution were added and mixed well. Two drops of hydrogen 
peroxide solution were then added and mixed well. Two drops of nickel solution were also added 
to obtain a grey-black stain desired. 
0.3% Hydrogen Peroxide Solution 
0.4ml of 30% H202 was dissolved in 40ml technical methanol just before use. 
Mouse monoclonal anti-tyrosine hydroxylase 
Monoclonal antibody was diluted in freshly prepare blocking solution as described above to a 
dilution of 1 :8000. The monoclonal antibody was stored as aliquots containing 50% glycerol. 
Glycerol was added to the aliquots to enable refreezing for storage purposes. For this reason, a 
1 :8000 dilution was a measurement of 21J1 of monoclonal antibody aliquot in 80001J1 blocking 
serum solution. 
1.5M Phophate Buffer Stock Solution (PBS) 
As desClibed above (section 2.2.1.5). 
2.2.7 CRESYL VIOLET NISSL STAINING 
Cresyl Violet Working Solution 
100ml of each ofthe buffer solutions and the pH was adjusted to 3.5. The solution was mixed with 
10ml of the thionin solution. 0.2 grams of Cresyl violet were dissolved in the solution to make up 
the working solution. 
0.1M Glacial Acetic Acid 
6ml acetic acid was mixed with 800ml distilled water. The solution was made up to 1L. 
0.1M Sodium Acetate Buffer Solution (pH 3.5) 
13.6 grams of sodium acetate (82.03 g/mol) was mixed with 800ml distilled water. The solution 
was made up to 1 L. 
1% Thionin solution 
·1 gram of thionin was dissolved in 100ml distilled water. 
ANNEX B CALCULATIONS OF Cal .. UPTAICE 







P!l.OIE'''PCI''~_ PROTt!NI'Il"'&OO,oI CPt.I"'~~ Cl'Mota~:I~"""c, norooIc.02'P!>' ~" ....... C.lrng~ 
1810 13577 2378.10 29000.00 197 14 .50 
2143 16076 2669.20 2900000 221 13.74 
28.89 21887 110430 29000.00 091 4 22 
3571 26782 1&40.00 2900000 \ 36 5.07 
23 02 172.85 2751 40 29000.00 228 1319 
46 02 345 15 30BI 10 29000 00 2.55 739 
40.31 ~--
54535 nmol C.2+ per microgflilm profeln HS 
16.00 ,.. __ _ 
.It 1400 








ISlE "'" .5 Ca Sl(I$ '" 29703 7 on 3011/00' m 277128 
273 305708 
35"'" '" 29803, \ ~ '" 2112508 '0000 ". 30113,1 • 25000 
'" 26642 1 
N -! _ 20000 
NMOA ~W' '" 21660 3 '3 1I 15000 on 30/. 1<)4 ,,. '''''' . • '" 2861116 • '0000 '51 2!5<115 i """ 23' 2115~ 5 " '" 27105\1 ,'" 277857 , 
-
Ca45 cpm vs ISlE 
10' "" ISlE 
-
NMOAsld 
,co '" ISlE 
'" '" 
'" .. " 










CONT ROL GROUI' 
" Ca" UPTAKE IN li.O.J\I 6_0HDA 
LESIONED RATS 
..:v ... ~ .... " .... q.. ..," ..,q.. 
SECTION 
LESION GROUP 1L 2L I Jl 1R j 2R I J R 11l -2lll-2L '1R.2R 3R_2R 
,H5 ,'2 145"i22[t31913,14 1501 1739 ~897 867 12_32 -
H6 :2 Ti'94 87 1646 ,6 11 [402 '994 1232T59 '2_15 1592 
16 2 13.44898 115_75'"i9nlala f1575::i46 1677 '~ ,57 
J7 2 11388.42 110,34 1 6.05~,95 r13,77 r296 1192 [111 -r8:82 
J8 2 ,10,39 612 19n 1491709 !12,15"iZf""'1365 '781 ,50s 
13 2 1823635[11513.14 1513 11474"'1188f11l5em 961 
J9 j2 1217 619 19.5 12.56 '68218.15 ,558 )331 57'4 1133 










" ,L, • --.L , 
• Lr 











































I _ , M'S!! 
~ •• 2L 
lR·2R 
M8M SId Dv " ". s. "" , ,. 
5131250 ,,~ 
76211250 2923535 8 . 4184103 . 
"""" 1,01061 .. ,.""" .... ,... 































PRE LIMI N AR Y RESULTS 
6-0HDA LES ION ED GROUP 
"Ca" ll l"TAKE IN 6-0H DA 
I£ SIONED RATS 
SEC TION 
r LESION GROUP lL fll ' 3L 1R~1iR IR-iL 13l-2L 11R-2R 3R-2R 
H3 1 6 22 [4451 46 '966 41 6781'377 -~301 5.5 345 -
H4 1 6 54 :3 16 14 49 6.45 fl.(),f !4 01 1338 [133'13 41 097 
, 11 ~359~ 41 PI36 ' 0585.05[12.97,9. 18 -1695 i553 7 92 
' ,5 , '6_2sf376 693 ~55 '2.74 " 47;249 ,il1~1 6.73 
J2 1 10 34 173 983 ',654 66 ,1 55413.04 -1253 9 74 .fI64 




.. 1""_ .... 
• •• • 
• 
• 
• I • 
~ • -• -. --, -L __ • 










"-~ , ,,_, at!iE 
, 
Il00' ......... _ 














































PREUMINARY DATASTATS REPORT II 
"'--'lESION GROUP~.----n-f3L·1RT2RT3R1L-2L '3l.2l '1iWR~ 
111 1359"441111361oS8150~ 11297918S9S 553 ·[7 92 -
IS 1 6.25 376 [693955 r2.14 111 47 12 49 ·317 681 1873 
·)2.1 .103<1"73""1963 185418.8 II5S4 1304 ,2.53 9.741684 
' J.fi1 ~B57""rs:s- 767 17 04 [9i""4~:003 0 63 21 
H3 ~ 1 822 445 1748 966 [415!761 -377j301 5.5 ,345 
li411 '6S4'"3""16l4496:45 1304 j4013:38'13313 41 '097 
16 '2 1344 696 ' 1575'"i"92218 18 11575~'6.11'1104if57-
J7 2 1138642 . I0341605~9S113.77:f96 192 III -reS2-
J6 2 ,1039 ,612 f977 149"":7,09 /12_15427 3.65 781 5.06 
13 3 1823 16,35 [i7T13.14) 13 114 74111 88 11i5801~ 
'" - 127716:19~1256j6B21&15 ' 658 3_31574 133 
J10 3 "1788 '11 5aI1134 1 643[9941'iB7~ ~024 ~876 
H5 ,2 145 '4221 13191374 lso7 !f39"1028a.97 '867[232 
HS '2 7.19 4e7'[646'Si'714021994 232 159 '215592 
DESCRIPTIVE 
STUDENT T.TESTS 
Mean S1d Dv N D,' SId Dv I , " , D,' 
" 1147357 3636574 
ANALYSISQFVARlANCE 
AOUl T RATS AGED 7 WEEKS ANAL ys.s REPORT (WITHIN GROUP ANALYSIS) 
SPREADSHEET 
rLESION GROUP [1i. ' 2L 3L "f1Rr 2R f i"R[1L-2L [iL-iL'1R-iR[3R:2R 
RAT1 13 1124614.5 10G4 !7.44 14,35 [1074 17.96 [S54 309 [6:39 
'AATi 13 [13 98!S6i"1o:i11337 6,29 '10 D6 f37[42706 377 
RAT 3 r3 [12 n r3.31 ,4 23 11 1 2,84 8lB [946 1092 8,26 IS.54 
RAH I3 [9:'9" 1498[94774 5,67 :1173 1492 1442 207 1606 
RATS 13 18,7s 'j4ss9.42 ' 7.79 3 .81 1928 1417 [484 398 547 
RAfi l3 19,58 1501987 '12""""1 5,84 1 94s "Ii57~,616 ,3,6, ' 
) 



































2.1, _ . __ 
1.043319 


























Mean Std.Dv. N 
1R 10.00857 2.362770 
2R 4.70429 1.256156 7 
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Mean Std.Dv. N 
10.43571 1.697477 
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Box & Whisker 1'101 
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D25%-75'111 :r: Mln-Max 
t df p 
6.159672 6 0.000840 
t df P 
7.994560 6 0.000204 
) 
Mean Std.Dv. N Diff. Std.Dv. 
Diff. 
1L-2L 6.731429 2.146093 
3L-2L 4.354286 1.608880 7 2.377143 3.132761 
Box & Whllker Plot 
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ll-2l 3l-2l 
Mean Std.Dv. N Diff. Std.Dv. 
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3R-2R 5.731429 1.896782 7 - 3.172647 -0.356205 
Box & Whisker Plot 
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Mean Std.Dv. N Diff. Std.Dv. t 
Dlff. 
3L-2L 4.354286 1.608880 
3R-2R 5.731429 1.896782 7 - 2.099267 -1.73564 
1.37714 
BOx & Whisker Plot 
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ADULT RATS AGED 7 WEEKS VENTRAL STRIATUM ANALYSIS REPORT (WITHIN 
GROUP ANALYSIS) 
DESCRIPTIVE STATIS'nCS 
Valid Mean Minimum Maximum Std. Dev. Standard 
N Error 
1L 7 12.80143 4.342697 1.641385 
2L 7 4.48143 0.965064 0.364760 
3L 7 11.27429 3.641977 1.376538 
1R 7 10.65143 3.832921 1.448708 
2R 7 4.80000 1.444934 0.546134 
7 10.31857 2.707609 1.023380 
7 6.88714 3.736771 1.412367 
7 7.34000 3.779471 1.428506 
7 5.85143 3.937501 1.488235 
7 5.51857 2.250000 10.32000 2.910598 1.100103 
STUDENTT·TEST 
Mean Std.Dv. N Dlff. Std.Dv. t df p 
Dlff. 
1L 12.80143 4.342697 
1R 10.65143 3.832921 7 2.150000 4.648172 1.223786 6 0.266906 
Mean Std.Dv. N Dlff. Std.Dv. t df P 
Dlff. 
2L 4.481429 0.965064 
2R 4.800000 1.444934 7 - 1.250965 - 6 0.525549 
0.318571 0.673768 
Mean Std.Dv. N Dlff. Std.Dv. 
t £1 P Dlff. 
3L 11.27429 3.641977 
3R 10.31857 2.707609 7 0.955714 1.779858 1.42066 6 0.205234 
) 
) 
Mean I Std.Dv. _N 
1L 12.80143 
2L 4.48143 1 0.965064 7 
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3L 2L 
t df P 
4.999721 6 0.002453 
t df P 
5.346689 6 0.001750 
Mean Std.Dv. N Dlft. Std •. Dv. t df P 
Dift. 
1R 10.65143 3.832921 
2R 4.80000 1.444934 7 5.851429 3.937501 3.931789 6 0.007697 














Mean I ~ .... Dv. N Dlft. Std.Dv. t df P 
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3R 10.31857 2.707609 
2R 4.80000 1.444934 7 5.518571 2.910598 5.016415 6 0.002413 
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Box" WhIsker Plot 
1l..a .... 1R~R 
N Olff. Std.Ov. 
Olff. 
7 1.035714 07357 










Mean Std.Dv. Olff. Std.Ov. 
Olff. 
3Lw2L 7.340000 3.779471 
3Rw 5.518571 2.910598 821429 2.366801 
2R 
Box" WhIsk..- Plo! 














0.471857 6 0.653700 
t df P 
2.036101 6 0.087918 




ValidN Mean Min rd 
Error 
1L 6 5.941667 4.24000 8.670000 0.712523 
2L 6 3.876667 2.00000 5.990000 0.645666 
3L 6 5.370000 3.48000 7.970000 0.685721 
6 6.926667 3.39000 9.050000 0.811179 
6 4.063333 3.01000 6.460000 0.514332 
6 6.201667 4.08000 7.920000 0.538234 
6 2.065000 -0.51000 5.880000 0.861652 
-1.17000 2.620000 1.524791 0.622493 
0.38000 4.610000 1.394900 0.569466 
0.19000 3.220000 1.125103 0.459321 
) sruDENT T-TESTS 
Mean Std.Dv. N o itt. Std.Dv. t df P 
o itt. 
1L 5.941667 1.745319 
1R 6.926667 1.986974 6 - 1.853739 -1.30156 5 0.249808 
0.985000 
Mean Std.Dv. N Diff. Std.Dv. t df P 
o itt. 
2L 3.876667 1.581552 
2R 4.063333 1.259852 6 - 1.148802 -0.398013 5 0.707046 
0.186667 
Mean Std.Dv. N 
~ 
t df P 
3L 5.370000 1.679667 
3R 6.201667 1.318399 6 - 1.636526 -1.24481 5 0.268365 
0.831667 
Mean Sld.Ov. I N Olff. Std.Ov. t df P 
Olff. 
1L 5.941667 1.745319 
2L 3.876667 1.581552 6 2.065000 2.110609 2.396558 5 0.061884 














Mean Std.Ov. N Olff. Std.Ov. t df P 
o Iff. 
3L 5.370000 1.679667 
2L 3.876667 1.581552 6 1.493333 1.524791 2.398955 5 0.061700 













Mean Std.Dv. N Diff. Std.Dv. t df P 
Dlff. 
1R 6.926667 1.986974 
2R 4.063333 1.259852 6 2.863333 1.394900 5.028106 5 0.004007 















Mean Std.Dv. N Diff. Std.Dv. t df p 
Diff. 
3R 6.201667 1.318399 
2R 4.063333 1.259852 6 2.138333 1.125103 4.655419 5 0.005555 














Mean Std.Dv. N Dlff. Std.Dv. t 
Dlff. 
1L-2L 2.065000 2.110609 
3L-2L 1.493333 1.524791 1.668333 0.839336 
BO)( & Whllker PlI:I\ 












·1 -'---- a Median 
D 25%-75% 
·2 I Mln-Max 
1L.2L 3L·2L 
Mean Std.Dv. H Diff. Std.Dv. t df P I Dlff. 
1R-2R 2.863333 1.394900 
3R-2R 2.138333 1.125103 I 6 I 0.725000 2.042643 0.869403 5 0.424387 
BO)( & Whllker Plot 
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N Diff. Std.Dv. t 
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6 2.373122 -0.665756 
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ADULT RATS AGED 16 WEEKS VENTRAL STRIATUM ANALYSIS REPORT 
(WITHIN GROUP ANALYSIS) 
SPREADSHEET 
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J~]l2 .j9:9.7 ,1~:64il~~!1Iho.:86J4:1 J8:~ .15:33. :l4.07'~.!614:82 
:[~~j~~'~ . . .......... J1o.:?~H~:3J~: 1;]~Q:o.~H~·9~J1.o.:~2!~9.<4]~Q:(]f'CJI~:~ .. . 
'!Z6112 .. ,If.97J[3.7f,~18.63T7.37:~!3.2el[2.1---]1 :26 .. :[:2.44' 
DESCRIPTIVE STA nsncs 
Valid Mean Minimum Maximum Std.Oev. Standard 
N Error 
NUCLEI 6 2.000000 2.00000 2.00000 0.000000 0.000000 
GROUP 
1l 6 8.093333 6.79000 10.24000 1.586804 0.647810 
2l 6 4.560000 3.04000 6.30000 1.354297 0.552889 
3l 6 7.108333 5.57000 9.61000 1.670885 
• 
1R 6 8.541667 6.41000 10.86000 1.711636 
2R I 6 4.551667 2.39000 7.37000 1.663086 
3R 6 7.790000 4.93000 10.82000 1.982100 
1l-2l 6 3.533333 0.91000 5.33000 1.523058 0.621786 
3l-2l 6 2.548333 -0.20000 4.07000 1.615121 0.659370 
1R-2R 6 3.990000 1.26000 6.76000 1.847972 0.754431 
3R-2R 6 3.238333 -2.44000 5.89000 2.964870 1.210403 
STUDENT T· TEST 
Mean Std.Ov. N Olff. Std.Ov. t df p 
Olff. 
1l 8.093333 1.586804 
1R 8.541667 1.711636 6 - 1.080619 -1.01626 5 0.356132 
0.448333 
Mean Std.Ov. N Olff. Std.Ov. t df p 
Olff. Roooo 1.354297 1667 1.663086 6 0.008333 1.867013 0.010933 5 0.991700 
Mean Std.Ov. N Olff. Std.Ov. t df P o Iff. 
3l 7.108333 1.670885 
3R 7.790000 1.982100 6 - 2.262577 - 5 0.493685 
0.681667 0.737979 




1L 8.093333 1.586804 
2L 4.560000 1.354297 6 3.533333 1.523058 5.682556 51 0.002351 


















Mean Std.Dv. N Diff. Std.Dv. t df P 
Dlff. 
3L 7.108333 1.670885 
2L 4.560000 1.354297 6 2.548333 1.615121 3.864797 5 0.011822 
















Mean Std.Dv. N Diff. Std.Dv. t df p 
Dlff. 
1R 8.541667 1.711636 
~32.22 2R 4.551667 1.663086 6 3.990000 1.847972 5.288752 












:I c Medlen 
025%-75% 
2 I Mln-Max 
1R 2R 
Mean Std.Dv. N Dlff. Std.Dv.· t df P 
Dlff. 
3R 7.790000 1.982100 
2R 4.551667 1.663086 6 3.238333 2.964870 2.675417 5 0.044061 


















Mean Std.Ov. N Olff. Std.Ov. t 
Oiff. 
1L-2L 3.533333 1.523058 












Box & Whllker PIOi 








1R.2R III. 3R4R 
o Medillll 
02& .... 7/1'11> :c Mln-Max 
N Oiff. Std.Dv. 
Olff. 


















































Sex & WhI,kllrl"lo! 






























t df P 
- 5 0.521638 
0.688734 
t df p 






ANALYSIS OF S11MULATED UPTAKE IN DORSAL STRIATUM OF 7 WEEK 
OLD AND 16 WEEK OLD UNTREATED RATS 
SPREADSHEET 
BREAKDOWN STATISTICS 
AGE I iL Means iL N 1L Std.Dev. iL Std.Err. 
GROUP 
11.42286 7 1.978743 0.747895 
5.94167 6 1.745319 0.712523 
All Grps 8.89308 13 3.363860 0.932967 












2 3 IMIn-Mex 
AGE GROUP 
AGE 2LMeans 2LN 2L Std.Dev. 2L Std.Err. 
GROUP 
2 4.691429 7 1.043319 0.394337 
3 3.876667 6 1.581552 0.645666 
I All Grps 4.315385 13 1.328606 0.368489 














AGE 3LMeans 3LN 3LStd.Dev. 3L Std.Err. 
GROUP 
2 9.045714 7 2.179135 0.823636 
3 5.370000 I 6 1.679667 0.685721 
All Grps 7.349231 13 2.680931 0.743556 




























CIIeg. Box .. WhIIkerPlol: 1R 













2 3 IMIn->MIIl( 
AGEGRQUP 
AGE 2RMeans 2RN 2R Std.Dev. 2R Std,Err. 
GROUP 
2 4.704286 7 1.256156 0.474782 
3 6 1.259852 0.514332 
All Grps 13 1.249365 0.346512 

















AGE 3R Means 3RN 
GROUP 
2 10.43571 7 
3 6.20167 6 
All Grps 8.48154 










AGE 1L-2L 1L-2L N 
GROUP Means 
2 6.731429 7 
3 2.065000 6 
All Grps 4.577692 13 


































AGE 3L·2L 3L·2L N 3L- L 3L-2L 
GROUP Means Std.Dev. Std.Err. 
2 4.354286 7 1.608880 0.608100 
3 1.493333 6 1.524791 0.622493 
All Grps 3.033846 0.586165 
Categ. Box & Whleker Plot: 3L~L 
e 
5 











3 I Mln-MIIX 
AGE GROUP 
AGE 1R·2R 1R-2R 
GROUP Means Std. Err. 
2 5.304286 7 0.861131 
3 2.863333 6 0.569466 
All Grps 4.177692 13 2.238367 0.620811 






























AGE 3R·2R 3R·2R N 3R-2R 3R·2R 
GROUP Means 5td.Dev. 5td.Err. 
2 5.731429 7 1.896782 0.716916 
3 2.138333 6 1.125103 0.459321 
All Grps 4.073077 13 2.408773 0.668074 








ANALYSIS OF VARIANCE 
55Effect~ t 55 Error elf M5 
Error Error 
97. 1 97.06345 38.72323 11 3.520293 
2.14470 1 2.14470 19.03762 11 1.730693 
43.65052 1 43.65052 42.59817 11 3.872561 
30.68629 1 30.68629 53.23642 11 4.839674 
1.32726 1 1.32726 17.40370 11 1.582155 
57.91851 1 57.91851 25.97945 11 2.361769 
70.35180 1 70.35180 49.90764 11 4.537058 
26.44400 1 26.44400 27.15590 11 2.468719 
19.24973 1 19.24973 40.87370 11 3.715791 



























ANALYSIS OF S'rlMULATED UPTAKE IN VENTRAL STRIATUM OF 7 
WEEK OLD AND 16 WEEK OLD UNTREATED RATS 
SPREADSHEET 
BREAKDOWN STATISTICS 
AGE 1LMeans 1L N 1L Std. Dey. 1L Std.Err. 
GROUP 
12.80143 7 4.342697 1.641385 
8.09333 6 1.586804 0.647810 
IGrps 10.62846 13 4.055424 1.124772 










Il lAedlan .. 02511>-76% 
2 3 IlAliWlax 
AGE GROUP 
AGE 2L Means 2LN 2LStd.Dev. 2L Std.Err. 
GROUP 
2 4.481429 7 0.965064 0.364760 
3 4.560000 6 1.354297 0.552889 
All Grps 4.517692 13 1.109753 0.307790 













2 :r: Mlh-Max 
AGE GIlOUP 
AGE 3L Means 3LN 3L Std.Dev. 3L Std.Err. 
GROUP 
2 11.27429 7 3.641977 1.376538 
3 7.10833 6 1.670885 0.682136 
All Grps 9.35154 13 3.530979 0.979317 
) 
) 
AGE 1R Means 1RN 1RStd.Dev. 1R Std.Err. 
GROUP 
2 10.65143 7 3.832921 1.448708 
3 8.54167 6 1.711636 0.698772 
All Grps 9.67769 13 3.124855 0.866679 















Means 2RN 2RStd.Dev. 2R Std.Err. 
2 4.800000 7 1.444934 0.546134 
3 4.551667 6 1.663086 0.678952 
All Grps 4.685385 13 1.487602 0.412587 







































3R Means 3RN 3R Std.Dev. 
10.31857 7 2.707609 
7.79000 6 1.982100 
9.15154 13 2.650267 








1L-2L 1L-2L 1L-2L 
Means N Std.Dev. 
6.887143 7 3.736771 
3.533333 6 1.523058 
5.339231 13 3.313094 





















































































C Mlldlan o L-..-~---~---~3------"----J 0 25%-15% 
2 I Min..,. 
AGEGftQUP 
AGE 3R·2R 3R-2R 3R-2R 3R·2R 
GROUP Means N Std.Oev. Std.Err. 
2 5.518571 7 2.910598 1.100103 
3 3.238333 6 2.964870 1.210403 
All Grps 13 3.049318 0.845729 
















025"""7514 2 3 :r: Mln-Max 
AGEGRQUP 
ANALYSIS OF VARIANCE 
SS Effect df MS SS Error df MS F P 
Effect Effect Error Error 
1L 71.61375 1 71.61375 125.7438 11 11.43126 6.264731 0.029352 
2L 0.01995 1 0.01995 14.7587 11 1.34170 0.014866 0.905158 
3L 56.07051 1 56.07051 93.5433 11 8.50393 6.593481 0.026154 
1R 14.38046 1 14.38046 102.7962 11 9.34511 1.538823 0.240600 
) 
2R 0.19924 1 o.~ 11 2.39603 0.083154 0.778429 3R 20.65648 1 20.6 11 5.78459 3.570951 0.085426 
1L-2L 36.33982 1 36.3 11 8.67084 4.191036 0.065290 
3L-2L 74.17869 1 74.17869 98.7495 11 8.97723 8.262985 0.015118 
1R- 11.19435 1 11.19435 110.0985 11 10.00895 1.118433 0.312928 
2R 
3R- 16.79834 1 16.79834 94.7818 11 8.61652 1.949549 0.190173 
2R 
ANNEXB 
NUMBER OF ROTATIONS CONDUCTED BY SHAM 
LBSIONBDAND 6-0HDA LESIONBD RATS 
LESION QUARTER COMPLETE 
GROUP ROTATIONS ROTATIONS 
K1 1 1419 355 
K2 1 1950 488 
K3 1 1341 335 
K4 1 453 113 
K5 1 760 190 
M1 1 1104 276 
M2 1 595 149 
M3 1 -402 -101 
M4 1 208 52 
MS 1 1700 425 
M8 1 707 176 
01 1 705 176 
02 1 1977 494 
04 1 -197 -49 
05 1 1022 256 
07 1 648 162 
010 1 1872 468 
K8 2 16 4 
K7 2 0 0 
K8 2 45 11 
Me 2 -220 -55 
Me 2 -303 -75 
M10 2 26 6.5 
M11 2 -278 -69 
M12 2 -22 -6 
011 2 -91 -23 
012 2 127 32 
013 2 -134 -34 
014 2 -157 -39 
015 2 -12 -3 
018 2 -80 -20 
Breakdown statistics showing mean number of rotations t sem conducted by 6"()HDA 
lesioned (group 1) and sham Iesloned rats (group 2). 
LESION QUARTER QUARTER QUARTER QUARTER COMPLETE COMPLETE COMPLETE COMPLETE 
GROUP Means N Stet.Dev. Stet.En". ROTATIONS ROTATIONS ROTATIONS ROTATIONS 
Means N Stet.Dey. Stet. Err. 
1 933.0588 17 714.9154 173.3925 233.2353 17 178.8129 43.36851 
2 -n.3571 14 127.3140 34.0261 I -19.3214 14 31.6699 8.48415 
AR Grp$ 476.7419 31 735.4492 132.0906 119.1774 31 183.8774 33.02536 
TREATMENT GROUP STATISTICS REPORT 




Valid N Mean Minimum Maximum Std.Dev. Standard 
Error 
1l 9 10.10333 6.150000 15.49000 2.776941 0.925647 
2l 9 6.56333 3.780000 9.16000 1.840095 0.613365 
3l 9 9.68778 5.570000 13.79000 2.679514 0.893171 
1R 9 9.37667 5.200000 14.75000 2.911348 0.970449 
2R 9 5.88556 3.790000 9.85000 1.880931 0.626977 
3R 9 10.08667 5.190000 15.84000 3.368338 1.122779 
1l- 9 3.54000 1.140000 6.58000 1.984332 0.661444 
2l 
3l- 9 3.12444 - 5.15000 1.707850 0.569283 
2l 0.390000 
1 R- 9 3.49111 0.300000 5.71000 1.724634 0.574878 
2R 























Std.Ov. N Oiff. 
2.776941 
1.840095 9 3.540000 = 2.679514 
1.840095 9 3.124444 
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~ c 
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1L 2L 
Box & Whisker Plot 
3L 'IS. a 
-.. _"" ....... 
i -I .-il ! c 
L. ... 7._ ••••• 
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Std.Ov. t df 
Oiff. 




























Box & Whisker Plot 
IR \IS.2R 
Ditt. Std.Dv. t 
Ditt. 
3.491111 1.724634 6.072787 









2 L----~-----------------'------':r:: Min-Max 
lR 





0 10 ! c L.-r-9 
I 
I 
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Mean Std.Dv. N Diff. Std.Dv. t df 
3.540000 1.984332 
3.124444 1.707850 9 0.415556 
Box & Whisker Plot 























-1 I...-____ ~ ______ ~ ______ ~ __________ .......J :~t: Min-Max 
1L·2L 3L-2L 
8 
Mean Std.Dv. N Diff. v. t df 
3.49111 
4.20111 9 -0.710000 -0.740327 8 
Box & Whisker Plot 














---'-- C Median 
[] 25%-75% 
































o :...-.--~---~---~--~--- :.:r: Min-MIIX 
1L·2l 1R·2R 




4.201111 2.776236 9 - 2.654016 - 8 
1.07667 
Box & Whisker Plot 
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VENTRAL SHAM LESIONED GROUP REPORT (WITHIN GROUP ANALYSIS) 
SPREADSHEET 
LESION 'IL 2L 3L 1R 2R 3R 
GROUP 
M10 2 5.07 1.87 
~ 
1.97 4.34 
. 011 2 11.53 4 4.47 9.99 
1
013 21 6.59 1.88 1.54 6.88 
014 fr 9.1 4.66 7.95 10.15 3.32 8.8 015 8.8 4.03 13.23 8 5.14 10.53 




2 3.2 3.16 1.78 2.37 
2 7.53 3.51 8.5 5.52 
013 2 4.71 3.31 3.32 5~ 
014 2 4.44 3.29 6.83 5.48 
015 2 4.77 9.2 2.86 5.39 
DESCRIPTIVE STATISTICS 
Valid N Mean Minimum Maximum Std.Oev. Standard 
Error 
LESION 5 2.000000 2.000000 2.00000 0.000000 0.000000 
GROUP 
1L 5 8.218000 5.070000 11.53000 2.482251 1.110096 
2L 5 3.288000 1.870000 4.66000 1.316537 0.588773 
3L 5 7.782000 5.030000 13.23000 3.319446 1.484501 
1R 5 7.946000 3.750000 12.97000 3.782556 1.691610 
) 2R 5 3.288000 1.540000 5.14000 1.550861 0.693566 
3R 5 8.108000 4.340000 10.53000 2.529460 1.131209 
1L·2L 5 4.930000 3.200000 7.53000 1.586427 0.709472 
3L·2L 5 4.494000 3.160000 9.20000 2.633710 1.177831 
1R·2R 5 4.658000 1.780000 8.50000 2.862887 1.280322 










































Box & Whiekerl"IOI 







































Mean Std.Ov. N Olff. 
3L 7.782000 3.319446 
2L 3.288000 1.316537 5 4.494000 










0 4 2 
o 
3l 2L 
Mean Std.Ov. N Oiff. 
1R 7.946000 3.782556 
2R 3.288000 1.550861 5 4.658000 
Box & Whllker PlOt 
1R VI.2R 
14 






















Mean Std.Dv. N Dlff. Std.Dv. t df p 
Dlff. 
3R 8.108000 2.529460 
2R 3.288000 1.550861 5 4.820000 1.371441 7.858777 4 0.001417 







) -'-- a 4 2 
C Median o 25%'7M1o 
0 :c Min-Max 
3R 2R 
Mean Std.Dv. N Dlff. Std.Dv. t df p 
Dlff. 
1L-2L 4.930000 1.586427 
3L-2L 4.494000 2.633710 5 0.436000 3.087026 0.315814 4 0.767936 




































Box & Whllker Plot 












Oltt. Std.Dv. t 
Olff. 
4.658000 2.862887 5 0.272000 1.862772 0.326508 
Box & Whllker Plot 
1t·2L \II. 1R·2R 9.---------__ ------__ r--------__ ------~------__, 


















Mean Std.Ov. N Oiff. Std.Ov. t 
Olff. 
4.494000 2.633710 
4.820000 1.371441 5 - 2.625163 -
0.326000 0.277681 
Box & Whisker Plot 







----- p Median 025%-75'111 




TREATMENT GROUP STATISTICS REPORT 
COMPARISON OF STIMULATED 45Ca2+ IN 6-OHDA LESIONED RATS 
DORSAL STRIA TUM 
DESCRIPTIVE ST ATISnCS 
Valid Mean Minimum Maximu~1 Std.Dev. Standard 
N Error 
1L 10 8.740000 5.43000 12.~()()()1 2.471841 0.781665 
2L 10 4.915000 2.47000 9.36000 2.039996 0.645103 
3L 10 9.496000 5.86000 16.10000 3.164119 1.000582 
1R 10 8.885000 5.06000 11.99000 2.612854 0.826257 
2R 10 4.984000 2.80000 7.24000 1.740174 0.550291 
3R 10 9.494000 5.96000 17.16000 3.505815 1.108636 
1L-2L 10 3.825000 -0.46000 7.00000 2.038198 0.644535 
3L-2L rf 4.581000 0.59000 7.27000 2.187243 0.691667 1R- 3.901000 -1.82000 8.40000 2.532923 0.800981 2R 
~ 























Std.Dv. N Diff. 
2.471841 
2.039996 10 13.825000 
3.164119 
























Mean Std.Dv. N Diff. 
1R 8.885000 2.612854 
2R 4.984000 1.740174 10 3.901000 
3R 9.494000 3.505815 
2R 4.984000 1.740174 10 4.510000 






























































Box& Whisker PI 01 














Box & Whllker Plot 
1R-2R VI. 3R·2R 
-,.-
--
































Box & Whisker Plot 
lL·2L vs. lR·2R 













Mean Std.Dv. N Diff. Std.Dv. t 
Diff. 
4.581000 2.187243 
4.510000 2.807288 10 0.071000 2.819214 0.079640 
Box & Whillker Plot 





















VENTRAL 6-OHDA LESIONED GROUP REPORT (WITHIN GROUP ANALYSIS) 
SPREADSHEET 
LESION 1L 2L 3L 1R 2R 
GROUP 
1 9.14 4.31 8.32 12.76 3.13 
1 .11.28 4.95 11.48 12.23 4.6 





010 1 7.91 4.34 8.49 7.5 3.08 5.55 
LESION 1L-2L 3L-2L 1R-2R 3R-2R 
GROUP 
M1 1 4.83 4.01 9.63 6.61 
01 1 6.33 6.53 7.63 8.8 
05 1 6.06 6.87 5.72 5.61 
010 1 3.57 4.15 4.42 2.47 
DESCRIPTIVE ANALYSIS 
Descriptive Statistics (Sheet1 in Imported from C:\Documents and 
Settings\Thabelo\My Documents\Neurosci\FINAL THESIS WRITE 
UP\RESUL TS\SPREADSHEETS\TREATMENT GROUP\NACC 60HDA ONLY 
JUNE.xls) 
ValidN Mean Minimum Maximum Std. Dev. Standard 
Error 
1L 4 9.68500 7.910000 11.28000 1.473918 0.736959 
2L 4 4.48750 4.310000 4.95000 0.308801 0.154401 
3L 4 9.87750 8.320000 11.48000 1.705020 0.852510 
1R 4 10.96500 7.500000 12.76000 2.379951 1.189975 
2R 4 4.11500 3.080000 5.65000 1.242699 0.621349 
3R 4 9.98750 5.550000 13.40000 3.317483 1.658741 
1L-2L 4 5.19750 3.570000 6.33000 1.266264 0.633132 
3L-2L 4 5.39000 4.010000 6.87000 1.520088 0.760044 
1R-2R 4 6.85000 4.420000 9.63000 2.274394 1.137197 











T-test for Dependent Samples (Sheet1 in Imported from C:\Documents and 
Settings\Thabelo\My Documents\Neurosci\FINAL THESIS WRITE 
UP\RESUL TS\SPREADSHEETS\TREATMENT GROUP\NACC 60HDA ONLY 
JUNE.xls) Marked differences are signifICant at p < .05000 
Mean Std.Dv. N Dlff. Std.Dv. t df 
Diff. 
9.68500 1.473918 
10.96500 12.379951 4 -1.28000 1.687503 -1.51703 3 
Mean Std.Dv. N Dlff. Std.Dv. t df ! 
Dlff. 
4.487500 0.308801 
4.115000 1.242699 4 0.372500 1.188483 0.626850 3 
Mean Std;Dv. N Dlff. Std.Dv. t df 
Diff. 
9.877500 1.705020 



















0.308801 4 5.197500 

















Mean Std.Ov. N Olff. Std.Ov. t 
Olff. 
9.877500 1.705020 
4.487500 0.308801 4 5.390000 1.520088 7.091696 
Box" Whllker Plot 













Mean Std.Ov. N Olff. Std.Dv. 
Olff. 
10.96500 2.379951 
00 1.242699 4 6.850000 2.274394 

















Mean Std.Dv. N Dlff. Std.Dv. t df P -
Dlff. 
3R 9.987500 3.317483 -
2R 4.115000 1.242699 4 5.872500 2.630594 4.464771 3 0.020928 
Box & Whlilker Plot 














Mean Std.Dv. N Dlff. Std.Dv. t df P 
Diff. 
1L-2L 5.197500 1.266264 




















Mean Std.Ov. N Oiff. Std.Ov. t 
Olff. 
0000 2.274394 
2500 2.630594 4 0.977500 1.869213 1.045895 
Box & Whllker PIal 


















6.850000 ., 4 - 2.209455 -1.49584 
Box & WllIlkar Plat 




































Box & Whisker Plot 















TREATMENT GROUP STATISTICS REPORT 
COMPARISON OF STIMULATED 45Ca2+ IN 6'()HDA LESIONED RATS vs SHAM 
LESIONED RATS 
DORSAL STRIATUM 







. [5.3-~ f----5.3~ . 6.3 
1-1.82 j3.31 
14.01 j3.08 








All Grps 9.38579 














All Grps '5.695789 







































1 2 Mln-Max 
LESION GROUP 
LESION 3L Means 3LN 3L Std.Dev. 3L Std.Err. 
GROUP 
1 9.496000 10 3.164119 1.000582 
2 9.687778 9 2.679514 0.893171 
All Grps 9.586842 19 2.864703 0.657208 













2 I Min-Max 
LESION GROUP 
LESION 1R Means 1RN 1R Std.Dev. 1R Std.Err. 
GROUP 
1 8.885000 10 2.612854 0.826257 
2 9.376667 9 2.911348 0.970449 
All Grps 9.117895 19 2.691506 0.617474 











2 I Min-Max 
LESION GROUP 
LESION 2RMeana 2RN 2RStd.Dev. 2RStd.Err. 
GROUP 
1 10 1.740174 0.550291 
2 9 1.880931 0.626977 
All Grps 19 1.816700 0.416780 














1 2 Mln,Max 
LESiON GROUP 
LESION 3RMeana 3RN 3R Std.Dev. 3R Std.Err. 
GROUP 
1 9.49400 10 3.505815 1.108636 
2 10.08667 9 3.368338 1.122779 
All Grps 9.77474 19 3.358621 0.770521 















LESION 1L-2L Means 1L-2L N 1L-2L 1L-2L 
GROUP Std.Dev. Std.Err. 
1 3.825000 10 2.038198 0.644535 
2 3.540000 9 1.984332 0.661444 
All Grps 3.690000 19 1.961768 0.450060 










·1 L-__ ~ ______ ~ ________ ~ ______ ~~----J 0 25%.75% 
1 2 I Mln-Max 
LESION GROUP 
LESION 3L-2L Means 3L-2L N 3L-2L 3L-2L 
GROUP Std.Dev. Std.Err. 
1 4.581000 10 2.187243 0.691667 
2 3.124444 9 1.707850 0.569283 
All Grps 3.891053 19 2.060741 0.472766 





o Median ·1 L-__ ~ ___ --, ______ -,-______ ",----J 0 25%.75% 
1 2 IM~ax 
LESION GROUP 
LESION 1R·2R 1R·2R N 1R·2R 1R·2R 
GROUP Means Std.Oev. Std.Err. 
1 3.901000 10 2.532923 0.800981 
2 3.491111 9 1.724634 0.574878 
All Grps 3.706842 19 2.138691 0.490649 












L-_-'--___ --'-____ ~ ___ __'_ _ ___J 0 25%-75% 
:r:. Min-M ax 
LESION GROUP 
LESION 3R·2R 3R·2R N 3R·2R 3R·2R 
GROUP Means Std.Oev. Std.Err. 
1 4.510000 10 2.807288 0.887742 
2 4.201111 9 2.776236 0.925412 
All Grps 4.363684 19 2.718656 0.623702 













1 2 I Min-Max 
LESION GROUP 
ANALYSIS OF VARIANCE 
SS Effect df MS Effect SS Error df MS F P 
Effect Error Error 
1L 8.80426 1 8.80426 116.6812 17 6.86360 1.282747 0.273111 
2L 12.87001 1 12.87001 64.5419 17 3.79658 3.389897 0.083117 
3L 0.17421 1 0.17421 147.5432 17 8.67901 0.020073 0.888998 
1R 1.14507 1 1.14507 129.2507 17 7.60298 0.150608 0.702772 
2R 3.85012 1 3.85012 55.5571 17 3.26806 1.178104 0.292895 
3R 1.66383 1 1.66383 201.3822 17 11.84601 0.140455 0.712463 
1L-2L 0.38475 1 0.38475 68.8889 17 4.05229 0.094946 0.761724 
3L-2L 10.04947 1 10.04947 66.3903 17 3.90531 2.573281 0.127098 
1R- 0.79583 1 0.79583 81.5362 17 4.79625 0.165928 0.688840 
2R 
3R- 0.45195 1 0.45195 132.5877 17 7.79928 0.057948 0.812648 
2R 
ANALYSIS OF UPTAKE IN VENTRAL STRIATUM OF TREATMENT GROUP 
BREAKDOWN STATISTICS 
lESION 1lN 1L Std.Dev. il Std.Err. 
GROUP 
1 4 1.473918 0.736959 
2 5 2.482251 1.110096 
All Grps 9 2.119729 0.706576 















UU~ 2LN 2LStd.Dev. 2L Std.Err. GROUP 
1 4.4875 4 0.308801 0.154401 
2 3.288000 5 1.316537 0.588773 
All Grps 3.821111 I 9 1.141079 0.380360 
C41t.g. 8Ql( I. Whisker Plot: 21. 
5.5 
5.'0 









2 :r: Mlri-Ma 
LESION GROUP 
LESION 3LMeans 3LN 3LStd.Dev. 3L Std.Err. 
GROUP 
1 9.877500 4 1.705020 0.852510 
2 7.782000 5 3.319446 1.484501 
All Grps 8.713333 9 2.796297 0.932099 
) 
















All Grps 9.28778 















All Grps 3.655556 














































































































LESION 3L-2L 3L-2L N 3L-2L 3L-2L 
GROUP Means Std.Dev. Std.Err. 
1 5.390000 4 1.520088 0.760044 
2 4.494000 5 2.633710 1.177831 
All Grps 4.892222 9 2.134882 0.711627 









'----~----~-1------~2--------~----' 0 25%-75% 
I Mln-Max 
LESION GROUP 
LESION 1R-2R 1R-2R 1R-2R 1R-2R 
GROUP Means N Std.Oev. Std.Err. 
1 6.850000 4 2.274394 
2 4.658000 5 2.862887 
All Grps 5.632222 9 2.715248 

































































10.67748 1 48.30308 








df MS Error F 
Error 
7 4.45194 1.074233 
7 1.03131 3.100271 
7 7.54231 1.293774 
7 10.60335 1.910165 
7 2.03623 0.746402 
7 8.37282 0.937563 
7 2.12533 0.074819 
7 4.95396 0.360123 
7 6.90044 1.547362 












DORsa-VENTRAL UPTAKE ANALYSIS 
ANALYSIS OF 1ST DORSAL SECllON VI 31m VENTRAL SECllON. 
The first dorsal s1riatum srlCe (1 L -2L and 1 R-2R) which was sectioned was the same slice 
1i'om which the 31d ventral s1riatum (3L -2L V and 3R-2RV) were dissected. 
6-OHDA LESIONED RATS 
SPREADSHEET 
Mean Std.Dv. 
1L-2L 2.662500 2.528891 
N o iff. Std.Dv. t df 
Diff. 
P 
3L-2LV 5.390000 1.520088 4 -2.72750 3.763592 -1.44941 3 0.243084 
Box & Whisker Plot 
1L·2L YS. 3L·2LV 
8 
7 




3 i c 
i 
I 2 I 
I i I ! 
I 
0 ._L .. c Median 
025'10-75'110 
·1 I Min·Max 
1L·21. 3L·2LV 
Mean Std.Ov. N Oiff. Std.Ov. t df t:J o iff. 
1R-2R 2.742500 3.137731 
3R-2RV 5.872500 2.630594 4 -3.13000 3.611546 -1.73333 3 0.181455 
Box & Whisker Plot 













-4 I Min-Max 
1R·2R 3R·2RV 
SHAM LESION ED RATS 
SPREADSHEET 
'[ .......... r····· .. ····· .... ········· .. ··········· .. ::·· .. ·· ........ ·f······· .. · .... · .. :: ........ · .. · .. 'r· .... ··· ........ :' .. · ............ ·~ .......... · .... · .. ·!·· ...... · .. ·····r .... · .... ·· .. ··· .. ·: 
; :!'NUCLEI GROUP~i1L-2L; 1L-2LVH3L-2LI'3L-2LVHiR-2Rj1R-2RV: 3R-2R:!3R-2RV:i 
........................................ : ............. : .............. :L .......... : ............... !! ........•..... ' .1 .... 1 .. :
·~·:ff·-----·-·-.... ·· .. ····<'·--··-··@-··· .. · .. -"'"",... .. -· f· .... _· .. _ ..·P_ ... _ .._ ............ _ .._. r .. · .......... ·: .. ··· .. · ...... · .. · .. ,! 
Mi0: 1 \i2.13 '3.2 H3.08· 3.16 H1.31 11.78 .1.46l2.37l 















Mean Std.Dv. N 
3.428000 1.890772 
i 4.494000 2.633710 5 








Box & Whisker Plot 






































1.0 L...---~--~~--~----,----'::r: Min-Max 
1 R·2R 3R·2RV 
t df P 
- 4 0.585351 
0.592561 
t df P 
- 4 0.032110 
3.22657 

